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!Abstract 
 
Neutrophil granulocytes are the first effector cells to be recruited to sites of infection. They 
rapidly release granule proteins and pro-inflammatory cytokines to efficiently kill intruding 
pathogens and recruit other immune cells. In exocytotic events, specific interactions of so-called 
soluble N-ethylmaleimide-sensitive-factor attachment receptor (SNARE) proteins lead to the 
formation of complexes in order to mediate membrane fusion. Because of the excessive release 
of neutrophil-derived mediators leading to the development of chronic inflammatory disorders, 
we aimed in the present scientific work to investigate in more details the regulatory processes 
of mediator release in neutrophils during inflammation, with emphasis on SNARE 
proteins. The main objectives were i) to characterize the release of pro-inflammatory 
mediators, ii) to profile SNARE expression, iii) to determine the functional role of SNAREs and 
SNARE complexes in cytokine release and degranulation, and iv) to identify the intracellular 
localization of SNAREs.  
 
To characterize the pro-inflammatory response in neutrophils in regard to exocytosis, extensive 
kinetic studies were performed in a first step on LPS-stimulated primary neutrophils. A novel 
linear fitting approach was created to correlate the relationship between granule proteins and 
cytokines secreted to the inflammatory site.  
In a second step, SNARE expression levels were determined by whole-transcript analysis and 
the similar profiles in primary neutrophils as well as DMSO-differentiated HL-60 cells (dHL-60 
cells), a neutrophil cell model, were underlined. Using an RNAi strategy, the SNARE syntaxin 3 
(STX3) was identified as an essential actor in the release of the cytokines IL-1α, IL-1β, IL-12b, 
and CCL4. It was also involved in MMP-9 exocytosis from gelatinase granules where it could 
partly be localized. The SNARE SNAP29, which shares common localization with STX3, 
functionally affects the release of IL-12b, CCL2 and IL-8 as well as MMP-9, and represents a 
potential candidate to form cognate complexes with STX3. The knockdown of VAMP3, another 
SNARE candidate, showed deregulated secretion of IL-12b, CCL4, IL-8 as well as MMP-9. 
However, VAMP3 was located at the plasma membrane and was thus excluded as being part of 
the STX3-SNAP29 complex.  
 
Our findings provide first evidence that SNARE fusion proteins are involved in the release of IL-
12b, IL-1α, IL-1β, CCL4, IL-8, and CCL2 in a neutrophil-like cell model. The impact of SNAREs 
on gelatinase degranulation led us to hypothesize that cytokines might be packaged in these 
granules before subsequent exocytosis.   
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I Generalities 
1. Inflammation and neutrophils 
Acute inflammation (latin inflammare = to set on fire) defines the necessary processes by which 
any tissue of the body responds rapidly to a local injury in order to protect from aggression or 
disease. Harmful stimuli that lead to tissue injury can be of very different nature: i) physical 
(mechanical trauma, thermal injury, radiation), ii) chemical (acids, bases, heavy metals, toxins), 
iii) infections (bacterial, fungal or viral), or iv) immunological reactions (hypersensitivity, allergic 
or autoimmune) (Merched, 2012).  
At the site of tissue injury, inflammatory processes are set in motion to neutralize the initiating 
stimulus, remove and repair damaged tissue (Medzhitov and Janeway, 1997). Inflammation can 
be characterized by four major cardinal signs that have been described by the Roman physician 
Cornelius Celsus (1st century A.D.): rubor et tumor cum calore et dolore. Redness (lat. rubor) 
and heat (lat. calor) of the inflamed tissue are observed due to an increased blood flow and cell 
accumulation in the vessel leading to localized hyperaemia. Swelling (lat. tumor) of the inflamed 
tissue is elicited by the vasodilatation of the blood vessels that increases vascular permeability 
thereby promoting leakage of humoral components (i.e. plasma-containing antibodies, 
complement components) (Cohnheim, 1873). Pain (lat. dolor) results from initial tissue damage 
or the release of inflammatory mediators that raises the sensitivity of pain receptors and might 
induce hypersensitivity (hyperalgesia). A fifth cardinal sign, proposed by the Greek Galen of 
Pergamon (2nd century A.D.), consists of functional disturbance (lat. functio laesa) that refers to 
loss of mobility in the joint, induced by swelling and pain of the inflamed tissue.  
Tissue contamination with pathogens results in the recruitment of high numbers of inflammatory 
cells to the infection site, including resident macrophages, which recognize pathogens and are 
able to release pro-inflammatory mediators with distinct properties. For example, the pyrogenic 
cytokines interleukin-1 (IL-1) and tumor necrosis factor (TNFα) mediate the expression of cell 
adhesion molecules by endothelial cells (Pober and Cotran, 1990) whereas interleukin-8 (IL-8) 
massively recruits leukocytes to the inflammatory site (Turk, 1994). Among these cells, 
neutrophils represent 40 to 70% of all peripheral blood leukocytes (Nathan, 2006) and are the 
most prominent leukocytes recruited rapidly towards sites of acute infection (Williams and 
Hellewell, 1992). Also known as polymorphonuclear (PMN) leukocytes, they are involved in the 
early recognition of invading pathogens (viruses, fungi, bacteria, protozoa) and represent the 
first line of innate immune defense (Nathan, 2006).  
INTRODUCTION                                     II Origin and development of neutrophils  
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II Origin and development of neutrophils 
In order to ensure immediate mobilization for the acute response to pathogen exposure, 
neutrophils circulate as dormant/resting cells in the blood stream or are present in marginating 
pools in the tissues (Cascao et al., 2009; Borregaard, 2010). Under steady-state conditions, 
neutrophils have a short half-life of only 6 to 10 hours in the blood, and a survival rate of one to 
two days in the marginating tissue pools due to their rapid clearance by constitutive apoptosis 
(Mollinedo, 2003; Tsukahara et al., 2003). Therefore, neutrophils are constantly generated in 
the bone marrow from multi-potent hematopoietic stem cells and progenitor cells. Each day, the 
production of more than 1011 neutrophils is regulated by colony-stimulating factors, such as     
G-CSF and GM-CSF (Anderlini et al., 1996). In case of acute inflammation, this production rate 
is increased to more than 1012 neutrophils per day (Williams and Hellewell, 1992). 
 
1. Granulopoiesis 
The stages of neutrophil maturation during granulopoiesis are associated to morphological 
alterations and notably to the sequential formation of differential granule subsets (Cascao et al., 
2009). Several morphological stages of cell maturation can be distinguished: myeloblast, 
promyelocyte, myelocyte, metamyelocyte, non-segmented band cell and segmented 
neutrophils, which are terminally differentiated and display a multi-lobed chromatin-dense 
nucleus (Figure 1).  
 
 
Figure 1 Morphological stages of neutrophil maturation in the bone marrow (Mollinedo, 2003; modified): Myeloblast, 
promyelocyte, myelocyte, metamyelocytes, band cell, and mature polymorphonuclear (PMN) leukocyte. Approximate 
cell size and relative percentage of each maturation stage relative to the total population in the bone marrow are 
given. Neutrophils, derived from hematopoietic stem cells in the bone marrow, spend about 7.5 days in the mitotic 
pool, and 6.5 days in the post-mitotic pool.  
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The initiation of granule synthesis is a hallmark of the transition between myeloblast to 
promyelocyte. In the early promyelocytic stage, immature transport vesicles arise from the Golgi 
apparatus and fuse together (Hartmann et al., 1995). Both myeloblasts and promyelocytes stain 
positive for peroxidase meaning that azurophil (primary) granules are formed at these stages 
(Borregaard et al., 1995b). The synthesis of specific (secondary) granules, originally identified 
as peroxidase-negative granules, is initiated at the stages myelocyte and metamyelocyte 
(Bainton et al., 1971). Gelatinase (tertiary) granules are formed in band cells and segmented 
mature neutrophils (Kjeldsen et al., 1992; Borregaard, 1997; Faurschou and Borregaard, 2003). 
In the very late stages of neutrophil development, secretory vesicles (quaternary granules) are 
formed by endocytosis (Karlsson and Dahlgren, 2002) and contain plasma proteins, such as 
albumin (Faurschou and Borregaard, 2003). 
 
In a time frame of about two weeks, over 300 antimicrobial and proteolytic proteins are 
distributed in a hierarchical order within four types of neutrophil granules. According to the 
targeting-by-timing hypothesis, the proteins synthesized during neutrophil development are 
attributed to the different granule types in a strictly time-dependent manner (Le Cabec et al., 
1996; Arnljots et al., 1998). The resulting structural and functional heterogeneity of the granules 
derives from differential gene expression, highly regulated by the combination of myeloid 
transcription factors present at define stages of cell development (Egesten et al., 1994; 
Borregaard et al., 1995a; Borregaard, 1997). Representing up to 15% of the cell volume, 
neutrophil granules have traditionally been classified as peroxidase-positive and peroxidase-
negative on the basis of their myeloperoxidase (MPO) content (Bainton and Farquhar, 1968). 
Later on, they were divided into three subsets: granules that contain lactoferrin (LTF) but no 
gelatinase (MMP-9) (15%), granules that contain LTF and MMP-9 (60%), and granules that 
contain MMP-9 but no LTF (25% of peroxidase-negative granules) (Arnljots et al., 1998). Many 
granule proteins are not solely found in one single granule type, thereby showing that neutrophil 
granules rather represent a continuum than strictly separate granule types (Rorvig et al., 2013).  
 
Mature neutrophils are displaced from the bone marrow into the blood circulation as fully 
functionally active cells with a pool of granules rapidly mobilizable upon appropriate stimulation 
(Klingauf and Neher, 1997).  
 
!  
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III Neutrophil recruitment  
As a consequence of tissue injury, tissue-resident macrophages release pyrogenic cytokines, 
which act on the endothelial cell wall and also on the circulating neutrophils in the blood stream. 
On one side, endothelial cells are activated and upregulate the expression of selectin adhesion 
molecules. On the other side, circulating neutrophils experience “priming”, a mechanism by 
which resting cells undergo the initial shape change and polarization necessary for migration to 
the site of inflammation (Coffer and Koenderman, 1997). Neutrophils are recruited along a 
gradient of soluble factors, i.e. bacterial agonists (e.g. formyl-methionyl-leucyl phenylalanine 
(fMLF)) or inflammatory mediators (e.g. complement component 5a (C5a), platelet-activating 
factor (PAF), IL-8, or leukotriene B4), all leading to chemotaxis of the neutrophils towards the 
site of tissue injury (Muller et al., 2002; Ley et al., 2007; Scheiermann et al., 2012).  
During recruitment to the inflammatory site, neutrophils go through multiple steps involving           
i) rolling, ii) activation and adherence to endothelium, and iii) diapedesis through the vascular 
barrier. The rolling phase is mainly mediated by low-affinity interactions between L-selectin and 
sialyl-Lewis X on neutrophils, and P- and E-selectin on inflamed endothelial cells. The integrin 
LFA-1 is the principal adhesion molecule on neutrophils that mediates transition from rolling to 
adhesion on the endothelial cell surface (Phillipson et al., 2006). Firm adhesion of the leukocyte 
to the vessel wall is mediated via the β2-integrin family, and intercellular adhesion molecule 
(ICAM) 1 and vascular cell adhesion molecule (VCAM) 1 expressed by endothelial cells 
(Phillipson et al., 2006; Cascao et al., 2009). To exit the vascular system, neutrophils cross the 
inflamed vascular barrier with increased permeability via diapedesis (Beutler, 2004). This can 
occur through paracellular transmigration at endothelial junctions or transcytosis at non-
junctional locations.  
 
 
!  
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IV Neutrophil-mediated defense during inflammation 
1. Innate defense mechanisms 
Once arrived at the inflammatory site, neutrophils are exposed to higher concentrations of the 
soluble agonists and subsequently undergo different steps of activation. To protect hosts from 
invading pathogens, activated neutrophils ensure an efficient killing of a broad range of infecting 
microorganisms by concomitantly activated processes originally classified into oxidative and 
enzymatic (non-oxidative) processes (Smith, 1994) (Figure 2).  
 
!
Figure 2 Innate1 immune defense mechanisms mediated by neutrophils. Upon tissue injury, neutrophils are recruited 
to the inflammatory site via series of interactions with the endothelial cell wall along a gradient of chemoattractants. 
Once arrived at the “combat field”, neutrophils become activated and execute different functions in order to protect 
the host against pathogens (1-3). Eventually, neutrophils commit apoptosis and are phagocytosed by macrophages 
for subsequent resolution of inflammation (4). Abbreviations: az. gr., azurophil granules; DC, dendritic cells; gel. gr., 
gelatinase granules; ICAM-1, intercellular adhesion molecule 1; LFA-1, leukocyte function-associated molecule 1; 
PMN, polymorphonuclear leukocyte; spec. gr., specific granules (Theilgaard-Monch et al., 2006). 
 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
1!Elie Metchnikoff (Nobel Prize in Physiology or Medicine, 1908) discovered that inflammation is a protective process 
of immunity, a host-mediated defense mechanism. He proved the existence of phagocytes while he was studying 
starfish larvae. 
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 Phagocytosis 1.1
Neutrophils are known to be professional phagocytes that recognize pathogens, immune 
complexes and other particles, either directly or indirectly via soluble molecules. Direct 
recognition occurs mainly through pattern receptors (e.g. CD14, toll-like receptors) while indirect 
recognition can be mediated by Fc (fragment crystallizable) or complement receptors binding to 
IgG coated- or iC3b-opsonized particles (Underhill and Ozinsky, 2002; Jutras and Desjardins, 
2005). By binding to the pathogen via surface receptors, actin filaments are polymerized in 
neutrophils. This leads to changes in the cytoskeleton structure and enables neutrophils to 
entirely engulf pathogens, as well as apoptotic cells (Greenberg and Grinstein, 2002). Upon 
formation of phagosomes, fusion occurs with lysosomes that lead to the acidification of the 
maturating phagolysosomes. Then, the intracellular fusion of granules with phagolysosomes 
leads to the release of antimicrobial enzymes upon which encapsulated pathogens are 
proteolytically digested (Pitt et al., 1992; Desjardins et al., 1997; Jahraus et al., 1998; 
Greenberg and Grinstein, 2002; Jutras and Desjardins, 2005). The lowering of the pH to 4-5 
inside the phagolysosome allows enzymes such as cathepsins to be highly active. 
 
 Production of reactive oxygen species 1.2
The process of phagocytosis is directly associated to the generation of reactive oxygen species 
(ROS) by activation of the NADPH oxidase (NOX2) situated at the phagosomal membrane 
(Bass et al., 1987; DeLeo et al., 1998). Originally described by Rossi et al. in 1972, NOX2 is a 
multicomponent enzyme that consists of the membrane-bound proteins gp91phox (cytochrome 
b558) and p22phox, as well as the cytosolic subunits p40phox, p47phox, and p67phox (Borregaard and 
Tauber, 1984) and the GTP-bound form of Rac (Bokoch and Diebold, 2002). Upon cell 
activation, phosphorylated cytosolic components are recruited to the membrane and Rac 
exchanges GDP for GTP, thus leading to the complex assembly of NOX2 (Segal et al., 1980). 
NOX2 oxidizes NADPH and reduces O2 to generate the superoxide radical (O2•−), a substrate 
for the production of hydrogen peroxide (H2O2) inside the phagosome (Babior et al., 1973).  
H2O2 in combination with chloride ions (Cl-) in the presence of MPO results in the formation of 
hypochlorous acid (HOCl). HOCl acts as a potent microbicial agent that ruptures the cell wall of 
ingested bacteria (Winterbourn et al., 1985;!Smith, 1994; Dale et al., 2008; Klebanoff et al., 
2013). The transport of Cl- into the phagosome is highly dependent on the recruitment of the 
cystic fibrosis transmembrane conductance regulator (CFTR) into the phagosomal membrane. 
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Moreover, fusion of azurophil granules with the phagosome provides the enzyme MPO, which in 
its turn catalyzes the reaction between H2O2 and Cl-, and yields generation of HOCl.  
NOX2 can also be situated at the plasma membrane and thus release ROS into the 
inflammatory tissue environment. By this mechanism, ROS act as essential signaling molecules 
to mediate amplification of the pro-inflammatory immune response (Finkel, 1998). However, 
excessively released ROS can also affect healthy surrounding tissue and thus, contribute to 
neutrophil-mediated tissue injury. 
 
 Degranulation 1.3
The ability of leukocytes to generate and secrete proteins that have destructive activity has 
been known since the 1860s (Segal, 2005; Wallach et al., 2014). Besides the intracellular fusion 
of granules with the phagolysosome, mentioned above, neutrophils release the different types of 
granules also to the extracellular environment. Under pro-inflammatory conditions, granule 
contents are released in a reversed chronological order compared to their synthesis according 
to the formed-first-released-last model (Sengelov et al., 1993; Borregaard, 1997; Pellme et al., 
2006). The rate and extent of secretion of each type of granules are remarkably different and 
vary depending on the activation stimulus (Kjeldsen et al., 1994). While exocytosis of secretory 
vesicles can occur within minutes, the release of azurophil and specific granules requires longer 
time periods. In 1993, Sengeløv et al. have shown that different types of granules are mobilized 
to the plasma membrane by different Ca2+ requirements for secretion (Sengelov et al., 1993). 
The induced increase in cytosolic Ca2+ levels, known as “calcium transient”, that induce half-
maximal marker release (half maximal effective concentration, EC50) of the granules are:       
140 nM for secretory vesicles, 250 nM for gelatinase granules, 550 nM for specific granules, 
and 680 nM for azurophil granules. Remarkably, a higher threshold for exocytosis of gelatinase 
granules is needed than for secretory vesicles (Kjeldsen et al., 1992;  Kjeldsen et al., 1993). 
Also, a higher threshold for specific degranulation is needed than for gelatinase degranulation, 
and azurophil granules can only be mobilized partially (Sengelov et al., 1993; Nusse et al., 
1998; Faurschou et al., 2002).  
 
The different granule types are time-dependently involved in the different stages of neutrophil 
recruitment and mechanisms of bacterial killing. Secretory vesicles are the most easily 
mobilized granules (Kobayashi and Robinson, 1991) and are mobilized when neutrophils 
adhere to the activated endothelial wall (Sengelov et al., 1993; Sengelov et al., 1994; Sengelov 
et al., 1995). Gelatinase granules facilitate the adhesion of neutrophils to the endothelial wall 
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and their migration through basement membranes (Mollinedo et al., 1991; Kjeldsen et al., 1993; 
Delclaux et al., 1996). Specific and azurophil granules are necessary for the neutrophil to 
migrate through tissue (Sengelov et al., 1995) and participate in the antimicrobial activities of 
neutrophils at the site of inflammation (Figure 3). 
The extracellular release of granule proteins is not only limited to help the neutrophil in its own 
functions but have recently been discovered to modulate also the recruitment of other immune 
cells to the inflammatory site, notably monocytes (Soehnlein et al., 2009).  
 
!
Figure 3 Neutrophil granules (Gullberg et al., 1999). The four types of cytoplasmic granules display structural and 
functional heterogeneity. They differ in density, size and cargo protein content, as well as in the ease of mobilization 
to the extracellular milieu. Also, distinct functions are associated with the granule content.  
 
1.3.1 Downstream signaling to granule mobilization 
Several kinases have been identified to be crucial for the exocytosis of neutrophil granules. 
First, ERK and p38 MAPK proteins are rapidly phosphorylated and activated upon cell 
stimulation (Grinstein and Furuya, 1992; Torres et al., 1993; Thompson et al., 1993; Krump et 
al., 1997; Nick et al., 1997; Meshki et al., 2004). Second, the spleen tyrosine kinase (Syk) is 
activated (Yan et al., 1997). Third, the three Src family members expressed in neutrophils, Hck, 
Fgr, and Lyn, are activated by fMLF receptor stimulation. Interestingly, different granule 
populations appear to be associated with different Src kinases. Following cell activation, Hck 
translocates to the azurophil granule population (Mohn et al., 1995) whereas Fgr becomes 
associated with specific granules (Gutkind and Robbins, 1989). The selective recruitment of Src 
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kinases indicates that different signaling pathways exist in neutrophils that induce the release of 
each granule population (Lacy, 2006). Rho proteins represent the link to the actin cytoskeleton 
(Ridley, 2001) in the exocytosis for secretory vesicles, gelatinase granules, and specific 
granules (Jog et al., 2007). Ral guanine triphosphatase (GTPase) controls specific granule 
release (Chen et al., 2011), and the phosphatidylinositol 3-kinase (PI3K)-induced Rho GTPase 
Rac2 is essential in the regulation of azurophil degranulation (Abdel-Latif et al., 2004; Mitchell et 
al., 2008).  
 
1.3.2 Neutrophil granule subsets 
1.3.2.1 Secretory vesicles 
Secretory vesicles mainly represent a pool of various membrane-associated receptors, such as 
CD13 (aminopeptidase N,! Kanayama et al., 1995), CD14 (glycoprotein), CD16 (FcγRIII 
receptor, Ravetch and Perussia, 1989), CD18 (β2 integrin, Walzog et al., 1994), complement 
receptor 1 (CR1, CD35, Sengelov et al., 1994; Kumar et al., 1997), CD45 (leukocyte tyrosine 
kinase) and fMLF receptor (Borregaard et al., 1987). Therefore, the mobilization of secretory 
vesicles to the plasma membrane prepares the neutrophil for outside-in signaling and renders it 
highly responsive to its environment.  
A characteristic protein carried by secretory vesicles is alkaline phosphatase, a 
phosphatidylinositol-linked membrane glycoprotein that is shown to inactivate bacterial 
lipopolysaccharide (Bentala et al., 2002;!Koyama et al., 2002). Due to the presence of alkaline 
phosphatase in secretory vesicles, these granules are also known as “phosphasomes”. Plasma 
proteins such as albumin and tetranectin (Nielsen et al., 1997) are also characteristic for 
secretory vesicles that are formed by endocytosis (Karlsson and Dahlgren, 2002). 
 
1.3.2.2 Gelatinase granules 
Gelatinase granules contain a glycoprotein member of the integrin family, CD11b that is the  
185 kDa α-chain of the macrophage receptor 1 (Mac-1). The 95 kDa β-chain belongs to CD18 
that interacts with ICAM and VCAM for the adhesion of the leukocyte to the vascular wall. The 
CD11b/CD18 complex (CR3, Gahmberg, 1997) resides in two different subcellular pools, similar 
to CR1 (Sengelov et al., 1994). Gelatinase granules were originally detected by the presence of 
MMP-9 (Kjeldsen et al., 1993; Kjeldsen et al., 1994). MMP-9, also known as gelatinase B, is a 
zinc-containing endopeptidase, and member of the Metzincin family. Stored as a latent inactive 
protein, it is activated by oxidants and proteases (Witko-Sarsat and Descamps-Latscha, 1994). 
Its major role consists of modifying or degrading the extracellular matrix and basement 
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membranes but leads also to specific processing and release of cytokines, i.e. IL-1β, TNFα, IL-8 
(Vaday et al., 2001). 
 
1.3.2.3 Specific granules 
About 4600 specific granules per cell (Nusse and Lindau, 1988) represent the main reservoir of 
the catalytic subunit of NOX2, cytochrome b558 (Karlsson and Dahlgren, 2002). By fusion of 
specific granules with the forming phagosomes, cytochrome b558 is assembled with cytosolic 
subunits resulting in an active NOX2 and production of ROS in the phagolysosome (Borregaard 
and Cowland, 1997). Specific granules express CD66b (CEACAM8, NCA-95, CD67) (Ducker 
and Skubitz, 1992; Beauchemin et al., 1999) as well as CD15 (3-fucosyl-N-acetyl-lactosamine, 
Nakayama et al., 2001).  
Characteristic proteins carried by specific granules are binding proteins, proteolytic enzymes, 
and serine proteases. Collagenase facilitates the neutrophil’s migration steps by cleaving 
collagen into two distinct and specific peptide fragments. LTF and lipocalin-2 both interfere with 
the iron metabolism of bacteria by binding iron directly or analog proteins of bacteria 
(siderophores) (Caccavo et al., 2002;!Farnaud and Evans, 2003). While lysozyme leads to the 
destruction of the bacterial cell envelope components, cathelicidin (LL-37 peptide) (Sorensen et 
al., 2001; Wang et al., 2004) inhibits the bacterial growth at micromolar concentrations (Turner 
et al., 1998).  
 
1.3.2.4 Azurophil granules 
Azurophil granules, also known as peroxidase-positive granules, have a mean diameter of       
260 nm (Borregaard et al., 1995a). Each human neutrophil contains about 1300 azurophil 
granules (Nusse and Lindau, 1988), that are called to be the cell-type specific secretory 
lysosomes representing both, a degradative and secretory compartment (Nusse and Lindau, 
1988; Lollike et al., 2002; Blott and Griffiths, 2002). In this type of granules, CD63 was first 
identified as granulophysin and is one of the major lysosomal membrane proteins and member 
of the tetraspanin superfamily (Horejsi and Vlcek, 1991; Kuijpers et al., 1991; Niessen and 
Verhoeven, 1992; Cham et al., 1994; Abdel-Latif et al., 2004). CD63 signaling triggers a 
transient activation signal that requires extracellular Ca2+ and regulates adhesive activity and 
surface expression of Mac-1 (Kuijpers et al., 1991; Berditchevski et al., 1997).  
The protein characteristic for this granule type is MPO (Arnljots et al., 1998). Accounting for 5% 
of the dry weight of the neutrophil (Segal, 2005), MPO is a heme containing glycoprotein 
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(Klebanoff, 1967; Lubbert and Koeffler, 1988) and ligand for Mac-1 (Borregaard and Cowland, 
1997).  
Azurophil granules contain various proteolytic and saccharolytic enzymes (Smith, 1994), all of 
which 30 to 50% are defensins (Ganz, 1987). Defensins are cationic arginine-rich granule 
peptides that can elicit the destruction of cell envelope components of bacteria (Ganz, 2003). 
For example, human β-defensin-2 can aggregate to generate “channel-like” pores leading to 
disruption of membrane integrity and function, and ultimately causing the lysis of pathogens 
(Hoover et al., 2000; Sahl et al., 2005). Serine proteases such as elastase, cathepsin G and 
proteinase 3 are implicated in antimicrobial defense by degrading engulfed microorganisms 
inside the phagolysosomes of neutrophils (Belaaouaj et al., 1998; Belaaouaj et al., 2000; 
Reeves et al., 2002; Weinrauch et al., 2002; Segal, 2005), and the proteolytic modulation of 
cytokines (Wessels et al., 2010). 
 
 Neutrophil extracellular traps 1.4
Over the last years, a new form of cell death different from apoptosis and necrosis has been 
discovered in neutrophils. Under the last action in a neutrophil’s life, so-called NETosis, 
neutrophil extracellular traps (NETs) with granule and cytosolic proteins are released by the cell 
in order to sequester bacteria (Brinkmann et al., 2004). These NETs represent chromatin fibers 
that are decondensed in association with citrullination of the core histones by conversions of 
histone arginine to citrulline residues by peptidylarginine deiminase 4 (Neeli et al., 2008; Wang 
et al., 2009). The main components of NETs are the core histones H2A, H2B, H3, and H4, 
which together account for about 70% of the protein mass (Urban et al., 2009). To enable 
granule and cytoplasmic proteins to mix with the chromatin, pores are formed in the nuclear 
membrane and secretory vesicle walls. About 24 neutrophil proteins have been associated with 
NETs (Urban et al., 2009). Among them were S100A8/A9 (MRP8/MRP14) proteins representing 
40% of neutrophil cytosolic proteins and are thus the most prominent NET components (Murthy 
et al., 1993). Also cationic DNA-binding proteins (histones, defensins, elastase, proteinase 3, 
heparin-binding protein, cathepsin G, lactoferrin, MPO) were found to be associated with NETs. 
Elastase released from azurophil granules degrades histones and synergizes with MPO to drive 
chromatin decondensation essential for NET formation (Papayannopoulos et al., 2010). The fact 
that granule proteins are released with the NETs might hinder proteases from diffusing and 
inducing damage to healthy tissue adjacent to the inflammatory environment. In this sense, 
NETs could serve as physical barrier that limits the spread of the pathogens.!  
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2. Neutrophils as link between innate and adaptive immunity 
Traditionally, neutrophils have solely been considered as storage for preformed antimicrobial 
peptides and proteolytic enzymes for direct killing of pathogens. For many decades, monocytes 
and macrophages have been assumed to be the most important sources of cytokines that are 
classified into interleukins, colony-stimulating factors, interferons, tumor necrosis factors, growth 
factors, and chemokines. 
 
!
Figure 4 Activated neutrophils communicate with various innate and adaptive immune cells through cytokine 
secretion (Wright et al., 2014). Abbreviations: MHC, major histocompatibility complex; DC, dendritic cell; NK natural 
killer.  
 
However, in the last decade, de novo expression of proteins has been detected in neutrophils 
(Theilgaard-Monch et al., 2006). Often underestimated, neutrophils are now also recognized as 
an important source of cytokines2 since they are the first effector cells vastly recruited to the 
inflammatory site that are able to communicate effectively with other immune cells  (Detmers et 
al., 1990; Xing et al., 1994; Scapini et al., 2000; Denkers et al., 2003). The inducible production 
of cytokines by neutrophils is usually preceded by, and largely dependent on a previous 
accumulation of the corresponding mRNA transcripts (Bazzoni et al., 1991). Although 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
2! !At the beginning of the 20th century, Henry Dale was the first to describe that cells are able to secrete soluble 
messengers that drive and coordinate inflammation via activation of cell surface receptors. At the inflammatory site, 
multiple cellular sources are releasing mediators in order to communicate with multiple targets and exerting multiple 
functions (Gabay and Kushner, 1999).!
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neutrophils have low transcriptional activity, data have pointed out that cytokine expression can 
be regulated at the level of mRNA stability in addition to a post-transcriptional mechanism of 
regulation. The secretion of these soluble messengers that drive and coordinate the onset and 
resolution of inflammatory processes in a time-regulated and sequential manner provide the 
neutrophils with the essential ability to modulate and amplify innate as well as adaptive3 immune 
responses (Nathan, 2006; Soehnlein et al., 2008) (Figure 4).  
 
 Neutrophil pro-inflammatory cytokine response 2.1
The capacity of neutrophils to produce cytokines has primarily been limited to IL-8 due to its 
constitutive release (Altstaedt et al., 1996). Upon treatment with diverse agonists, also other 
pro-inflammatory cytokines have been detected in neutrophil supernatants. In previous reports, 
neutrophils have been described to produce pro-inflammatory cytokines, i.e. CXC chemokines 
(e.g. CXCL1-6), CC chemokines (e.g. CCL2, CCL3, CCL4), pro-inflammatory cytokines (e.g.           
IL-1α, IL-1β, IL-6), as well as immunoregulatory cytokines (e.g. IL-12) (Mantovani et al., 2011). 
However, to date, the production of several neutrophil-derived cytokines, i.e. IL-6 and CCL2, 
has been subject to controversy due to the constantly raised question of neutrophil purity in 
primary cell preparations (Tamassia et al., 2014). 
 
2.1.1 Downstream signaling to cytokine production 
The neutrophil-derived cytokines, mentioned above, are all under the control of the gene 
activator nuclear factor kappa-light-chain-enhancer of activated B cells, NF-κB, which is at the 
end of a signaling pathway, amongst other agonists mainly induced by bacterial 
lipopolysaccharide (LPS). Being a major structural component of the outer membrane of gram-
negative microbes, LPS is known to be an endotoxin to induce inflammation that may result in 
endotoxic shock  (Rietschel and Brade, 1992). Pfeiffer et al. first reported the principal biological 
effects of bacterial endotoxin (Pfeiffer et al., 1996). A simplified overview of LPS-induced 
signaling pathways is illustrated in Figure 5.  
Upon host infection, LPS molecules have been described to bind to LPS-binding proteins (LBP) 
in plasma. The resulting LPS-LBP complex interacts with the glycoprotein CD14 on the cell 
membrane to form a ternary complex (Couturier et al., 1991; Troelstra et al., 1997; Troelstra et 
al., 1999). Exceptionally, binding of LPS to CD14 might not be LBP-dependent with higher LPS 
concentrations of 100 ng/mL (Troelstra et al., 1997). In this case, LBP seems not to be essential 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
3!Paul Ehrlich (Nobel Prize in Physiology or Medicine, 1908) discovered that adaptive immunity detects molecular 
components (antigens) that are specific to individual pathogens and thus, distinguishes between self from non-self.  
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for LPS-mediated activation but rather to accelerate the downstream signaling (Tsukamoto et 
al., 2010). The ternary LPS-LBP-CD14 complex transfers LPS to another non-anchored protein, 
myeloid differentiation factor-2 (MD-2), which in turn associates with the pattern recognition 
receptors (PRR) called toll4 -like receptor 4 (TLR4) (Poltorak et al., 1998). Docking of LPS to the 
TLR4 complex leads to receptor dimerisation and recruitment of adaptor proteins MyD88-
adapter like (Mal) and myeloid differentiation primary response gene 88 (MyD88) via 
interactions with toll/interleukin-1 receptor (TIR) domains (Akashi et al., 2003).  
The MyD88-dependent pathway leads to the activation of the IL-1 receptor associated kinase 
(IRAK) 4 and subsequently to IRAK1, guiding to the activation and ubiquitinylation of TNF 
receptor associated factor 6 (TRAF6) (Li et al., 2002). Ubiquitinated TRAF6 in turn activates the 
transcription factor interferon regulatory factor (IRF) 5, and also interacts with the TAK-binding 
protein (TAB) 1, 2, and 3 complex, which in turn activates transforming growth factor-β-activated 
kinase 1 (TAK1). TAK1 activates inhibitor of κB (IκB) kinases (IKKs), which phosphorylate IκBs. 
The IKK complex containing either IKKα or IKKβ kinase phosphorylates IκBα or IκBβ when 
activated by protein kinase B (Akt), receptor interacting protein (RIP) or other upstream kinases. 
Hence, phosphorylated IκBs are degraded by the ubiquitin-proteosome and the free NF-κB 
translocates to the nucleus (McDonald et al., 1997). The transcription factor NF-κB traditionally 
refers to the ubiquitous, constitutive and inducible heterodimer p50/p65, which is an anti-
apoptotic gene regulator. Regulated by phosphorylation and acetylation, the p65 (RelA) subunit 
provides gene activator activity for a wide variety of genes in the nucleus, most prominently 
genes of inflammatory cytokines (McDonald et al., 1997; Beutler et al., 2001; Caroff et al., 2002; 
Pasare and Medzhitov, 2005). Phosphorylated p65 promotes interaction with the DNA, while 
acetylated p65 determines strength and duration of gene activation. After gene activation, p65 
eventually releases the DNA and binds to newly synthesized IκBα. The IκBα: NF-κB (p50/p65) 
complex translocates back to the cytoplasm. 
Activation of gene expression can also derive from mitogen-activated protein kinase (MAPK) 
signaling pathways induced by LPS (Nick et al., 1999; Fessler et al., 2002; Ear et al., 2005; 
Cloutier et al., 2009; Fortin et al., 2011). In this part of the pathway, TAK1 generally activates 
also p38 (Nick et al., 1999), c-jun N-terminal kinase (JNK) and extracellular signal-regulated 
kinase (ERK). In neutrophils, JNK is overwhelmingly cytoplasmic and does not translocate to 
the nucleus (Cloutier et al., 2003), with the exception of adherent neutophils in which JNK can 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
4!The toll gene has originally been identified as being essential for dorsal-ventral polarity in embryonic development 
in Drosophila monocytogenes. The discovery of toll receptor-deficiency in adult Drosophila leading to the 
development of fungal infections has been awarded with the Nobel Prize in Physiology or Medicine 2011 to Bruce A. 
Beutler and Jules A. Hoffmann (Lemaitre et al., 1996). 
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be moderately activated (Avdi et al., 2001; Cloutier et al., 2003). MAP kinases mediate the 
activation of transcription factor AP-1. Another transcription factor, IRF5, associates with MyD88 
and TRAF6, becomes activated and translocates into the nucleus. AP-1, NF-κB and IRF5 all 
lead to the activation of inflammatory cytokine gene synthesis. 
 
!
Figure 5 Simplified view of the LPS-induced TLR4 signaling pathways (Casella and Mitchell, 2008, modified). Only 
MyD88-dependent signaling is depicted, since MyD88-independent signaling has been shown not to be mobilized in 
neutrophils (Tamassia et al., 2007). The transcription factors AP-1, NF-κB and IRF-5 together stimulate production of 
inflammatory cytokines. 
!
2.1.2 Neutrophil-derived cytokine response 
2.1.2.1 Interleukin-8 
The CXC chemokine IL-8 is known to be the major chemoattractant for neutrophils (Oppenheim 
et al., 1991; Bazzoni et al., 1991; Cassatella et al., 1992; Baggiolini and Clark-Lewis, 1992; 
Takahashi et al., 1993; Baggiolini et al., 1994). Also, IL-8 accumulates and activates monocytes, 
macrophages and lymphocytes.  
As a member of the CXC chemokine α-subfamily, IL-8 possesses a glutamic acid-leucine-
arginine (ELR) motif preceding the first two cysteines (Scapini et al., 2000). In neutrophils, the 
constitutive expression of IL-8 as a 99 amino acid precursor results from regulated 
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transcriptional (e.g. CCAAT-enhancer-binding protein β (C/EBPβ), Cloutier et al., 2009), and/or 
post-transcriptional steps (Scapini et al., 2000). On the post-translational level, it undergoes 
processing by neutrophil elastase, cathepsin G and proteinase-3 (Padrines et al., 1994). After 
proteolytic cleavage, it can exist in two different isoforms and is secreted into the extracellular 
milieu either from intracellular storage upon CD66b crosslinking, or de novo production (Strieter 
et al., 1992; Baggiolini and Clark-Lewis, 1992; Padrines et al., 1994; Baggiolini et al., 1995). IL-8 
secretion occurs by the standard canonical pathway (Figure 6A) in two phases: an early one (20 
to 30% of the total IL-8), directly induced by LPS itself and that can be inhibited by interferon-
gamma (IFNγ), and a late, prolonged one, due to LPS-stimulated release of endogenous 
mediators, including TNFα and IL-1β (Cassatella et al., 1993).  
 
2.1.2.2 Interleukin-12 
Interleukin-12 (IL-12) was identified as a heterodimeric glycosylated protein consisting of two 
subunits, a 40 kDa heavy chain (p40) and a 35 kDa light chain (p35). While p40 is homologous 
to the extracellular domains of members of the hematopoietic cytokine-receptor family, p35 is 
rate-limiting for the generation of the bioactive heterodimeric form of IL-12 (p70) (Carra et al., 
2000). Both genes need to be expressed and processed by cleavage in a coordinated fashion 
by the same cell in order to produce biologically active IL-12 (Carra et al., 2000; Trinchieri et al., 
2003). The dimerization of p35 and p40 takes place in the endoplasmic reticulum (ER) (Carra et 
al., 2000; Murphy et al., 2000) and secretion occurs via the classical or canonical pathway 
(Duitman et al., 2011) (Figure 6B). In this pathway, proteins are translocated across the ER 
through the Golgi apparatus to the plasma membrane, either directly or indirectly through 
primary lysosomes or secretory granules (Stanley and Lacy, 2010). While the production and 
secretion of IL-12 in murine neutrophils has been proven in several studies (Romani et al., 
1997; Bliss et al., 1999; Petrofsky and Bermudez, 1999), the ability of human neutrophils to 
release this cytokine is still under debate (Wessels et al., 2010). 
IL-12 is known to be a key mediator of TH1 responses and thus, bridges innate and adaptive 
immunity against infection (Muller et al., 2009). Stimulation with IL-12 results in increased IL-8 
production and release in neutrophils (Ethuin et al., 2001) and production of IFNγ (Ethuin et al., 
2004).  
 
2.1.2.3 Tumor necrosis factor α 
The potent and multifunctional early response cytokine TNFα is produced (Hehlgans and 
Pfeffer, 2005)!upon gene activation by the transcription factors NF-κB, or AP-1 (Gaestel et al., 
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2009). Although TNFα is not expressed by neutrophils circulating in the bloodstream, its 
expression is rapidly and transiently inducible by LPS. Levels of mRNA are detected 60 min 
after stimulation and reach maximal amounts upon 4 h (McColl et al., 1992). The TNFα 
precursor protein travels through the ER-Golgi compartments as type II transmembrane 
proteins. In the Golgi, it transiently accumulates before being delivered to the plasma membrane 
(Manderson et al., 2007; Horiuchi et al., 2010). TNFα is localized to secretory granules and to 
the plasma membrane in resting and activated cells, respectively. At the cell surface, pro-TNFα 
is rapidly cleaved by metalloproteinases, e.g. the TNF-converting enzyme (TACE) (Barbara et 
al., 1996). The released ectodomain represents the soluble and mature TNFα cytokine (Black et 
al., 1997). Many studies indicate that both the plasma membrane-bound as well as the soluble 
TNFα forms of the cytokine are biologically active (Hehlgans and Pfeffer, 2005) and are able to 
act in different signaling pathways, e.g. TNFα-induced survival pathway (Pimentel-Muinos and 
Seed, 1999). Non-stimulated neutrophils have been shown to secrete very low TNFα                
(30-60 pg/mL), whereas levels augmented to 160-190 pg/mL upon stimulation (Djeu et al., 
1990). The early release of TNFα is required to contribute to rapid vasodilatation, recruit mainly 
monocytes and neutrophils to the infection site, and potentially activate T lymphocytes 
(Cassatella et al., 1993; Onnheim et al., 2008; Muller et al., 2009) (Figure 6C).  
 
2.1.2.4 Interleukin-1α and interleukin-1β 
From the β-trefoil interleukin-1 (IL-1) family, IL-1α and IL-1β are the most studied members in 
inflammation and immunity to infections (Lord et al., 1991). Effective and rapid IL-1 mRNA 
synthesis requires three signals: firstly, IKKβ-, p38- or casein kinase (CK) 2-dependent signaling 
pathways need to be activated by TLRs, nucleotide-binding oligomerization domain-like 
receptors, retinoic acid-inducible gene (RIG)-like helicases. Secondly, the inflammasome needs 
to be activated to induce pro-IL-1 cleavage. Existing as a biologically inactive precursor on free 
ribosomes in the cytoplasm, pro-IL-1 processing into active fragments depends on cleavage by 
enzymes (e.g. IL-1β converting enzyme (Thornberry et al., 1992) or caspase-1 (Franchi et al., 
2009)) inside the cell or upon secretion (e.g. neutrophil proteinase 3, elastase, and cathepsin G 
(Coeshott et al., 1999; Netea et al., 2010). Thirdly, the nucleotide P2X7 receptor needs to be 
activated by extracellular adenosine triphosphate (ATP,!Qu et al., 2007; Gaestel et al., 2009; Qu 
et al., 2009).  
IL-1α and IL-1β are both secreted by a non-canonical pathway (Rubartelli et al., 1990; Lord et 
al., 1991) (Figure 6D). As “leaderless” proteins, they lack the conventional hydrophobic signal 
sequence (Halban and Irminger, 1994; Park and Loh, 2008) and are therefore released 
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independently from the ER and Golgi apparatus (Nickel, 2003; Prudovsky et al., 2003). Their 
secretion pathway has been postulated to occur by i) exocytosis of secretory lysosomes, a 
process that requires a functional microtubule network (Andrei et al., 1999; Andrei et al., 2004; 
Carta et al., 2006), ii) shedding of plasma membrane microvesicles (MacKenzie et al., 2001;!
Nickel, 2003;!Bianco et al., 2005; Pizzirani et al., 2007), or iii) guided release via specialized 
transporters (Hamon et al., 1997; Marty et al., 2005; Brough and Rothwell, 2007). The secretion 
of IL-1β by human neutrophils is still discussed controversially (Wessels et al., 2010). 
IL-1α and IL-1β both i) stimulate acute phase proteins, e.g.!C-reactive protein, whose function is 
to localize the inflammation and to support the immune system (Gabay and Kushner, 1999),     
ii) signal endothelial cells to induce vasodilatation and upregulation of adhesion molecules that 
aids the migration of neutrophils, monocytes, and lymphocytes, iii) activate mainly monocytes, 
macrophages and neutrophils, and iv) co-stimulate adaptive cellular responses mediated by T 
helper (TH) lymphocytes. 
 
!
!
Figure 6 Canonical and non-canonical pathways of cytokine secretion. (A) The standard pathway, (B) the unit 
interaction pathway, (C) the membrane-deposit pathway, and (D) non-canonical pathway of cytokine secretion 
(Duitman et al., 2011, modified).  
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2.1.2.5 Interleukin-6  
Interleukin-6 (IL-6) is one of the cytokines that has been seen as a sign of monocyte 
contamination in neutrophil preparations (Cassatella, 1995) and is still under debate as being a 
neutrophil-derived cytokine. IL-6 gene expression has been reported to be induced via the           
NF-ĸB pathway (Libermann and Baltimore, 1990). The functional form of IL-6 is a homodimer. 
Different secretion pathways for IL-6 have been postulated: i) independent from secretory 
granule release in mast cells (Kandere-Grzybowska et al., 2003), ii) in secretory vesicles in 
eosinophils (Melo et al., 2005), and iii) by constitutive exocytosis in macrophages (Stow et al., 
2009).  
During inflammation, IL-6 is an important regulator of the transition from neutrophil to monocyte 
recruitment (Kaplanski et al., 2003) and orchestrates chemokine production (Fielding et al., 
2008). IL-6 is one of the few cytokines that can act in a cytokine-receptor complex for paracrine 
signaling (Jones et al., 2001). When the IL-6 receptor at the cell surface is cleaved by 
proteases, the soluble receptor (sIL-6R) and IL-6 form complexes that bind to gp130 and thus 
induce signaling cascades (Jablonska et al., 1999). IL-6 also has systemic effects by i) inhibiting 
the expression of TNFα (Xing et al., 1994), ii) stimulating the production of acute-phase proteins 
iii) inducing differentiation of B lymphocytes towards antibody-producing plasma cells, and          
iv) supporting TH2 and TH17 cell differentiation (Muller et al., 2009).  
 
2.1.2.6 Chemokine (C-C motif) ligand 2, 3, 4 and 5 
CCL2 (MCP-1) is the first discovered human CC chemokine (Deshmane et al., 2009). A higher 
level of CCL2 attracts monocytes (Baggiolini et al., 1994) and augments the TH lymphocyte 
response (Theilgaard-Monch et al., 2004; Yoshimura and Takahashi, 2007; Deshmane et al., 
2009). In freshly isolated neutrophils, CCL2 has been claimed to be poorly produced upon 
induction with various stimuli (Van Damme et al., 1994).  
CCL3 (MIP1α) and CCL4 (MIP1β) (Kasama et al., 1993; Kasama et al., 1994) are 
chemoattractants for monocytes and subpopulations of T lymphocytes (Theilgaard-Monch et al., 
2004). Upon proteolysis of CCL3 by neutrophil serine proteases (Ryu et al., 2005), mature 
CCL3 can also activate effector functions in macrophages, neutrophils (Oppenheim et al., 
1991), eosinophils, basophils, immature dendritic cells (Schroder et al., 2006) and NK cells 
(Scapini et al., 2000). CCL4 also elicits chemotaxis of dendritic cells and TH1 lymphocytes 
(Scapini et al., 2000; Schroder et al., 2006).  
CCL5 (RANTES) can exist in different truncated variants (Lim et al., 2005). CCL5 production is 
induced via the NF-ĸB pathway in a Nod-like receptor-dependent manner. CCL5 secretion has 
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been documented to occur through the standard canonical pathway (Lacy and Stow, 2011). 
Besides the recruitment of immature dendritic cells and T lymphocytes towards the site of injury 
(Werts et al., 2007), CCL5 is the only CC chemokine also able to cause chemotaxis and 
activation of eosinophils (Deshmane et al., 2009). 
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V Development of chronic inflammatory diseases 
The healthiest outcome of acute inflammation is resolution, which is essential in order to 
maintain homeostatic conditions in the tissues (Henson, 2005). However, long-term 
inflammation can occur through premature activation of neutrophils during migration, excessive 
extracellular release of antimicrobial products during killing, inappropriate removal of infected 
and damaged host cells, and failure to terminate acute inflammatory responses (Smith, 1994). 
In such a scenario, an imbalance between levels of pro- and anti-inflammatory cytokines 
evolves (Salvioli et al., 2006). The abnormal host response creates a persistent inflammatory 
microenvironment with ongoing release of inflammatory mediators (Nathan and Ding, 2010;!
Serhan, 2011) and thus, predisposes to a series of chronic diseases that include cancer, 
chronic obstructive pulmonary disease, rheumatoid arthritis, irritable bowel disease, gastric 
disorders, and autoimmune skin disorders (Henson, 2005; Florean and Diederich, 2012). Some 
examples of chronic inflammatory diseases are given below. 
 
1. Clinical examples of chronic leukocyte-induced injury 
 Rheumatoid arthritis 1.1
Rheumatoid arthritis is a chronic inflammatory disease mainly characterized by synovial 
hyperplasia and joint destruction. Neutrophils are the first immune cells to infiltrate the joint at 
the early disease stage and are activated by soluble immune complexes in the synovial fluid 
(Smith, 1994; Cascao et al., 2009; Myasoedova et al., 2010). In response, excessive 
degranulation by neutrophils includes overabundant collagenase and elastase secretion. Also, 
cytokines have been attributed a role in the pathogenesis of rheumatoid arthritis (Firestein et al., 
1990; Brennan et al., 1991; Feldmann, 1996; McInnes and Schett, 2007) and are used for 
biomarkers of the disease (Burska, 2014).  
 
 Atherosclerosis 1.2
Atherosclerosis defines the deposition of fat, blood clots, tissue, and lime in the blood vessels. 
Literally translated, the term atherosclerosis refers to hardening of the connective tissue in the 
arteries. The origin for the development of atherosclerosis might be damage or dysfunction of 
the endothelium. As a result, low-density lipoprotein (LDL) molecules can reach subendothelial 
layers of the tunica intima, and inflammatory reactions can occur: i) oxidation of LDLs mediated 
by oxidants and MPO of neutrophil origin (Smith, 1994; Pattison and Davies, 2006; Loria et al., 
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2008; Tavora et al., 2009), and ii) formation of atherosclerotic patches, the "plaques". Also, 
cathelicidin (Doring et al., 2012), azurocidin, LL-37, α-defensins, and neutrophil gelatinase-
associated lipocalin (NGAL) (Hemdahl et al., 2006) which only can derive from neutrophils, have 
been identified in atherosclerotic lesions (Soehnlein, 2012). Moreover, cytokines have a 
modulatory effect on the inflammatory responses in atherosclerosis (Tedgui and Mallat, 2006).  
 
 Inflammatory bowel disease 1.3
Inflammatory bowel disease defines a group of inflammatory conditions of the colon and small 
intestine. Crohn's disease and ulcerative colitis are the principal types of inflammatory bowel 
disease. In patients with ulcerative colitis, the circulating levels of neutrophils are found to be up 
to three times the level in healthy controls (Hanai et al., 2004), resulting in an increased 
production of IL-8 and other cytokines in the inflamed mucosa (Isaacs et al., 1992; Grimm and 
Doe, 1996; Muzes et al., 2012; Neurath, 2014). Also, ulcerative colitis has been associated with 
oxidative damage, which could be quantified by MPO-induced oxidation (Winterbourn et al., 
2000). Levels of MMP-9, characteristic protein of gelatinase granules, are found elevated in 
inflammatory bowel disease (Bailey et al., 1994; Baugh et al., 1999).  
 
Since neutrophils are able to recruit, differentiate and activate B and T lymphocytes as well as 
to program antigen-presenting cells, they represent an important bridge between innate and 
adaptive immune system. It is therefore essential to maintain a balance in the production of 
neutrophil-derived mediators in order to prevent excessive release of these products that highly 
contribute to the development of chronic inflammatory diseases (Akgul et al., 2001). Among the 
most effective treatment options for chronic inflammatory disorders are blocking agents that 
specifically target cytokines or their receptors (e.g. TNF, IL-1R) (Maini and Taylor, 2000; 
Bresnihan et al., 2000; Genant, 2001; Taylor, 2003; Furst, 2010). Thus, profound and detailed 
understanding of regulatory processes in the intracellular vesicle trafficking pathways and 
exocytosis to the inflammatory environment are essential in order to determine new potential 
pharmacological targets in chronic inflammatory diseases that could prevent the release of 
mediators into the pro-inflammatory environment. 
!  
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VI Pathways of exocytosis 
1. Different types of exocytosis 
The vesicle transfer of proteins between the cellular compartments is essential for all intra- and 
intercellular processes (Weber et al., 1998). Proteins that are carried within the vesicles are 
called cargo proteins. In general, trafficking pathways maintain the inward flux of vesicles from 
the plasma membrane via endocytosis (Maxfield and McGraw, 2004), and in the opposite 
direction, the liberation of vesicles into the extracellular milieu via exocytosis (Cox et al., 1999), 
(Hackam et al., 1998). Those trafficking pathways are generally known as the endocytic cycle 
(Figure 7). Here, we focus on the exocytotic pathways, for which two general mechanisms exist: 
• Constitutive exocytosis, in which no outer signal is needed, defines continuous vesicular 
trafficking of cargo proteins or dynamic tubulovesicular carriers of newly synthesized 
proteins deriving directly from mRNA translation, or receptor-mediated de novo transcription 
(Shukla et al., 2000; Lacy and Stow, 2011).  
• Regulated exocytosis involves cell-type specific vesicles that are stored in the cytoplasm 
and undergo fusion with the plasma membrane upon stimulation via ligand-receptor 
signaling (Palade, 1956; Shukla et al., 2000). During this receptor-coupled mechanism that 
exists in neuroendocrine and exocrine cells, homo- or heterotypic membrane fusion can 
occur: fusion involving vesicle-intracellular membranes, vesicle-vesicle, or vesicle-plasma 
membrane (Shukla et al., 2000).  
 
Regulated exocytosis can either occur with a non-secretory or secretory outcome. During non-
secretory exocytosis, transfer of membrane patches from specific organelles to the plasma 
membrane results in no discharge of segregated material. Main purposes are the translocation 
of membrane components to the cell surface and the compensation for large plasma membrane 
internalization taking place during phagocytosis. In this sense, exocytosis is highly required for 
phagocytosis in macrophages (Hackam et al., 1998; Braun and Niedergang, 2006). Regulation 
of non-secretory exocytosis can occur independently of that of secretory events taking place in 
the same cell (Chieregatti and Meldolesi, 2005; Falcone et al., 2006). The mechanisms for 
secretory exocytosis are described in the following sections. 
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Figure 7 Intracellular vesicle trafficking between the compartments of the exocytic (secretory, lysosomal/vacuolar) 
and endocytic pathways (Bonifacino and Glick, 2004). The involvement of coat proteins (COPI in red, COPII in blue 
and clathrin in orange) in specific transport steps is depicted. Abbreviations: ER, endoplasmic reticulum; ERGIC, ER-
Golgi intermediate compartment; COPI and II, coat proteins I and II; TGN, trans-Golgi network. 
 
2. Classical secretory exocytosis 
Many cells are able to temporarily store proteins in secretory granules until the cell receives an 
appropriate stimulus. The ability to maintain a regulated secretory pathway is dependent on 
continued synthesis of proteins that are needed for formation of regulated storage granules 
(Borregaard and Cowland, 1997). In neutrophils, several cytokines are believed to be stored in 
granules before extracellular release (Terebuh et al., 1992; Calafat et al., 1997; Bliss et al., 
2000; Brandt et al., 2000; Matzer et al., 2001). For example, Denkers et al. proposed that IL-6, 
IL-12 and CXCL2/MIP2 might be stored within secretory vesicles or gelatinase granules 
(Denkers et al., 2003). Elbim et al. discovered an intracellular pool of IL-10 receptors in specific 
granules of human neutrophils (Elbim et al., 2001). Only about 10% of secretory vesicles are 
docked to the plasma membrane and immediately available to quickly release their content in 
response to an extracellular stimulus (Cheviet et al., 2004). These vesicles represent the readily 
releasable pool (RRP, Martin, 2002) while the majority of the vesicles remains in a reserve pool 
(RP), which is released at a later time point (Sorensen, 2004). Moreover, the newest vesicles 
are mainly localized near the plasma membrane, whereas older ones were regrouped deeper in 
the cytoplasm (Duncan et al., 2003). 
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Secretory exocytosis was first described by Palade5 to occur in pancreatic exocrine cells as a 
stimulation-induced fusion between specialized secretory organelles and the plasma membrane 
(Palade, 1975). Secretory vesicles travel through many compartments that are interconnected 
by trafficking routes. An elaborate system of internal membrane-bounded structures is required 
for the exocytosis of vesicles via the classical pathway (Hackam et al., 1998; Cox et al., 1999): 
the ER, the Golgi apparatus, and the trans-Golgi transport vesicles (Figure 7). The amount and 
organization of exocytic organelles varies from organism to organism and cell type to cell type.  
Activation of the secretory pathway can be divided into three classes: i) Ca2+ influx as result of 
depolarization of excitable membranes or mobilization from intracellular stores; ii) G protein 
activation; and iii) receptor tyrosine kinase activation. While proteins are synthesized and 
properly folded in the ER, they are modified and sorted in the Golgi, in order to be eventually 
carried by the trans-Golgi transport vesicles to the final destination. Here, the pathway involves 
sequential steps: i) wrapping of proteins by membranes deriving from the trans-Golgi, ii) vesicle 
budding from the trans-Golgi, and iii) vesicle biogenesis and maturation (Farquhar and Palade, 
1981; Tooze, 1998). This process can occur according to the “sorting by entry” hypothesis, in 
which proteins are sorted directly from the trans-Golgi, the central processing and sorting station 
of the secretory pathway, into specific nascent vesicles (Arvan and Halban, 2004). For example, 
lysosome proteins are recognized and sorted by the trans-Golgi due to the mannose 6-
phosphate residues on the N-linked oligosaccharide. Alternatively, according to the “sorting by 
retention” mechanism, proteins are packaged unsorted into the vesicles and are subsequently 
sorted throughout vesicle maturation (Blazquez and Shennan, 2000). For example, MPO 
propeptide undergoes retention in the ER (Bulow et al., 2002).  
In mammals, an octameric protein complex (Sec3p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, 
and the hydrophilic proteins, Exo70p and Exo84p) called the exocyst serves the trafficking from 
trans-Golgi in a polarized fashion towards the plasma membrane (TerBush et al., 1996; Kee et 
al., 1997; Wu et al., 2010;!He and Guo, 2009).  
During secretory regulatory exocytosis, the cytoskeleton is highly important. While microtubule 
assembly is responsible for the movement of vesicles over a longer intracellular distance               
(> 1 µm) and the vectorial exocytosis (Tapper et al., 2002), actin depolymerization is required 
for releasing vesicles over short distances in the nanometers range (Burgoyne and Morgan, 
2003; Varadi et al., 2005; Abu-Hamdah et al., 2006; Malacombe et al., 2006).  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
5!George Emil Palade was a Romanian cell biologist whom was awarded the Nobel Prize in Physiology and Medicine 
in 1974 for his innovations in electron microscopy and cell fractionation leading him to the discovery of ribosomes and 
the endoplasmic reticulum. 
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3. Non-classical secretory exocytosis 
The most commonly used export strategy for cargo proteins is the classical ER-Golgi pathway, 
mentioned above. However, also non-classical pathways exist which have been discovered only 
several years ago. The molecular identity implicated in these export routes has not yet been 
elucidated in details.  
The generation of so-called multivesicular bodies by the internalization of many small vesicles 
from the membrane of large “mature” endosomes can predispose “prelysosomal exocytosis”, 
the regulated trafficking from endosomes to lysosomes. The inward budding of vesicles results 
in the formation of 40 to 100 nm segregated vesicles of endocytotic origins called exosomes 
(Raposo et al., 1996; Savina et al., 2002; Fevrier and Raposo, 2004; Yu et al., 2006; Schorey 
and Bhatnagar, 2008; Simons and Raposo, 2009; Thery et al., 2009).  
Endosomal-derived vesicles called ectosomes or microvesicles (Hess et al., 1999; Cocucci et 
al., 2009; Lee et al., 2011) that can bud off by shedding (MacKenzie et al., 2001; Bianco et al., 
2005; Pizzirani et al., 2007) are, in general, larger than exosomes (ranging from 100 nm up to   
1 µm in diameter), and are characterized by an enrichment of phosphatidylserine on their outer 
surface.  
Additionally, lysosomal exocytosis involving secretory lysosomes tightly linked to endocytic 
system has been described to occur in leukocytes and macrophages (Griffiths, 1996; 
Dell'Angelica et al., 2000; Blott and Griffiths, 2002; Luzio et al., 2010). As lysosomes are known 
to be control centres for clearance of cellular products during autophagy, this mechanism does 
not represent simple degradation in lysosomes (Wu et al., 2007). Indeed, the soluble contents of 
the vesicles are released to the outside, and the vesicle membrane becomes part of the plasma 
membrane.  
 
4. Neutrophil-specific secretory exocytosis 
Besides the secretory pathways described above, variations of the export routes have been 
described in neutrophils. 
 
 Piecemeal degranulation 4.1
A variation of regulated secretory exocytosis is called piecemeal degranulation, a type of 
degranulation that was first identified by electron microscopy in eosinophils (Dvorak et al., 
1991), and that leads to the differential and selective transport of cytokines from secretory 
granules to the cell surface. Originally, this mechanism was hypothesized to provide progressive 
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losses of granule contents without any evidences for fusion events (Crivellato et al., 2003). 
However, each transport step in this pathway also requires sets of trafficking machinery 
molecules to enable vesicular transport and membrane fusion. Piecemeal degranulation has 
also been observed in mast cells, and basophils. In neutrophils, this specific mechanism of 
degranulation has been described for azurophil granules (Mahmudi-Azer et al., 2010). 
 
 Compound exocytosis 4.2
In another variant of regulated secretory exocytosis, called compound exocytosis, fusion of 
granules occurs at the plasma membrane, and between granules from deeper inside the cytosol 
thereby forming degranulation channels (Dvorak and Ishizaka, 1995; Pickett and Edwardson, 
2006) (Figure 8). This variant of exocytosis has already been described to mobilize more than 
50% of granules stored in the cytosol in mast cells (Brochetta et al., 2008, Blank, 2011), 
basophils, eosinophils (Scepek et al., 1998), neutrophils (Lollike et al., 2002), and platelets 
(Morgenstern, 1995).  
Furthermore, two types of compound exocytosis can be distinguished. During sequential 
compound exocytosis, a primary fusion occurs between vesicle and plasma membrane. 
Docking of deeper-lying granules to the first vesicles leads to release of granule content (Figure 
8, left). During multivesicular compound exocytosis, vesicles can fuse with each other in a 
homotypic fashion leading to the formation of large intracellular structures, which eventually can 
fuse with the plasma membrane (Hafez et al., 2003) (Figure 8, right). 
 
!
Figure 8 Compound exocytosis. Scheme depicting the sequential (left) and multivesicular (right) configurations of 
compound exocytosis (Kasai et al., 2012). Activation stimuli regulate each fusion step between cytosolic vesicles or 
with the plasma membrane. 
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VII Soluble N-ethylmaleimide-sensitive-factor attachment 
receptor proteins  
All types of exocytosis mentioned above have been described to depend on regulatory 
coordinators of membrane fusion events, the evolutionarily conserved soluble                                     
N-ethylmaleimide-sensitive-factor attachment receptor (SNARE) protein superfamily (Sollner et 
al., 1993; Weimbs et al., 1997; Gerst, 1999; Duman and Forte, 2003; Jeremic et al., 2004). They 
can be present in multiple tissues in the same organism (Bennett and Scheller, 1993; McMahon 
et al., 1993; Rossetto et al., 1996). SNAREs are tail-anchored membrane proteins involved in 
the vesicle fusion process. In mammalian cells, 38 different SNAREs have been identified that 
lead to the specific trafficking of vesicles (Bennett et al., 1992; Sollner et al., 1993). 
 
1. SNARE classification 
Two different classifications of SNARE proteins exist. Firstly, SNAREs can be classified into      
t-SNAREs localized to the target membrane (Weber et al., 1998; Johannes and Galli, 1998; 
Pfeffer, 1999; Scales et al., 2001), and v-SNAREs localized to the membrane of the trafficking 
vesicle. According to the SNARE hypothesis6 (Rothman and Warren, 1994), one v-SNARE tail-
anchored at the transport vesicle, interacts with two t-SNAREs consisting of either two or three 
polypeptides (Fukuda et al., 2000). In this define stoichiometry, they form trans-SNARE 
complexes (Antonin et al., 2002) and specifically mediate fusion of two opposing membranes 
(Cho et al., 2002). While t-SNAREs can generally be subdivided into syntaxins (STXs) and 
synaptosomal associated proteins (SNAP), v-SNAREs consist of vesicle-associated membrane 
proteins (VAMPs, synaptobrevins). Four of the SNARE members could not be classified, for 
example, STX6 is the most divergent member of the STX family identified so far (Bock et al., 
1997).  
Secondly, a more elaborate classification addresses the formation of the trans-SNARE complex 
or SNAREpin (Poirier et al., 1998) and its central region. The so-called “0-layer” is composed of 
four homologue SNARE motifs, and harbors glutamine (Q) and arginine (R) residues (Katz and 
Brennwald, 2000) deriving from the relative Q- and R-SNAREs. According to this classification, 
three Q-SNAREs (subdivided into Qa, Qb, and Qc depending on the position in the SNARE 
complex) bind to one R-SNARE, thus forming ring complexes of approximately 20 nm in 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
6!The SNARE hypothesis, postulated in 1993, (Sollner et al., 1993; Ferro-Novick et al., 1994) is originally based on 
the discovery of the trans-SNARE complex, together with the fusion proteins SNAP (Clary et al., 1990) and NSF 
(Block et al., 1988).  
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diameter (Hanson et al., 1997; Cho et al., 2005). Qa-SNAREs are represented by the STX 
family, Qb,c-SNAREs by SNAP25 homologues and R-SNAREs by the synaptobrevin family. The 
“QabcR-rule” indicates that all functional SNARE complexes are thought to contain one member 
of each subfamily (Jahn and Sudhof, 1999). The Q/R-SNARE nomenclature has been privileged 
due to its comprehensive classification according to the conserved mechanism and structure of 
SNARE proteins (Kloepper et al., 2007). 
 
!
Figure 9 Structure of the neuronal SNARE proteins (Lang and Jahn, 2008). Syntaxin 1A, SNAP25 and synaptobrevin 
all contain one to two SNARE motifs. SNARE interaction leads to formation of a stable complex, in which each of the 
SNARE motifs adopts an α-helical structure. The stability of the four parallel α-helices in the complex is mediated by 
layers of interaction (−7 to +8). Abbreviations: TMR, transmembrane region. 
 
 Qa-SNAREs 1.1
The first STX was discovered in 1992 (Bennett et al., 1992). The STX family consists of 16 
mammalian members that are integral membrane proteins with a transmembrane domain at the 
C-terminal that anchors the protein in the membrane (Advani et al., 1998; Teng et al., 2001). 
The N-terminal cytoplasmic part has coiled-coil regions, which interact with synaptobrevins and 
SNAP25 homologues (Shukla et al., 2000) (Figure 9).  
In general, SNAREs are concentrated at glycosphingolipid- and cholesterol-rich sites (Lang et 
al., 2001; Duman and Forte, 2003; Sieber et al., 2006), namely lipid rafts (Chamberlain et al., 
2001), in the plasma membrane of neuronal and non-neuronal cells. The lipid raft might be 
important to accumulate various sets of molecules (e.g. phosphatidylinositol-4,5-bisphosphate 
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PIP2; Liu et al., 1998) to facilitate the efficacy of membrane traffic (Martin, 2001; Maxfield, 2002; 
Salaun et al., 2004). It has been proposed that lipid rafts are primarily important for capturing 
vesicles from the cytoplasm (Yoshizaki et al., 2008). Additionally, STX1A was found to self-
oligomerize and form clusters at concentrations above 2 µM (Murray and Tamm, 2009). Also, 
STX3 was found enriched in lipid rafts (Pombo et al., 2003) and clusters in the plasma 
membrane of epithelial cells before establishment of cell polarity (Low et al., 2006). Therefore, it 
has been proposed that STX clustering is a mechanism of membrane patterning (Sieber et al., 
2006) and identifying a compartment. In this sense, homotypic fusion (also referred to as 
“nucleation”) may solely rely on the Q-SNAREs and does not involve R-SNAREs (Weber et al., 
1998; Lang and Jahn, 2008). Using stimulated emission depletion (STED) microscopy, the 
SNARE motif has been described to be essential for the formation of STX clusters in the plasma 
membrane (170 to 256 nm; Sieber et al., 2006) in order to form vesicular tubular clusters.  
 
 Qb,c-SNAREs 1.2
Qb,c-SNAREs are also called subfamily of SNAP25 homologues. Since its discovery in 1989, 
SNAP25 has been considered almost exclusively expressed in the brain (Oyler et al., 1989; 
Bark et al., 1995; Brumell et al., 1995). SNAP23 (23-kDa synaptosome-associated protein) is 
59% identical to SNAP25, and has originally been regarded as the SNAP25 homologue in non-
neuronal tissues substituting for the lack of SNAP25 in these cells. Although SNAP23 is 
ubiquitously expressed in all tissues (gastrointestinal and hepatopancreatic epithelial cells, 
neuroendocrine cells and mast cells (Faigle et al., 2000; Frank et al., 2011) to fibroblasts 
including brain (Ravichandran et al., 1996; Hepp et al., 1999)), the functional equivalence to 
SNAP25 remains elusive.  
SNAP23 and SNAP25 possess two SNARE motifs, but lack the typical transmembrane domain 
(TMR) at the C-terminus common to most other SNAREs (Jahn et al., 2003) (Figure 9). Instead, 
SNAP23 has palmitoyl groups for binding to the membrane (Veit, 2000).  
SNAP23 has a target sequence for post-translational fatty acid acylation and two potential target 
sequences of phosphorylation by cAMP/cGMP-dependent protein kinase (Mollinedo and Lazo, 
1997). Cell stimulation can lead to the phosphorylation of SNAP23 and thus, to functional 
activation for mast cell degranulation (Hepp et al., 2005). SNAP23 is subcellularly localized in 
the apical and basolateral domain of the plasma membrane (Low et al., 1998) but also 
intracellularly in endosomal and lysosomal compartment of polarized epithelial cells (Rao et al., 
2004).  
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In in vitro experiments, SNAP23 bound to glutathione S-transferase (GST)-STX1, STX2, STX3 
and STX4 with similar efficiency. Also SNAP23 has been shown to interact to VAMP1 and 
VAMP2 (Ravichandran et al., 1996). SNAP23 has been reported to interact as well with VAMP3 
(Galli et al., 1998). In the exocrine system, SNAP23 and STX4 interact (Wang et al., 2007) and 
their complex might be involved in histamine secretion in mast cells (Salinas et al., 2008).  
Another SNAP25 homologue is SNAP29, which is also ubiquitously located on multiple 
membranes (Steegmaier et al., 1998). Unlike SNAP23, SNAP29 does not possess a lipid 
anchor, which suggests that SNAP29 can only associate with membranes by interacting with 
membrane-bound proteins. SNAP29 protein has been involved in endocytic recycling of 
transferrin and β1-integrin (Rapaport et al., 2010) as well as mast cell phagocytosis (Wesolowski 
et al., 2012). SNAP29 also interacts with several syntaxins (Steegmaier et al., 1998).  
 
 R-SNAREs  1.3
Many R-SNAREs have been identified through their specific cleavage by botulinum and tetanus 
toxins. R-SNAREs are defined by two subfamilies, the “brevin” family, which includes VAMP2 
(synaptobrevin 2, Figure 9), VAMP3 (cellubrevin) and VAMP8 (endobrevin); and the “longin” 
family, characterized by an N-terminal extension called the longin domain (e.g. TI-
VAMP/VAMP7) (Rossi et al., 2004; Wen et al., 2006). Upon their synthesis, VAMPs are post-
translationally inserted into the ER membrane. This insertion is dependent on ATP, and sorting 
is directed by the SNARE motif.  
As one of the 8 members of the R-SNARE family (Advani et al., 1998), VAMP3 differs from 
VAMP1 and VAMP2 by its shorter N-terminus and its lower molecular weight of only 14 kDa 
(McMahon et al., 1993). Also, while the R-SNARE VAMP1 has been restricted to 
neuroendocrine and neuronal tissues and was thus not detected in cell extracts of human 
neutrophils (Trimble, 1993), VAMP3 on the contrary is expressed in a variety of tissues 
(McMahon et al., 1993), but not in neurons (Chilcote et al., 1995). Subcellularly, VAMP3 is 
localized mainly in intracellular vesicle and granule membranes and is important for vesicle 
recycling to endosomes (McMahon et al., 1993; Rossetto et al., 1996). It has been found in the 
apical as well as in the basolateral endosomal fraction (Steegmaier et al., 2000) but also in the 
region of the ER and Golgi (Galli et al., 1994; Daro et al., 1996; Bajno et al., 2000; Mallard et al., 
2002). In animal experiments, VAMP3 knockout mice do not show any particular biological 
changes of the intracellular membrane transport processes (Yang et al., 2001). VAMP3 acts in 
membrane fusion processes with multiple binding partners such as Qa-SNAREs STX2, 3, 4 and 
the Qb,c-SNAREs SNAP23 and SNAP25 (Galli et al., 1998).  
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2. SNARE cycle 
The defining feature of all Q- and R-SNAREs is an evolutionarily conserved domain of 60 to 70 
amino acids that is arranged in heptad repeats (Lu et al., 2010). The SNARE motif (Jahn and 
Sudhof, 1999) mediates the association of SNAREs into trans-SNARE complexes (Antonin et 
al., 2002) (Figure 9). While Qa-SNAREs (STXs) and R-SNAREs (synaptobrevins) only carry one 
single SNARE motif, anchored to the plasma membrane by a C-terminal transmembrane region 
and attached to a large N-terminal domain via a linker region, Qb,c-SNAREs (SNAP25 
homologues) can carry two SNARE motifs (Figure 9). Also, Qb,c-SNAREs can lack 
transmembrane domains and are membrane-anchored by post-translationally attached lipids.  
During SNARE assembly, each SNARE contributes one helix (Sutton et al., 1998) in the way 
that one 3-helical bundle from one membrane and one from the opposing membrane assemble 
according to the zippering model (Fasshauer, 2003) towards a twisted parallel 4-helical bundle 
(Weber et al., 1998) with an overall length of 12 nm (Cho et al., 2005). While single SNAREs 
can be denatured by heat and are cleaved by botulinum and tetanus neurotoxins (Jahn and 
Sudhof, 1999), Q- and R-SNAREs form complexes that are resistant to these stresses (Jeong et 
al., 1998). For example, human STX3 in complex with SNAP23 is insensitive to botulinum toxin 
C1 (Galli et al., 1998). Upon complex formation, SNARE proteins that are on opposing 
membrane bilayers bring vesicle and plasma membrane into close proximity, which normally 
repulse each other due to negatively charged phosphate groups and the hydration barrier. This 
close proximity of approximately 2.8 Å leads to a destabilization of the normal conformation of 
the lipid membrane, thus allowing membrane fusion and the subsequent release of the cargo 
molecules (Lin and Scheller, 1997).  
For subsequent rounds of fusion, SNARE complexes are disassembled, recycled and sorted to 
their appropriate membranes (Figure 10). In 2006, Jeremic et al. discovered that there is an 
ATP-dependent disassembly of the highly stable SNARE complexes (Jeremic et al., 2006). In 
2007, the chaperone NSF was discovered to be a right-handed molecular motor (Block et al., 
1988; Malhotra et al., 1988; Cho et al., 2007) and to act in conjunction with adaptor proteins α- 
and β-SNAPs (soluble NSF attachment protein) (Clary et al., 1990; Waters et al., 1992; 
Whiteheart et al., 1993; Jahn et al., 2003) in the uncoiling of each SNARE bundle within the ring 
complex (Cho et al., 2007). NSF is a hexamer with an N-terminal domain for substrate binding 
and two nucleotide binding domains D1 and D2 for ATP hydrolysis and hexamer stability. When 
acting upon STX or SNAP25, its ATPase activity is stimulated more than ten-fold. During 
SNARE disassembly, Q- and R-SNARE vesicles are dissociated with a rate constant k=1.1s-1. 
The Q-SNAREs are recycled to the starting membrane compartment.  
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Figure 10 The SNARE conformational cycle (Jahn and Scheller, 2006). Qa-, Qb- and Qc-SNAREs form clusters at the 
acceptor membrane prior to assembly with R-SNAREs from a vesicle. This assembly towards a four-helical trans-
SNARE complex requires Sec1/Munc18 proteins. The zippering of the SNARE motifs leads to opening of a fusion 
pore. In regulatory exocytosis, late regulatory proteins control the transition states between loose and tight trans-
SNARE complex formation. During membrane fusion, SNAREs undergo cis-configuration and are disassembled by 
NSF and SNAPs (see text). 
!  
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3. Regulation of SNARE complex formation 
The SNARE hypothesis proposes that the specificity of vesicle fusion is due to specific 
combinations of SNARE interactions (Rothman and Warren, 1994; McNew et al., 2000) and that 
each fusion step of the secretory pathway thus implicates a specific set of SNAREs (Sollner et 
al., 1993; Bennett and Scheller, 1993; McMahon et al., 1993; Bethani et al., 2007). For example, 
STX6 mediates vesicle trafficking in the trans-Golgi network (Bock et al., 1997). While the 
mechanisms underlying SNARE complex formation are largely uncovered, the molecular basis 
of SNARE regulation still remains to be elucidated (Jahn and Scheller, 2006; Bethani et al., 
2007). Several studies showed that, i) SNARE isoforms that do not fuse in vivo can form 
SNARE complexes in vitro (Fasshauer et al., 1999; Yang et al., 1999; Tsui and Banfield, 2000), 
ii) some SNAREs are known to operate in different fusion steps (Bethani et al., 2007), and       
iii) some SNAREs are able to substitute for another in vivo (Gotte and Gallwitz, 1997; Liu and 
Barlowe, 2002; Borisovska et al., 2005). In this sense, it has been demonstrated that SNARE 
proteins are both necessary and sufficient for specific membrane fusion in vitro, but so-called 
cognate and also non-cognate SNARE complexes with no functional cross-talk can form in vivo. 
Although only cognate SNARE complexes have functional impact, cognate as well as non-
cognate configurations are able to form complexes with equally high thermostabilities 
(Fasshauer et al., 1999; Scales et al., 2000).  
Recent findings demonstrate that the formation of acceptor complexes between Qa- and Qb,c-
SNAREs is the rate-limiting step of membrane fusion (Figure 10). However, only when 
complementary R-SNAREs engage, a productive fusion event is initiated (McNew et al., 2000) 
that mediates specificity only in trans-configuration and later stage in the SNARE assembly-
disassembly cycle (Bethani et al., 2007). Although one SNARE complex is sufficient for 
membrane fusion (van den Bogaart et al., 2010), the most critical parameter turns out to be the 
surface density of SNARE proteins, which controls the rate and extent of SNARE-mediated 
membrane fusion (Ji et al., 2010). 
 
 Regulatory proteins of trafficking specificity 3.1
Regulatory proteins that could restrict SNARE activity spatially or temporally, or perform proof-
reading for SNARE pairing in trans, have been proposed to be essential in the vesicle trafficking 
requisite for the proper functioning of the cells (Shen et al., 2007). In this sense, kinetics of 
SNARE assembly in vivo (Rothman and Sollner, 1997) can be controlled by several accessory 
proteins termed SNARE-masters (Gerst, 1999): i) Rab proteins (Darchen and Goud, 2000; 
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Zerial and McBride, 2001; Stenmark, 2009), ii) the Ca2+ sensor synaptotagmin7 (SYT) (Brose et 
al., 1992; Jahn and Niemann, 1994; Chapman, 2002), iii) Munc13 proteins and STX-binding 
Sec1/Munc18-proteins (Jahn and Sudhof, 1999; Guo et al., 2000; Jahn et al., 2003; Gerst, 
2003), and iv) complexins.  
 
3.1.1 Rab GTPases 
The role of Rab (ras genes from rat brain) family members in vesicular trafficking was first 
discovered in 1988 in yeast. Approximately 70 Rabs and Rab-like proteins are encoded by the 
human genome (Pfeffer, 2001; Pfeffer, 2005; Stenmark, 2009). Recent evidence suggests that 
monomeric Rab proteins, which form the largest branch of the Ras superfamily, function in the 
initial steps of membrane tethering/docking for guidance of vesicular transport towards the 
acceptor compartment (Balch, 1990; Jahn and Sudhof, 1999; Zerial and McBride, 2001). They 
are considered to ensure the specificity of vesicle docking by acting upstream of SNARE 
complex assembly (Zerial and McBride, 2001) but are not involved in the fusion reaction itself. 
In order to temporally and spatially coordinate membrane transport, Rab GTPases cycle 
between an active GTP-bound (membrane-associated) and an inactive GDP-bound state 
(soluble). This conformational cycle highly depends on downstream Rab effectors that control 
the rates of GDP-GTP exchange and GTP hydrolysis (Takai et al., 2001; Zerial and McBride, 
2001; Lee et al., 2009; Stenmark, 2009).  
In neutrophils, for example, Rab5a is a key regulator of phagolysosome maturation (Perskvist et 
al., 2002) while Rab7 determines later fusion events with late endosomes and lysosomes (Vieira 
et al., 2003; Roberts et al., 2006). Phagosome maturation requires the recycling of certain 
membrane compounds, a process that involves Rab11 (Leiva et al., 2006). Rab27a controls 
azurophil granule exocytosis and regulates the activation of the NADPH oxidase at the plasma 
membrane (Stinchcombe et al., 2001; Izumi et al., 2003; Munafo et al., 2007; Johnson et al., 
2010; Johnson et al., 2011). Also, Herrero-Turrión et al. identified Rab27a in the exocytosis of 
gelatinase and specific granules (Herrero-Turrion et al., 2008). 
 
3.1.2 Intracellular Ca2+ 
Ca2+ has been identified as a key point for secretory regulated exocytosis (Blank et al., 2001) 
due to its effect on the orientation of membrane bilayers. The binding of Ca2+ to the phosphate 
head groups of the opposing bilayers leads to the release of water from hydrated Ca2+ ions and 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! !!!!!!!!!!!!!!!!!!!!
7!In the 1990s, Thomas Südhof (Nobel Prize in Physiology or Medicine, 2013) discovered the role of synaptotagmins 
and Munc proteins in the regulation of SNARE-mediated membrane fusion.   
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bilayer destabilization in order to promote membrane fusion (Jeremic et al., 2006). The low 
fusion rate of trans-SNARE complex formation corresponds in the absence of Ca2+ to  τ= 16min 
whereas it changes dramatically to τ~10s in the presence of Ca2+. The phospholipid PIP2 has 
long been known as an important activator of Ca2+-dependent regulated exocytosis due to its 
trigger function of the Ca2+ release from the ER, the major reservoir for free Ca2+ ions (Montero 
et al., 1995). Also, Ca2+ around the Golgi is contributory to the membrane trafficking in ER-to-
Golgi-to-plasma membrane delivery of cargo (Micaroni, 2010; Pizzo et al., 2010). In general, a 
temporary increase of Ca2+ in the cytosol is observed during a pulse of protein traffic (Lew et al., 
1986; Micaroni, 2010). However, it is important to note that Ca2+ alone cannot regulate the 
degree of vesicle content release (Snyder et al., 2006). Additional levels of regulation are 
mediated by Ca2+-binding proteins, such as SYT. 
 
3.1.2.1 Synaptotagmin 
SYT was the first regulator discovered in the membrane of synaptic and large dense-core 
vesicles (Chapman, 2002; Sudhof, 2002). By now, 13 isoforms have been identified in neurons 
and non-neuronal cells (Sudhof, 2002). SYT has one transmembrane domain, a Qa-SNARE 
binding domain, a lysine- and arginine-rich linker and two Ca2+ binding domains, C2A and C2B 
at the C-terminus (Chapman, 2002). SYT is able to interact with STX1 and SNAP25 upon 
phosphorylation thus bringing them into close proximity (Bennett and Scheller, 1993; Davletov 
et al., 1993; Popoli, 1993; Verona et al., 2000; Rizo, 2010). Also, SYT was demonstrated to be a 
substrate for calmodulin-activated kinase II (Popoli, 1993) and casein kinases I and II (Bennett 
and Scheller, 1993; Davletov et al., 1993). When Ca2+ is present, the Ca2+ sensor SYT (Geppert 
et al., 1994; Fernandez-Chacon et al., 2001; Bai and Chapman, 2004) releases the Qa-SNAREs 
so they can fully zipper with the R-SNARE, thus affecting kinetics of exocytosis (Nagy et al., 
2006; Snyder et al., 2006) and whether full or kiss-and-run fusion will take place (Wang et al., 
2003). After activation of exocytosis, the Ca2+ binding regions are inserted into the membrane. 
The exact mechanism by which SYT stimulates membrane fusion before or after Ca2+ influx is 
elusive (Mahal et al., 2002). In neutrophils, SYTII is associated with specific granules, and 
translocates to the plasma membrane upon stimulation (Lindmark et al., 2002).  
 
3.1.2.2 Munc13 proteins 
In the docking step, Sec1/Munc18 (SM) proteins are able to fold into a clasp structure (Misura et 
al., 2000; Izumi et al., 2007) (Figure 11) and specifically bind to the N-terminal regulatory Habc 
domain of STX, thus preventing other SNARE proteins from binding to it (Fan et al., 2007). 
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Alternatively, they can accelerate fusion for only the cognate SNAREs for exocytosis, therefore 
enhancing fusion specificity (Snyder et al., 2006; Shen et al., 2007). Munc18-1 has been shown 
to interact with STX1, 2, and 3; Munc18-2 with STX1, 3 (Tadokoro et al., 2007; Peng et al., 
2010), and slightly with STX2 (Hata and Sudhof, 1995); Munc18-3 interacts with STX2 and 4 
(ter Beest et al., 2005; Latham et al., 2006) and to a lesser extent with STX1 (Tellam et al., 
1995). Recently, Munc18-2 has also been shown to interact with STX11 (Cote et al., 2009). In 
neutrophils, Munc18-2 is associated preferentially with azurophil granules but could also be 
found with secondary and gelatinase granules, while Munc18-3 is majorily associated with 
secondary and gelatinase granules (Brochetta et al., 2008). Displacement of Munc18 from STX 
might be regulated by either phosphorylation (Shuang et al., 1998; Fujita et al., 1998; Fletcher et 
al., 1999; Reed et al., 1999; Liu et al., 2007) or by other proteins such as tomosyn (Fujita et al., 
1998) or Munc13 (Betz et al., 1998). Munc13 proteins are Ca2+-binding proteins that are 
responsive to the stimulation with protein kinase C (Li et al., 2011; Sudhof and Rizo, 2011; 
Boswell et al., 2012) and play an essential role in vesicle priming. Both releasable vesicle pools, 
slowly releasable pool (SRP) and readily releasable pool (RRP), are refilled from the unprimed 
pool (UPP) by a process called vesicle priming (Becherer and Rettig, 2006), a process of 
different ATP-dependent reactions (Klenchin and Martin, 2000; Stojilkovic, 2005; Becherer and 
Rettig, 2006). Munc13-1 protein markedly accelerates the transition from the STX-Munc18 
complex to the SNARE complex by binding with its C2A domain to the SNARE, and with its C2B 
to the membrane (Boswell et al., 2012). In neutrophils, Munc13-4 regulates exocytosis of 
azurophil (Johnson et al., 2011) and gelatinase granules (Pivot-Pajot et al., 2008). 
 
3.1.3 Complexins 
Complexins, also called synaphins, are soluble proteins of 15 kDa (Marz and Hanson, 2002) 
able to bind to the partially assembled trans-SNARE complex with nanomolar affinity in order to 
clamp membrane fusion at later stages of SNARE assembly (McMahon et al., 1995; Tokumaru 
et al., 2001; Giraudo et al., 2006). Complexin I and II are highly homologous proteins that bind 
strongly and with a 1:1 stoichiometry to the SNARE complex (McMahon et al., 1995; Marz and 
Hanson, 2002) at the STX-VAMP interface (Chen et al., 2002; Bracher et al., 2002). Upon an 
increase in Ca2+ concentration, SYT displaces complexin allowing the SNARE complex to fulfill 
membrane fusion (Tokumaru et al., 2008; Sudhof, 2013).  
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Figure 11 Primed vesicle fusion complex, involving SNARE proteins, Munc18-1 and complexin with synaptotagmin 
ready to mediate fusion pore formation upon Ca2+ binding (Sudhof, 2013). 
 
 Phosphorylation of SNAREs and their regulators 3.2
Q- and R-SNAREs can be modified post-translationally, mainly by phosphorylation (Turner et 
al., 1999; Gerst, 2003; Snyder et al., 2006) in order to regulate interactions between SNAREs 
and their regulators (Craig et al., 2003). SNAREs can be substrates for protein kinase A, C, 
Ca2+- and calmodulin-activated kinases II as well as casein kinases I and II (Nielander et al., 
1995; Lin and Scheller, 2000). Qa-SNAREs are phosphorylated by casein kinases II and I on 
two separate phosphorylation sites next to the N-terminal regulatory Habc domains (Bracher and 
Weissenhorn, 2004) thereby increasing the binding affinities to regulatory proteins Munc18 and 
SYT (Risinger and Bennett, 1999). On the contrary, phosphorylation of STX4 by protein kinase 
C has been shown to disrupt their interaction in endothelial cells (Fu et al., 2005). Interestingly, 
protein tyrosine phosphatase, an ubiquitously expressed non-receptor tyrosine-specific 
phosphatase localized on the cytoplasmic face of the ER (Frangioni et al., 1992), also regulates 
the interaction of Munc18-1 with STX1 through dephosphorylation of a specific tyrosine residue 
of Munc18-1 (Lim et al., 2013).  
In vitro phosphorylation of SNAP25 by protein kinase C results in a decrease in affinity for STX 
(Shimazaki et al., 1996). Phosphorylation of SNAP23 on threonine residue 138 by protein 
kinase A (Han et al., 2004) can lead to an increased secretion from vesicles. SNAP23 can also 
be phosphorylated by protein kinase C (Polgar et al., 2003), whereas modification by STX-
associated kinase is able to affect SNARE stability and assembly (Cabaniols et al., 1999).  
INTRODUCTION  VII SNARE proteins 
!
39 
 
Also SNARE regulatory proteins have been described to have phosphorylation sites. For 
example, SYT can be phosphorylated by CK I at threonine 128 in rats and threonine 129 in 
bovine (Davletov et al., 1993).  
 
4. SNAREs in neutrophils 
Since the discovery of the first SNARE complex involving SNAP25, STX1A and VAMP2 
(Jeremic et al., 2004), the so-called minimal fusion machinery (Weber et al., 1998), SNAREs 
have intensively been characterized in the regulated exocytosis of neurotransmitters in neurons 
(Weimer and Jorgensen, 2003). Emerging evidence shows that SNARE proteins also play a 
critical role in the regulation of immune responses mediated by neutrophils (Stow et al., 2006).  
 
 SNARE expression  4.1
Previous evidences have identified a number of SNARE proteins being expressed in 
neutrophils. In 1997, Nabokina et al. reported that SNAP25 is mainly present in peroxidase-
negative granules of human neutrophils (Nabokina et al., 1997). Controversial studies 
questioned the apparently low amount of this protein present in human neutrophils.  
In 1999, Martín-Martín et al. published the expression profile of SNAREs in DMSO-differentiated 
HL-60 cells, a cell model for neutrophils. On the mRNA level, the Qa-SNAREs STX1A, 3, 4, 5, 6, 
7, 9, 11, and 16 were expressed in dHL-60 cells. The level of expression of STXs 3, 4, 6, and 11 
was increased during neutrophil differentiation of HL-60 cells, whereas the expression of STXs 
1A, 5, 9, and 16 was unchanged (Martin-Martin et al., 1999). In 2001, Smolen et al. detected 
VAMP2 and STX4 in neutrophils and in the neutrophil-like HL-60 library to be upregulated upon 
differentiation (Smolen et al., 2001). In addition, several members of the R-SNARE family, such 
as VAMP1 to 5, were also found expressed in the dHL-60 cells and primary neutrophils 
(Mollinedo et al., 2006). The upregulated expression of these SNAREs following differentiation 
of the HL-60 cells has been argumented to point towards a functional importance.  
Many studies have aimed to elucidate the functional importance of these SNARE proteins in 
neutrophil responses. Table 1 summarizes the results of studies assessing SNARE implication 
in neutrophil responses, respectively.  
 
 SNARE proteins in phagocytosis and the respiratory burst 4.2
Phagosome maturation during internalization of bacteria in neutrophils requires several 
interactions mediated by SNARE proteins (Stow et al., 2006). However the precise molecular 
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mechanisms regulating the formation of the phagolysosome in neutrophils are still elusive 
(Perskvist et al., 2002). In studies using intracellular and extracellular bacterial pathogens, 
Perksvist et al. found that the Qa-SNARE STX4 was retained for a longer time period with the 
Rab GTPase Rab5a in GTP-bound form on the membrane of the intracellular pathogen 
Mycobacterium tuberculosis, compared to the extracellular pathogen Staphylococcus aureus.  
The expression of the Qa-SNARE STX7 has been investigated in human peripheral blood 
neutrophils and neutrophil-differentiated HL-60 cells. Xie et al. found that STX7 was located in 
the membranes of the neutrophil-specific granules, with a major location in azurophil granules 
(Xie et al., 2010). Due to its primary location, STX7 might be involved in azurophil granule fusion 
during phagocytosis (Xie et al., 2010). 
Regarding the phagocytosis-stimulated H2O2 production in neutrophils, treatment with HIV 
transactivator of transcription (TAT)-SNAP23 fusion protein resulted in reduced respiratory burst 
activity by 60% (Uriarte et al., 2011). Using a mouse model to investigate sepsis, the same 
authors also detected that TAT-SNAP23 significantly decreased the neutrophil respiratory burst 
(Bai et al., 2014). By using the same approach, TAT-STX4 was also introduced into neutrophils 
and affected the respiratory burst activity (McLeish et al., 2013).  
 
 SNARE proteins in degranulation  4.3
Martín-Martín et al. show that STX6 and SNAP23 are involved in human neutrophil exocytosis. 
After localizing STX6 mainly at the plasma membrane and SNAP23 in the gelatinase and 
specific granules, they found them colocalized upon neutrophil activation. Studies using 
antibodies against STX6 resulted in inhibited exocytosis of CD67- and CD63-enriched granules, 
while antibodies against SNAP23 only resulted in inhibited exocytosis of CD63-enriched 
granules (Martin-Martin et al., 2000). 
Using the same approach, specific antibodies against the R-SNARE VAMP2 inhibited the 
exocytosis of CD66b-enriched specific and gelatinase granules in electropermeabilized 
neutrophils (Mollinedo et al., 2003). Upon cell activation with phorbol myristate acetate, VAMP2 
interacts with STX4 localized to the plasma membrane, and is thus also involved in exocytosis 
of specific and gelatinase granules (Mollinedo et al., 2003). The localization of VAMP2 is in 
accordance with the findings of Feng et al. who labeled neutrophils with immunonanogold 
antibodies against VAMP2 (Feng et al., 2001).  
While Nabokina found VAMP1, which might be causing decreased capacity to exocytosis in 
chronic myeloid leukemia (Nuyanzina and Nabokina, 2004), to be associated with membranes 
of gelatinase and specific secretory granules (Nabokina and Revin, 2002), Mollinedo et al. 
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further investigated the axis with involvement of other SNAREs. Their data indicate that VAMP1 
and VAMP7 can complex also with STX4, together with the Qb,c-SNARE SNAP23. This SNARE 
combination has been attributed the regulated secretion of azurophil granules. In addition, the 
previously discovered VAMP2-STX4 complex potentially interacts with SNAP23 in the 
exocytosis of specific and gelatinase granules (Mollinedo et al., 2006). Contrary to Martín-Martín 
et al. and in accordance with Mollinedo et al., Logan et al. found STX4 but not STX6 interacting 
with SNAP23 (Logan et al., 2006). 
Furthermore, the R-SNAREs VAMP7 and VAMP8 were localized to granule and membrane-
enriched fractions in neutrophils. Using anti-VAMP7 antibodies, Logan et al. observed impaired 
secretion of MPO, LTF and MMP-9 (Logan et al., 2006).  
Brochetta et al. described that the Sec/Munc18 protein Munc18-2 is located in all cytoplasmic 
granules and interacts with the Qa-SNARE STX3 in neutrophils (Brochetta et al., 2008). 
While Martín-Martín et al. and Mollinedo et al. both described the Qb,c-SNARE SNAP23 to be 
localized on gelatinase and specific granules, Uriarte et al. observed significant inhibition of 
stimulated exocytosis of secretory vesicles and gelatinase and specific granules by introducing 
TAT-SNAP23 fusion protein into neutrophils (Uriarte et al., 2011). Also studies by Uriarte et al. 
confirmed the SNAP23 interplay with VAMP2 and STX4. 
In a mouse model, D’Orlando et al. investigated the knockout effect of the Qa-SNARE STX11. 
While STX11 controls the cytotoxic release from NK cells and CD8 T lymphocytes, it also 
regulates neutrophil degranulation (D'Orlando et al., 2013). 
As described above, several SNAREs have already been investigated to play an important role 
in neutrophil functions. However, to date, none of them has been implicated in neutrophil-
mediated cytokine secretion. 
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Table 1 SNARE proteins involved in neutrophil functions. 
 
SNARE Species Biological function(s) Reference 
Qa-SNAREs    
STX3 Human Degranulation (Brochetta et al., 2008) 
STX4 Human Phagocytosis (Perskvist et al., 2002) 
STX4 Human Degranulation (Mollinedo et al., 2003) 
STX4 Human Respiratory burst  (McLeish et al., 2013) 
STX7 Human Phagocytosis (Xie et al., 2010) 
STX11 Mouse Degranulation (D'Orlando et al., 2013) 
Qb,c-SNAREs    
SNAP23,  
STX6 (Qc) 
Human Degranulation (Martin-Martin et al., 2000) 
SNAP23 Human Degranulation (Mollinedo et al., 2006) 
SNAP23 Human 
Respiratory burst,  
Degranulation 
(Uriarte et al., 2011) 
SNAP23 Mouse Respiratory burst (Bai et al., 2014) 
SNAP25 Human Degranulation (Nabokina et al., 1997) 
R-SNAREs    
VAMP1 Human Degranulation 
(Nabokina and Revin, 2002)  
(Nuyanzina and Nabokina, 2004)  
(Mollinedo et al., 2006) 
VAMP2 Human Degranulation 
(Feng et al., 2001)  
(Mollinedo et al., 2003) 
(Mollinedo et al., 2006) 
VAMP7 Human Degranulation (Logan et al., 2006) 
 
! 
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Scope and Aim of the Thesis 
Neutrophil granulocytes are crucial effector cells in the innate and adaptive immunity. As the 
first cells to be recruited to sites of infection, they are able to rapidly release a broad variety of 
granule proteins and pro-inflammatory cytokines to efficiently kill intruding pathogens and recruit 
other immune cells to the inflammatory environment, respectively. In eukaryotic cells, specific 
interactions of so-called soluble N-ethylmaleimide-sensitive-factor attachment receptor 
(SNARE) proteins lead to the formation of SNARE complexes in order to guide intracellular 
vesicle trafficking and exocytosis. Due to the important contributory impact of neutrophil-derived 
products to the development of chronic inflammatory diseases, a profound and detailed 
understanding of the regulatory release mechanisms of neutrophil-derived products is essential 
for the development of anti-inflammatory therapies in chronic inflammatory diseases.  
 
The overall aim of the present study was to investigate the regulatory processes of 
mediator release in neutrophils during inflammation.  
 
So far, not a single study has focused on the expression and the role of the SNARE exocytic 
machinery in the release of neutrophil-derived cytokines and granules during inflammation. 
Therefore, our objectives are the following:  
 
1. Characterization of the pro-inflammatory response in regard to exocytosis.  
Primary human neutrophils were incubated with bacterial LPS to mimic pro-inflammatory 
conditions. The effect of LPS on degranulation and secretion of pro-inflammatory cytokines, 
described to have a prominent role in the development of chronic inflammatory diseases, was 
characterized via flow cytometry. A novel linear fitting approach was built to perform correlative 
investigations on the kinetic profiles derived from cytokine secretion and degranulation. This 
approach gives a first basis for deeper understanding of the relationship between these two 
processes.  
 
2. Profiling the expression of Qa-, Qb,c-, and R-SNAREs.  
Expression levels of Qa-, Qb,c-, and R-SNAREs in native and differentiated HL-60 cells (dHL-60 
cells), a neutrophil-like cell model, as well as primary neutrophils were determined via whole-
transcript analysis, qPCR and immunoblotting. Since i) syntaxin 3 (STX3) expression was 
upregulated upon HL-60 differentiation, ii) no study has considered its role in neutrophils, we 
investigated whether STX3 is required for neutrophil functions. 
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3. Determination of the functional role of the Qa-SNARE STX3 in cytokine release and 
degranulation during inflammation. 
Using an RNAi strategy and cytometric bead array approach, the Qa-SNARE STX3 was 
identified as an essential actor in the release of IL-1α, IL-1β, IL-12b, and CCL4 without 
alteration of other cytokine secretion in dHL-60 cells. Additionally, ELISA results demonstrated 
that STX3 was involved in MMP-9 exocytosis from gelatinase granules.  
 
4. Determination of STX3 intracellular localization. 
Neutrophils and dHL-60 cells were labeled against STX3 in order to determine its intracellular 
localization by immunofluorescence analysis. STX3 was localized to gelatinase granules as well 
as secretory vesicles. 
 
5. Identification of Qb,c- and R-SNARE interaction partners of STX3. 
To further investigate the precise mechanism by which STX3 regulates the trafficking pathway, 
we aimed to find potential Qb,c- and R-SNARE partners interacting with STX3 that specifically 
direct the pro-inflammatory mediator release.  
On one hand, immunofluorescence analysis presented that STX3 colocalizes with the Qb,c-
SNAREs SNAP23 and SNAP29. However, knockdown experiments showed that SNAP23 only 
affected IL-8 release while SNAP29 regulated the release of IL-12b, CCL2 and IL-8 as well as 
MMP-9.  
On the other hand, dHL-60 cells treated with siRNA against the R-SNARE VAMP3 resulted in 
deregulated secretion of CCL4, IL-8 as well as MMP-9. Proximity-ligation studies although 
revealed that VAMP3 did not interact with the Qb,c-SNARE SNAP29. Hence, VAMP3 is 
hypothesized to interfere with the secretory pathway at the level of the plasma membrane. 
 
Taken together, our findings provide first evidence that the Qa-SNARE STX3 controls secretion 
of IL-1α, IL-1β, IL-12b, and CCL4 during gelatinase degranulation in a neutrophil-like cell model. 
Also, STX3 together with SNAP29 might form so-called “cognate” SNARE complexes that 
specifically mediate IL-12b and MMP-9 trafficking under pro-inflammatory conditions. The role of 
the R-SNARE VAMP3 is not entirely determined due to its localization at the plasma membrane.  
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I Regulation of neutrophil degranulation and cytokine 
secretion: a novel model approach based on linear 
fitting  
 
Neutrophil granulocytes represent the first immune cells recruited to the site of inflammation. 
For many decades, they have been solely regarded as storage cells of preformed granules. 
Over the last years, the discovery that neutrophils are also capable of de novo synthesis and 
secretion of pro-inflammatory cytokines reveals that their role is not only limited to the direct 
killing of pathogens but also includes immunomodulation of the adaptive immune system. Here, 
we aimed to characterize the concurrent behavior of neutrophil-mediated cytokine release 
and degranulation upon pro-inflammatory conditions. 
 
Purified human neutrophils were stimulated for different time points with bacterial 
lipopolysaccharide (LPS). Cells as well as supernatants were analyzed by flow cytometry 
techniques and used to establish kinetic secretion profiles of granules and cytokines, which 
have been described to play essential roles in the development of inflammatory disorders. The 
capacity for degranulation was investigated by the upregulation of granule-specific membrane 
molecules as a consequence of membrane fusion from granules with the plasma membrane 
(Borregaard and Cowland, 1997). The secreted amount of several cytokines was detected 
simultaneously in supernatants via antibody-labeled beads with discrete fluorescence intensities 
in a cytometric bead array approach.  
 
To analyze the link between cytokine release and degranulation time series, we propose an 
original strategy based on linear fitting, which may be used as a guideline, to investigate in more 
details the relationship of granule proteins and cytokines secreted to the inflammatory site.  
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Abstract 
Neutrophils participate in the maintenance of host integrity by releasing various antimicrobial 
and cytotoxic proteins during degranulation. Due to recent advances, a major role has been 
attributed to neutrophil-derived cytokine secretion in the initiation, exacerbation and resolution of 
inflammatory responses. Because the release of neutrophil-derived products orchestrates the 
action of other immune cells at the infection site and thus, can contribute to the development 
and chronicity of inflammatory diseases, we aimed to investigate in more details the 
spatiotemporal regulation of neutrophil-mediated release mechanisms of pro-inflammatory 
mediators. 
Purified human neutrophils were stimulated for different time points with bacterial 
lipopolysaccharide. Cells and supernatants were analyzed by flow cytometry techniques and 
used to establish secretion profiles of granules and cytokines, which have been described to 
play crucial roles in the development of inflammatory disorders. To analyze the link between 
cytokine release and degranulation time series, we propose an original strategy based on linear 
fitting, which may be used as a guideline, to i) define the relationship of granule proteins and 
cytokines secreted to the inflammatory site, and to ii) investigate the spatial regulation of 
neutrophil cytokine release.  
The model approach presented here aims to predict the correlation between neutrophil-derived 
cytokine secretion and degranulation and may easily be extrapolated to investigate the 
relationship between other types of short-time series of functional processes. 
 
Keywords: inflammation, neutrophils, cytokine secretion, degranulation, linear fitting 
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Introduction 
Historically, neutrophils were described as simple professional killers of invading pathogens to 
the human organism (Nathan, 2006). In this regard, it was considered that only the release of 
various antimicrobial and cytotoxic proteins, synthesized and distributed into different types of 
granules, participated in the innate immune response mediated by neutrophils. Granule types 
have been characterized to be readily mobilized upon an inflammatory stimulus towards the 
plasma membrane in reverse order to their formation according to the formed-first-released-last 
model (Pellme et al., 2006). Indeed, in the different stages of neutrophil development, azurophil 
granules are formed first followed by specific granules, gelatinase granules and lastly by 
secretory vesicles, which are the most easily mobilized organelles in the mature neutrophils. 
Due to recent progress, this classical view has been expanded by the acknowledgment that 
appropriately activated neutrophils constitute a substantial source of a variety of secreted 
cytokines supporting a direct contribution of these cells in the regulation framework of the 
adaptive immune response (Cassatella et al., 1995; Scapini et al., 2000; Kasama et al., 2005). 
Neutrophils are not only a source of de novo synthesis of cytokines dependent on gene 
induction but have also the capacity to express cytokines at a basal level from preformed stores 
(Pellme et al., 2006). However, precise intracellular localization of these packaged cytokines 
and mechanisms underlining their secretion remain largely elusive. The assumption widely 
accepted is that multiple secretory pathways coexist in neutrophils allowing the regulated 
release of diverse pro-inflammatory mediators (Stanley and Lacy, 2010). Preformed cytokines 
are instantly released upon ligand-receptor signaling during the so-called "regulated exocytosis" 
process (Duitman et al., 2011) whereas de novo synthesized cytokines may be released after 
trafficking via recycling endosomes during the mechanism referred to as "constitutive 
exocytosis" (Crivellato et al., 2003; Moqbel and Coughlin, 2006). Additionally, variations of these 
two main classical secretion pathways have also been reported (Pickett and Edwardson, 2006). 
These distinct processes selectively control the combination of granule proteins and cytokines 
released into the local microenvironment from neutrophils over a temporal and spatial range, 
and are thus regulatory mechanisms important for the onset and resolution of inflammation 
enabling the development of an appropriate inflammatory response (Matsukawa and 
Yoshinaga, 1998).  
It is now largely recognized that neutrophil-derived granule proteins and cytokines contribute to 
the maintenance of the inflammatory response and the ongoing process of tissue damage 
leading to the development of many chronic inflammatory disorders such as inflammatory bowel 
diseases (Radford-Smith and Jewell, 1996), rheumatoid arthritis (Edwards and Hallett, 1997), 
RESULTS  Manuscript I 
53 
 
and atherosclerosis (Soehnlein, 2012). Determination of the regulatory mechanisms mediating 
the different patterns of cytokine trafficking and release may create opportunities to define new 
targets or strategies to selectively reduce cytokine secretion in clinical diseases. 
Therefore, we selected relevant cytokines, secreted by neutrophils and described to contribute 
to the development of chronic inflammation diseases, in order to investigate their release in 
combination to degranulation upon stimulation with bacterial lipopolysaccharide (LPS).  
Here, we propose an appealing model based on a linear fitting approach of cytokine secretion 
and degranulation giving a first basis for deeper understanding of the relationship between 
these two processes. It also provides a predictive view on the distribution of cytokines in 
neutrophils and offers an outstanding starting point to target future research on release 
mechanisms involved in inflammatory processes. 
 
Materials and Methods  
Purification of human neutrophils 
Peripheral blood of healthy volunteers was collected in EDTA-containing tubes (BD Vacutainer®, 
BD Biosciences, Erembodegem, Belgium). Samples were collected in accordance with the good 
clinical practices and following the national and international ethical recommendations. 
Neutrophils were isolated from blood samples by Polymorphprep™ separation procedure (Axis-
Shield, Dundee, Scotland) according to manufacturer’s instructions. Remaining erythrocytes in 
the neutrophil cell suspension were lysed for 10 min with red blood cell lysis buffer (pH 7.4). 
Neutrophils were washed and resuspended in PBS 1X (pH 7.4). Purity of isolated neutrophils 
was analyzed by the BD FACSCanto™ II flow cytometer (BD Biosciences) using two mixtures of 
selection markers CD66b-FITC/CD11b-PE/CD14-APC and CD15-FITC/CD16-PE/CD45-APC 
(Immunotools, Friesoythe, Germany) on 10,000 events in the gated population of homogenous 
(FSC-A vs. SSC-A), single (SSC-A vs. SSC-H) and living cells (negative cells for Sytox Blue 
staining (Invitrogen, Gent, Belgium)). Purified neutrophils are positive for all the selection 
markers used by flow cytometry. Eosinophils can be distinguished from the neutrophil 
population since they are known to be CD16- (van de Geijn et al., 2011). Human neutrophils 
were cultured in X-VIVO™ 15 medium with L-glutamine, and gentamicin (Lonza, Verviers, 
Belgium) at 37°C and 5% CO2 up to 24 h after purification. 
Cell stimulation  
Purified neutrophils were stimulated with bacterial LPS from E. coli serotype O111:B4 (Sigma, 
Bornem, Belgium) for simulating pro-inflammatory conditions. For kinetic studies of cytokine 
secretion and degranulation, neutrophils were stimulated with 100 ng/mL LPS for 2, 4, 6, 12, 
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and 24 h under serum-free conditions to avoid any serum component contamination, which 
could interfere with specific LPS-induced cell responses.  
Cell analysis by flow cytometry  
The most relevant markers have been selected for degranulation analysis, in accordance with 
the literature (Borregaard and Cowland, 1997). Degranulation was determined by measuring the 
expression of CD markers characteristic for azurophil granules (CD63-PE), specific granules 
(CD15-FITC, CD66b-FITC), gelatinase granules (CD11b-PE), and secretory vesicles (CD13-
APC, CD14-APC, CD18-FITC, CD35-FITC, CD45-APC) at the plasma membrane by flow 
cytometry (all antibodies are from BD Biosciences except CD14-APC from Immunotools).  
IgG1-FITC, IgG2a-PE (BD Biosciences) and IgG1-APC antibodies (Immunotools) were used as 
negative isotype controls, whereas CD45-FITC, CD45-PE or CD45-APC (BD Biosciences) 
single dye staining was used to set compensations. Data analysis was performed by measuring 
the mean fluorescence intensity (MFI) for each CD marker with BD FACSDiva software (BD 
Biosciences) on the gated population of granulocytes (FSC-A vs. SSC-A), single (SSC-A vs. 
SSC-H) and living cells (negative cells for Sytox Blue staining (Invitrogen)). In total, 10,000 
events were recorded per staining. The relative translocation of CD markers to the plasma 
membrane for each granule was determined by calculating the ratio between MFI of LPS-
stimulated cells and non-stimulated control from the same time point. 
Measurement of cytokine secretion by Cytometric Bead Array (CBA) 
Density of human neutrophils was adjusted to 10x106 cells per condition for subsequent 
quantitative measurement of cytokine secretion by LPS-stimulated cells, respectively. Fresh 
supernatants were collected and used directly for cytometric bead array (CBA, BD Biosciences) 
analysis. The multiplex standard curve composed of mixed cytokine standards was set up by 
serial dilutions according to the manufacturer’s instructions. Selected capture beads were 
prepared and added to supernatants. The following beads were used: CCL2 (MCP1, bead D8), 
CCL3 (MIP1α, bead B9), CCL4 (MIP1ß, bead E4), CCL5 (RANTES, bead D4), IL-1α (bead D6), 
IL-1β (bead B4), IL-6 (bead A7), IL-8 (CXCL8, bead A9), IL-12b (bead E5), and TNFα (bead 
C4). After 1 h of incubation, detection reagent was added to each sample. After 2 h of 
incubation, samples were rinsed with wash buffer and centrifuged. Samples were washed again 
prior to flow cytometry analysis (BD FACSCanto™ II, BD Biosciences). Results were quantified 
using the standard curves and the Flow Cytometric Analysis Program (FCAP) Array software 
(Soft Flow, Minneapolis, USA).  
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Linear fitting approach via R statistical software 
Kinetic profiles of cytokine secretion and degranulation were imported into R statistical software 
(www.r-project.org) and a linear regression approach was applied. This approach was used to 
find the optimal proportionality factor, namely the slope of the model, and provide methods to 
evaluate the significance of our models. All ratio values between LPS- and non-stimulated 
control conditions (stimulation points 0, 2, 4, 6, 12, and 24 h) from the time series of cytokine 
secretion and degranulation were log10 normalized to minimize scale effect. For each granule-
specific CD marker, a linear model has been fitted with the secreted cytokines. For each model, 
ANOVA analysis has been performed and the adjusted R-squared (RSQ) value and the slope of 
the model were retained. Models with a significant difference to the null model (p-value ≤ 0.05) 
and with a high adjusted RSQ value between degranulation marker vs. secreted cytokine           
(RSQ ≥ r, r being determined by simulations, see Simulations to determine the optimal RSQ 
threshold) were considered as underlying a strong similarity of pattern between a cytokine 
secretion and a degranulation marker. Then, cytokines linked to the same degranulation marker 
were clustered. To visualize these clusters, time series of the degranulation marker and its 
relative cytokines of the cluster were plotted. To permit comparison between time series from 
different scales, values from the secreted cytokines were divided by the slope of their linear 
model. 
Simulations to determine the optimal RSQ threshold 
To define the optimal RSQ threshold r, we simulated the fitting between pairs of granule marker 
and cytokine with controlled perturbations between them and choose the threshold r by 
determining at which level of perturbation the RSQ was drastically dropping. The simulations 
were designed as follows: Time series of each granule-specific marker and cytokines were 
taken individually (19 time series in total) and used to simulate matching time series with more 
or less perturbations. For the six points of each time series (0, 2, 4, 6, 12, and 24 h), a random 
number between Vi - e and Vi + e was drawn. Vi is the ith element of the time series and e is a 
pre-defined constant. e controls the intensity of the perturbation: the highest e is, the more 
different both profiles are expected to be. All values from 0 to 1 with a step of 0.1 were tested for 
e (0, 0.1, 0.2, etc. to 1). Then the RSQ of the original profile vs. simulated profile was computed 
as mentioned in Linear fitting approach via R statistical software. This process was repeated 
100 times and, for each of the 19 original profiles, the average of the RSQs was computed and 
plotted against the e value. To define the optimal RSQ threshold that defines a cut-off between 
linear fitting models with “high RSQ” and “low RSQ”, we clustered the distribution of averaged 
RSQ into two groups, using a k-means approach (a silhouette analysis of all clustering solution 
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with 2 to 10 clusters confirmed that 2 clusters was the best solution, data not shown). The last 
element of the cluster with the highest center, namely 0.82, was taken as RSQ threshold for our 
analysis.  
Statistical analysis 
Statistical analysis was performed by using the 2-tailed unpaired Student's t-test in the Prism5 
software (Graph Pad Software, La Jolla, CA, USA). The difference between the means are 
considered statistically significant when the p-value is * = p < 0.05; ** = p < 0.01; *** = p < 0.001. 
 
Results 
Behavior of cytokine levels secreted by human neutrophils upon LPS stimulation 
Since recent reports have implicated neutrophils in the development of chronic inflammatory 
disorders, we wanted to characterize the regulatory mechanisms in the release of neutrophil-
derived products. In a first step, cytokine candidates found to be secreted by highly purified       
(≥ 98%) neutrophils upon LPS stimulation (see Manuscript II), were selected for integration into 
our mathematical model. These cytokines have a particular relevance since they have been 
reported to contribute to the development of different chronic inflammatory diseases through the 
recruitment of diverse immune cells to the inflammatory site (Table I). 
To develop a reliable model that investigates the relationship between degranulation and 
cytokine secretion, different sets of experimental data were generated. Time series of cytokine 
secretion were determined to serve as input to our model. Neutrophils were treated with          
100 ng/mL LPS for 2, 4, 6, 12, 24 h and subsequent quantitative measurement of cytokine 
secretion was performed by the CBA technique. A basal secretion level of all cytokines was 
detected in neutrophils under non-stimulated conditions. Secretion of most of the cytokines 
released into the extracellular medium was augmented with increasing time stimulation by LPS, 
except for CCL5, IL-1α and IL-12b, whose release was not significantly affected by LPS 
treatment (Fig. 1, Table IIA).  
The secretion pattern was different for each cytokine in the way that different profiles could be 
identified. Except for IL-1α, secretion levels of cytokines increased up to 6 h or 12 h after 
treatment with LPS and decreased after 24 h. Maximal cytokine secretion was observed at i) 6 h 
LPS for IL-1β, CCL3, and TNFα; ii) 12 h LPS for IL-6, IL-8, CCL2, CCL4, and IL-12b. Moreover, 
quantities of released cytokines were highly variable. TNFα, IL-1α, IL-1β, CCL3, CCL5, and    
IL-12b were only discretely secreted (≤ 150 pg/mL) whereas IL-6, CCL2, and CCL4 were 
secreted at an intermediate level (~ 250-600 pg/mL) and IL-8 was highly secreted                      
(≥ 30000 pg/mL). 
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Effect of LPS on degranulation in neutrophils 
To collect data for the implementation of the model, the second series of experiments consisted 
in identifying the kinetic profiles of the different granule types upon time-dependent LPS 
stimulation. Degranulation can be determined by the upregulation of granule membrane 
molecules as a consequence of membrane fusion from granules with the plasma membrane 
(Borregaard and Cowland, 1997). Therefore, LPS-treated cells were analyzed for cell surface 
expression of several CD molecules known as degranulation markers, as described in Materials 
and Methods. 
Results showed that LPS stimulation clearly affected the ease of mobilization of intracellular 
granule types in neutrophils in a time-dependent manner, as reflected by increased 
translocation of CD markers to the cell surface (Fig. 2, Table IIB). In a temporal pattern, LPS 
stimulation increased the presence of CD15 and CD66b, CD11b as well as CD13, CD18, CD35 
and CD45 reflecting an increased release of specific granules, gelatinase granules and 
secretory vesicles, respectively.  
Maximal increase for the majority of these CD markers was detected after 12 h of LPS 
stimulation, except for i) CD35 which showed maximal translocation towards the plasma 
membrane already after 6 h of LPS, and ii) CD13 whose expression was highest upon 24 h LPS 
at the plasma membrane (related to the non-stimulated control at the same time point). On the 
other hand, LPS was unable to trigger the mobilization of azurophil granules since CD63 
expression was not changed at the plasma membrane. 
 
Linear fitting of cytokine secretion and degranulation kinetics 
Many approaches exist for the examination of time series of expression data (e.g. Ernst and 
Bar-Joseph, 2006), but none of them could be applied to analyze short-time series of secretion. 
For this reason, we used a novel model approach to explore the relationship between cytokine 
secretion and degranulation by their kinetic profiles (Fig. 3).  
We hypothesized that time series of secreted cytokines with similar pattern to time series of 
degranulation markers present at the plasma membrane should have proportional values at 
each time point of LPS stimulation, so that a proportionality factor between the two profile 
curves can be defined. To address this question, we choose to use the linear regression 
approach, which fits best to our needs: i) it captures proportionality well, ii) it can be used with 
only one pair of profiles (in our case cytokine vs. granule-specific marker), and iii) it includes 
measures to evaluate the results (significance of the model and R-squared value, see Materials 
and Methods). All ratio values between LPS- and non-stimulated control conditions from the 
time series of cytokine secretion and degranulation (Table II) were log10 normalized.  
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For each model, ANOVA analysis has been performed and the adjusted R-squared (RSQ) value 
and the slope of the model were retained. While the ANOVA analyses the efficiency of this 
model (i.e. proportional kinetic profile curves are significantly different from the null model), the 
adjusted RSQ value measures the correlation between the kinetic profiles (i.e. proximity to the 
linear fitting). Models with a significant difference to the null model (p-value ≤ 0.05) and with a 
high adjusted RSQ value between degranulation marker vs. secreted cytokine were considered 
as underlying a strong similarity of pattern between a degranulation marker and a secreted 
cytokine. The optimal RSQ value was determined by simulations, in which pre-defined 
perturbations were introduced to our kinetic profiles (see Materials and Methods). Fig. 4A 
shows how augmenting perturbations (e from 0 to 1) influenced the linear fitting between two 
time series, in our example the linear fitting between the granule marker CD15 and the cytokine 
CCL4. The original kinetic profile is depicted by the black line, whereas the one with 
perturbations is represented by the red line. By plotting the average RSQ values (derived from 
100 repetitions of simulations) against e values, k-means clustering can differentiate between 
“high” and “low” RSQ (Fig. 4B). By setting these parameters non-significant outcomes with “low” 
RSQ were eliminated, and the threshold for RSQ was set to RSQ ≥ 0.82. In Fig. 4C, an 
example of a significant linear fitting model is shown, in which the behaviour of CCL4 is 
correlated to CD15. Due to its p-value of 0 and RSQ of 0.91, the correlation between CCL4 and 
CD15 fits to the model.  
 
Relationship between degranulation and cytokine secretion 
After filtering only highly significant correlation data, results from human neutrophils were 
plotted. The linear fitting approach applied to the time series data showed that the secretion of 6 
out of our 10 selected pro-inflammatory cytokines strongly correlated with the release of 
secretory vesicles, gelatinase granules, and specific granules. Four cytokines have not been 
correlated to any degranulation markers: TNFα, IL-12b, CCL2, and CCL5.  
Secretory vesicles represented by the markers CD13, CD14, CD18, CD35 and CD45, were 
fitted to 4 cytokines, namely IL-1α, IL-1β, IL-8 and CCL3 (Fig. 5A). Moreover, time series of     
IL-1α and IL-8 release were strongly correlated to the degranulation marker CD11b, showing a 
relationship between gelatinase granules and these cytokines (Fig. 5B). Furthermore, the 
release of the cytokines IL-6, and CCL4 fitted to CD15 suggesting that secretion of these 
cytokines correlated to specific granules. In line with our results for IL-1α and IL-8, the two 
cytokines were also associated with CD66b. Interestingly there was a high overlap of cytokines 
that was fitted to the given markers of specific and gelatinase granules. Since no significant 
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cytokine correlation has been observed for CD63, azurophil granules are probably not 
associated with cytokine secretion.  
 
Discussion and Conclusion 
For many years, the contributory impact of neutrophils to the development of chronic 
inflammation was not extensively taken into account since they have been considered as 
terminally differentiated cells synthesizing low amount of RNA and protein (Witko-Sarsat et al., 
2000). Though, the vast number of neutrophils found at the site of infection cannot be neglected 
due to the fact that their secreted amounts of granule proteins and cytokines exert a synergistic 
and cumulative effect on the inflammatory tissue environment (Soehnlein, 2012). These pro-
inflammatory soluble mediators are highly decisive for the onset of inflammatory processes, the 
activation and the recruitment of various immune cells to the infection site (Nathan, 2006). 
However, little is known about the combination in which cytokines and granule proteins are 
secreted by neutrophils. In the present report, we therefore aimed to predict the spatiotemporal 
regulation of pro-inflammatory mediator release by neutrophils.  
Our study proposes an original approach allowing the establishment of a relationship between 
cytokine secretion and degranulation in neutrophils. We used the linear fitting approach to 
integrate data generated from own experiments and obtained from LPS-mediated short-time 
series of degranulation and cytokine secretion. Other approaches, such as Pearson correlation, 
are based only on the average of all correlated values. In contrast, our model is able to reliably 
establish time-specific associations between the two dynamic functions in neutrophils, 
respecting each time point of stimulation.  
According to our results, a number of cytokines could be fitted to the different types of neutrophil 
granules. The cytokines IL-1α, IL-1β, IL-8 and CCL3 correlated to secretory vesicles (Fig. 6A), 
which are the most easily mobilized organelles in mature neutrophils (Borregaard and Cowland, 
1997). Interestingly, IL-1α and IL-8 secretion was correlated to gelatinase and specific granules. 
The release of IL-6 and CCL4 was also fitted to specific degranulation. In contrast, 
degranulation of azurophil granules seems unchanged by LPS suggesting that either i) this 
granule type may require further cell activation to induce its mobilization towards the plasma 
membrane (Metzler et al., 2011), or ii) the upregulation of CD63 at the plasma membrane might 
not be significant enough to be detected since azurophil granules are rather poor in receptors in 
contrast to secretory vesicles (Borregaard and Cowland, 1997). For this reason, no cytokine 
could probably be fitted to CD63 in human neutrophils.  
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Given our results, the linear fitting approach characterizes the concurrent behavior of a large 
range of neutrophil-derived cytokines and granules upon inflammation. While granules have 
already been characterized to be mobilized towards the plasma membrane in reverse order to 
their formation according to the formed-first-released-last model (Pellme et al., 2006), our linear 
fitting approach underlines the key role of granules and cytokines released in a hierarchical 
sequence in accordance to their roles during the microbial elimination processes and 
inflammatory response. In addition, we would like to postulate the hypothesis that neutrophil 
cytokines are localized in or mobilized to the different granule types (Fig. 6B).  
Indeed, we found a significant correlation between kinetics of IL-8 secretion and the release of 
specific and gelatinase granules as well as secretory vesicles in human neutrophils. Given that 
cytokines can exert pleiotropic functions, some of them are probably localized in different types 
of granules as suggested by our model. In line with this observation, Pellmé et al. reported that 
IL-8 is stored in cytoplasmic granules in resting peripheral blood neutrophils and thus, can be 
rapidly mobilized and released by the cells (Pellme et al., 2006). Further, Terebuh et al. showed 
by immunohistochemical staining of neutrophils that IL-6 might be localized in gelatinase 
granules and secretory vesicles (Terebuh et al., 1992). The fact that their results derived from 
murine neutrophils might explain the discrepancy to our observations in which human 
neutrophil-derived IL-6 could be fitted to specific granules only. Moreover, the role of azurophil 
granules during cytokine secretion appears very restricted. In line with our results showing that 
this granule type is not significantly translocated to the plasma membrane upon LPS stimulation 
in neutrophils, the release of these granule contents might be rather concentrated to their 
involvement in neutrophil extracellular trap formation (Metzler et al., 2011).  
Additional studies are required to investigate the intracellular localization of cytokines in 
neutrophils, but this determination remains largely elusive by the fact that reliable staining for 
electron microscopy is facing challenges due to the low intracellular amount of cytokines. 
Further, other techniques used to document subcellular organelle location of cytokines have 
limited resolution (e.g. subcellular fractionation) (Pasquali et al., 1999).  
In comparison to the modelling approach proposed by Rørvig et al. (Rorvig et al., 2013), which 
is based on proteomic and mRNA array data to predict localization of proteins in granules, our 
approach is complementary by including functional data analysis. Hence, the linear fitting 
between degranulation and cytokine release in LPS-treated neutrophils represents an attractive 
method to investigate the potential localization of cytokines in the different types of granules 
even if additional experiments are required to confirm the intracellular localization of cytokines. 
Also, since our linear fitting approach has been adapted to investigate secretion kinetics, it can 
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easily be extrapolated for the analysis of other short-time series deriving from other cell-types, 
disease or developmental states, e.g. protein arrays or proteomics data.  
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Table I List of selected pro-inflammatory cytokines contributing to the development of chronic 
inflammatory disorders. 
 
Cytokine Cell recruitment Chronic inflammatory disorders 
TNFα Monocytes, neutrophils 
RA (Edwards and Hallett, 1997),  
IBD (Billiet et al., 2014),  
A (Zhang et al., 2014) 
IL-1α Neutrophils, monocytes, T cells 
RA (Hueber et al., 2007),  
IBD (Ludwiczek et al., 2004) 
IL-1β Neutrophils, monocytes, T cells RA (Edwards and Hallett, 1997) 
IL-6 Monocytes, B cells 
RA (Edwards and Hallett, 1997),  
IBD (Carey et al., 2008),  
A (Hartman and Frishman, 2014) 
IL-12b T cells 
RA (Vandenbroeck et al., 2004),  
IBD (Schmidt et al., 2002),  
A (Yong et al., 2013) 
CCL2 Monocytes, T cells 
RA (Hueber et al., 2007),  
A (Gerszten et al., 1999) 
CCL3 Monocytes, T cells 
RA (Chintalacharuvu et al., 2005),  
A (Kuziel et al., 2003) 
CCL4 Monocytes, T cells 
RA (Robinson et al., 1995),  
IBD (Banks et al., 2003),  
A (Kuziel et al., 2003) 
CCL5 Eosinophils, dendritic cells and T cells 
RA (Yao et al., 2006),  
A (Kuziel et al., 2003) 
IL-8 Neutrophils, macrophages, and lymphocytes 
RA (Edwards and Hallett, 1997),  
A (Gerszten et al., 1999),  
IBD (Mitsuyama et al., 1994) 
RA rheumatoid arthritis, IBD inflammatory bowel disease, A atherosclerosis 
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Table II Time-dependent secretion of cytokines and granules expressed in ratio between LPS- and non-stimulated cells ± SEM of at least three 
independent experiments. Significantly different from non-stimulated control at the same time point: * p < 0.05, ** p < 0.01, *** p < 0.001. 
(A) 
Relative secretion 0h LPS 2h LPS 4h LPS 6h LPS 12h LPS 24h LPS 
TNFα 0.85 ± 0.15 5.00 ± 1.86 19.91 ± 7.59 43.44 ± 18.23 * 44.23 ± 15.54 * 8.38 ± 2.90 
IL-1α 0.49 ±0.49 1.12 ± 0.24 3.06 ± 1.39 6.46 ± 4.53 6.43 ± 2.90 9.79 ± 1.80 
IL-1β 0.79 ±0.41 1.69 ± 0.32 * 4.53 ± 0.40 6.78 ± 2.99 8.05 ± 1.20 * 2.99 ± 0.40 
IL-6 0.92 ±0.09 1.22 ± 0.21 27.79 ± 20.60 55.48 ± 38.34 162.39 ± 44.37 * 13.40 ± 4.68 
IL-12b 1.05 ±0.11 0.86 ± 0.08 1.10 ± 0.02 1.21 ± 0.21 9.49 ± 4.87 1.39 ± 0.37 
CCL2 0.89 ±0.09 0.84 ± 0.11 1.17 ± 0.20 1.18 ± 0.25 73.21 ± 28.97 * 3.25 ± 1.32 
CCL3 1.00 ±0.00 14.55 ± 5.92 * 50.66 ± 20.85 * 97.10 ± 54.82 * 60.90 ± 32.28 * 6.55 ± 5.20 
CCL4 1.01 ±0.07 1.97 ± 0.58 7.03 ± 2.93 10.32 ± 6.72 100.54 ± 52.95 * 6.27 ± 5.42 
CCL5 0.93 ±0.02 1.61 ± 0.70 1.00 ± 0.08 0.90 ± 0.17 0.93 ± 0.06 1.03 ± 0.07 
IL-8 1.00 ±0.10 4.89 ± 1.76 * 7.80 ± 0.47 * 13.18 ± 1.13 * 25.40 ± 3.31 * 25.87 ± 2.54 
 
(B) 
Relative degranulation 0h LPS 2h LPS 4h LPS 6h LPS 12h LPS 24h LPS 
CD63 1.47 ± 0.63 1.09 ± 0.07 0.97 ± 0.07 1.02 ± 0.11 0.88 ± 0.16  0.92 ± 0.07 
CD15 1.02 ± 0.08 1.08 ± 0.11 1.26 ± 0.08 ** 1.23 ± 0.19  1.56 ± 0.24 ** 1.34 ± 0.12 
CD66b 1.02 ± 0.08 1.14 ± 0.09 1.37 ± 0.11 * 1.72 ± 0.05 *** 2.41 ± 1.77 *** 1.87 ± 0.26 *** 
CD11b 1.05 ± 0.14 1.29 ± 0.17 1.62 ± 0.18 ** 2.11 ± 0.13 *** 2.57 ± 0.23 *** 2.03 ± 0.34 * 
CD13 1.07 ± 0.18 1.08 ± 0.07 1.18 ± 0.09 1.38 ± 0.07 1.94 ± 2.33 * 1.76 ± 0.19 * 
CD14 1.00 ± 0.04 1.13 ± 0.12 1.31 ± 0.08 1.58 ± 0.31 1.23 ± 0.55 1.00 ± 0.23 
CD18 1.05 ± 0.14 1.26 ± 0.06 1.23 ± 0.08 1.61 ± 0.08 2.22 ± 0.88 ** 1.68 ± 0.15 * 
CD35 1.11 ± 0.23 1.26 ± 0.15 1.37 ± 0.18 1.60 ± 0.27 1.01 ± 0.33 1.05 ± 0.19 
CD45 1.03 ± 0.12 1.19 ± 0.09 1.39 ± 0.07 * 1.58 ± 0.12 ** 2.18 ± 0.39 *** 1.84 ± 0.29 ** 
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Figure Legends 
Figure 1 Time-dependent effect of LPS on cytokine secretion in human neutrophils. 
Cytokine secretion was measured by CBA upon stimulation with 100 ng/mL LPS for 0, 2, 4, 
6, 12 and 24 h. Results are mean secretion (pg/mL) ± SEM of at least three independent 
experiments. Significantly different from cytokine secretion in non-stimulated control at the 
corresponding time: * p < 0.05. 
Figure 2 Temporal pattern of degranulation upon LPS stimulation in human 
neutrophils. Translocation of degranulation markers to the plasma membrane was 
assessed using flow cytometry after cell treatment with 100 ng/mL LPS for 0, 2, 4, 6, 12 and 
24 h. Results are expressed in mean fluorescence intensity (MFI) of LPS-stimulated cells 
and non-stimulated control ± SEM of at least three independent experiments. Significantly 
different from non-stimulated control at the same time point: * p < 0.05, ** p < 0.01,              
*** p < 0.001.  
Figure 3 Workflow of linear fitting of LPS-mediated cytokine secretion and 
degranulation. A novel approach based on linear fitting was used to find linear relationship 
between short-time series of secreted cytokines with similar pattern to degranulation 
markers present at the plasma membrane. After importing data into R statistical software, all 
ratio values between LPS-stimulated and non-stimulated control conditions were log10 
normalized and treated as mentioned in Materials and Methods.  
Figure 4 Linear fitting approach for the kinetic analysis of degranulation and cytokine 
secretion. (A) Simulations were performed to find the optimal threshold for RSQ value, as 
described in Materials and Methods. After introducing perturbations (e value) to the kinetic 
profiles, the linear fitting decreases in significance. Here, the example depicts how the linear 
fitting between the granule marker CD15 and the cytokine CCL4 evaluates by introducing 
perturbations to the kinetic profiles. (B) Plot of average RSQ deriving from simulations 
(n=100) against augmenting e values. (C) Linear fitting model in which the behaviour of 
CCL4 is correlated to CD15. Due to its p-value of 0 and high RSQ of 0.91, the correlation 
between CCL4 and CD15 corresponds to a significant linear fitting model. 
Figure 5 Linear fitting of LPS-mediated kinetics of cytokine release and degranulation 
in human neutrophils. Enlisted cytokines on the histograms fitted to the kinetics of the 
degranulation markers characteristic for (A) secretory vesicles (CD13, CD14, CD18, CD35, 
CD45), (B) azurophil granules (CD63), specific granules (CD15, CD66b) and gelatinase 
granules (CD11b), according to the selection of p-value ≤ 0.05, and RSQ ≥ 0.82.  
Figure 6 Hypothetical model of fitted cytokines and granules in human neutrophils.                    
(A) Neutrophil-derived cytokines are released in a hierarchical sequence coincident with the 
roles of granules (IV secretory vesicles, III gelatinase granules, II specific granules,                
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I azurophil granules) during the microbial elimination processes and inflammatory response. 
Cytokines and granules are released in a concurrent fashion but (B) could additionally be 
localized in or mobilized to the different granule types. Classical secretory pathways are 
mediated through the endoplasmic reticulum (ER) and Golgi complex (e.g. IL-6, IL-8, CCL3, 
and CCL4). IL-1α and IL-1β are secreted on a non-conventional pathway. Possible routes for 
cytokine trafficking (after ER-Golgi or after cleavage) and mobilization to the plasma 
membrane relative to degranulation are shown in red. Different types of granules are 
characterized by their CD markers and proteolytic enzymes (triangles): CD63, 
myeloperoxidase and elastase for azurophil granules; CD66b as well as lactoferrin for 
specific granules; CD11b and gelatinase for gelatinase granules; and CD13, CD14, CD18, 
CD35 and CD45 for secretory vesicles. Upon mobilization of the granules to the plasma 
membrane, granule docking and fusion leads to the translocation of the CD markers to the 
plasma membrane as well as the release of proteolytic enzymes (myeloperoxidase, 
elastase, lactoferrin, and gelatinase) into the extracellular environment. 
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Figure 5 
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II An essential role of syntaxin 3 protein for granule 
exocytosis and secretion of IL-1α, IL-1β, IL-12b, and 
CCL4 from differentiated HL-60 cells  
 
Emerging evidence shows that neutrophils are able to package a variety of cytokines into 
cytoplasmic granules. In a prior study, we determined the concurrent behavior of LPS-mediated 
cytokine release and degranulation. In this part of the study, the aim is to characterize the 
intracellular SNARE machinery regulating neutrophil-derived cytokine secretion and 
degranulation.  
 
To investigate the functional role of SNAREs in neutrophil functions, we downregulated SNARE 
expression via RNAi interference. Since primary neutrophils are merely transfectable, we used 
the HL-60 cell line, which originates from malignant cells in the peripheral blood of a 36-year old 
female patient with acute promyelocytic leukemia (Lubbert and Koeffler, 1988). HL-60 cells can 
be differentiated into neutrophil-like cells (Koeffler and Golde, 1980; Collins, 1987) upon addition 
of dimethyl sulfoxide for 4.5 days (Collins et al., 1978; Mollinedo et al., 2008). 
 
In a first step, we identified the expression profiles of key regulators in exocytosis, members of 
the SNARE protein superfamily. We focused on the Qa-SNARE syntaxin 3 (STX3) whose 
expression is upregulated upon cell differentiation. Functional analysis revealed that STX3 
knockdown affects the secretion of the cytokines IL-1α, IL-1β, IL-12b, and CCL4, as well as 
gelatinase degranulation upon LPS stimulation. Using immunofluorescence microscopy, STX3 
could be partially localized in gelatinase B-positive compartments.  
 
In this part of the study we provide first evidence that STX3 interferes with cytokine secretion 
and degranulation while being localized in gelatinase granules in neutrophil-like HL-60 cells 
under pro-inflammatory conditions.  
!  
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Abbreviations 
CBA cytometric bead array 
dHL-60 DMSO-differentiated HL-60 cells 
LPS bacterial lipopolysaccharide from E.coli  
LTF lactoferrin 
MMP-9 gelatinase B, matrix metallopeptidase-9 
MPO myeloperoxidase 
SNARE soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
STX3 syntaxin 3 
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Abstract 
Besides their roles in the killing of pathogens, neutrophils have the capacity to package a variety 
of cytokines into cytoplasmic granules for subsequent release upon inflammatory conditions. 
Because the rapid secretion of cytokines orchestrates the action of other immune cells at the 
infection site and thus, can contribute to the development and chronicity of inflammatory 
diseases, we aimed to determine the intracellular soluble N-ethylmaleimide sensitive factor 
attachment protein receptor (SNARE) machinery responsible for the regulation of cytokine 
secretion and degranulation. 
From a constructed gene expression network, we first selected relevant cytokines for functional 
validation by the cytometric bead array approach. We established a cytokine secretion profile for 
human neutrophils and differentiated HL-60 cells (dHL-60 cells) underlining their similar ability to 
secrete a broad variety of cytokines within pro-inflammatory conditions mimicked by LPS 
stimulation.  
Secondly, after screening of SNARE genes by microarray experiments, we selected syntaxin 3 
(STX3) for further functional studies. Using a small interfering RNA strategy, we show that STX3 
is clearly required for the maximal release of IL-1α, IL-1β, IL-12b, and CCL4 without alteration of 
other cytokine secretion in dHL-60 cells. In addition, we demonstrate that STX3 is involved in 
MMP-9 exocytosis from gelatinase granules where STX3 is partly localized.  
Our results suggest that the secretion of IL-1α, IL-1β, IL-12b, and CCL4 occurs during 
gelatinase degranulation, a process controlled by STX3. In summary, these findings provide first 
evidence that STX3 has an essential role in trafficking pathways of cytokines in neutrophil 
granulocytes. 
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Introduction 
Neutrophil granulocytes are involved in the early recognition of microbial pathogens and 
subsequent triggering of an extensive pro-inflammatory response. To protect hosts from 
invading pathogens and ensure an efficient killing of infecting microorganisms, neutrophils 
possess, among other properties, the ability to liberate a plethora of potent cytotoxic molecules 
during the degranulation process (Borregaard and Cowland, 1997). 
During neutrophil maturation, over 300 antimicrobial and proteolytic proteins are distributed in a 
hierarchical order within four different types of granules: azurophil (primary), specific 
(secondary), gelatinase (tertiary) granules, as well as secretory vesicles (Borregaard and 
Cowland, 1997). These distinct intracellular granules are readily mobilized under pro-
inflammatory conditions and their contents are released in a reverse chronological order 
compared to their synthesis (Le Cabec et al., 1996; Cowland and Borregaard, 1999; Almkvist et 
al., 2001). 
Neutrophils are also a source of cytokines, which have a pivotal position in innate and adaptive 
immune regulatory networks. Initially, it was assumed that cytokines were stored by the 
neutrophil as preformed mediators within granules and released upon appropriate stimulation. 
Despite their terminal differentiation, it is now obvious that neutrophils display the capacity to 
rapidly de novo synthesize cytokines in response to a variety of inflammatory stimuli (Stanley 
and Lacy, 2010). Although subcellular fractionation of human neutrophils demonstrates that 
VEGF is stored within specific granules (Gaudry et al., 1997),! the precise intracellular 
localization of other neutrophil-derived cytokines has not yet been clearly characterized. 
Pro-inflammatory mediators orchestrate the action of other immune cells at the site of 
inflammation and also many functions of neutrophils themselves (Scapini et al., 2000), but they 
may also contribute to the persistence of inflammatory processes and hence the development of 
chronic inflammatory diseases, such as sepsis, rheumatoid arthritis, atherosclerosis or 
inflammation-related cancer (Kasama et al., 2005). On this basis, it is therefore evident that 
cytokine secretion needs to be tightly controlled to prevent deregulated or inappropriate release 
and subsequent pathological conditions. 
The signaling event required for rapid delivery of cytokines to the cell surface for extracellular 
secretion is still poorly characterized. In the past years, evidence has accumulated, which 
shows that soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNAREs) 
proteins (Sollner et al., 1993) are required for the regulation of granule fusion in neutrophils and 
release of their contents (Martin-Martin et al., 2000;!Mollinedo et al., 2003; Uriarte et al., 2011). 
Although it is now unequivocal that many SNARE proteins are expressed and involved in 
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intracellular vesicular trafficking pathways in neutrophils, specific mechanisms underlying the 
release of cytokines in neutrophils have not yet been clearly reported and data about 
involvement of SNAREs in this process appear poor in these cells. 
The aim of our work was to determine the role of the SNARE syntaxin 3 (STX3) in cytokine 
secretion and degranulation following activation by bacterial lipopolysaccharide (LPS) through 
cell surface receptors. Because neutrophils are short-lived and terminally differentiated, these 
cells are not amenable to genetic manipulation, such as transfection. For this reason, we used          
DMSO-differentiated HL-60 (dHL-60) cells, which exhibit neutrophil-like phenotypes (Harris and 
Ralph, 1985), to investigate molecular mechanisms related to exocytosis and SNARE proteins. 
Complementary experiments were performed in human primary neutrophils to ensure the 
relevance of our results. 
After determination of cytokine and SNARE expression profiles in dHL-60 cells and validation in 
human neutrophils, we showed that STX3 is involved in the secretion of IL-1α, IL-1β, IL-12b, 
and CCL4. We pointed out that STX3 is partly localized in gelatinase granules and is also 
required for exocytosis of their contents suggesting a common secretory pathway involving 
cytokine release and degranulation.  
 
Materials and Methods 
Cell culture  
The promyelocytic HL-60 cell line (Collins et al., 1977) was purchased at ATCC-American Type 
Culture Collection (Manassas, Virginia, USA) (CCL-240) and was cultured in RPMI-1640 
medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 
U/mL penicillin and streptomycin (Lonza, Verviers, Belgium). HL-60 cells were differentiated into 
neutrophil-like cells by addition of 1.3% DMSO to the culture medium for 4.5 days. The 
differentiation status of HL-60 cells upon DMSO treatment is evidenced by the monitored 
upregulation of CD11b (Carrigan et al., 2005), and downregulation of transferrin receptor 
(CD71) (Mora-Jensen et al., 2011) (data not shown).  
Purification of human neutrophils 
Peripheral blood of healthy volunteers was collected in EDTA-containing Vacutainer® tubes          
(BD Biosciences, Erembodegem, Belgium). Samples were collected in accordance with the 
good clinical practices and following the national and international ethical recommendations. 
Neutrophils were isolated from blood samples by Polymorphprep™ separation procedure (Axis-
Shield, Dundee, Scotland) according to manufacturer’s instructions. The efficacy of the 
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Polymorphprep method for neutrophil isolation from peripheral blood has been validated (Degel 
and Shokrani, 2010). Remaining erythrocytes in the neutrophil cell suspension were lysed for 10 
min with red blood cell lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4). 
Neutrophils were washed and resuspended in PBS 1X (pH 7.4). Purity of the isolated neutrophil 
population was ≥ 98% as analyzed by the BD FACSCanto™ II flow cytometer (BD Biosciences) 
using two mixtures of selection markers CD66b-FITC (clone B13.9)/ CD11b-PE (clone MEM-
174)/ CD14-APC (clone MEM-18) and CD15-FITC (clone MEM-158)/ CD16-PE (clone 
LNK16)/CD45-APC (clone MEM-28) (Immunotools, Friesoythe, Germany) on 10,000 events in 
the gated population of homogenous (FSC-A vs. SSC-A), single (SSC-A vs. SSC-H) and living 
cells (negative cells for Sytox Blue staining (Life Technologies, Gent, Belgium)). Purified 
neutrophils were positive for all the selection markers used by flow cytometry. Monocytes could 
be distinguished from the neutrophil population by CD11b+ CD66b- CD14high, lymphocytes by 
CD11b- CD66b- CD14-, and eosinophils by CD45+ CD16- and SSChigh (Suppl. Fig. 5). Human 
neutrophil samples were cultured in X-VIVO™ 15 medium with L-glutamine, and gentamicin 
(Lonza) at 37°C and 5% CO2 up to 24 h after purification. 
Cell stimulation  
dHL-60 cells and highly purified neutrophils were stimulated with bacterial LPS from E. coli 
serotype O111:B4 (Sigma, Bornem, Belgium) for simulating pro-inflammatory conditions. 
Because LPS at concentrations of 100ng/mL also acts on neutrophils independently of serum 
lipopolysaccharide-binding protein (Nakatomi et al., 1998), and to avoid any serum component 
contamination, which could interfere with specific LPS-induced cell responses, stimulations 
were carried out under serum-free conditions. For kinetic studies of cytokine mRNA expression, 
1x107 cells were treated with 100 ng/mL LPS for 2, 6 and 12 h. To analyze cytokine secretion 
and degranulation, dHL-60 cells or neutrophils were stimulated with different LPS 
concentrations (10, 30 and 100 ng/mL) for 6 or 12 h, respectively. Time points of 6 and 12 h of 
LPS stimulation were chosen according to the maximal cytokine mRNA expression levels.  
Total RNA extraction and quality control  
RNA from dHL-60 cells was extracted using innuPrep RNA mini kit (Analytik, Jena, Germany) 
according to manufacturer’s instructions. The quantity and quality of total RNA were evaluated 
by a NanoDrop® ND-2000 spectrophotometer (Thermo Scientific, Erembodegem, Belgium). To 
determine the integrity of total RNA, samples were examined on Agilent 2100 Bioanalyzer 
(Paolo Alto, USA) using an RNA 6000 Nano LabChip kit following supplier’s instructions.  
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Affymetrix microarray and data analysis 
Total RNA samples were reverse-transcribed to double-stranded cDNA using specific primers, 
which reduce the priming of rRNA. Then, cRNA was generated by in vitro transcription and 
reverse transcribed into a sense single-stranded cDNA. Afterwards, the cDNA was fragmented, 
labeled and hybridized on Affymetrix GeneChip® Human Gene 1.0 ST Arrays (Santa Clara, 
USA) according to the Ambion® WT Expression kit for Affymetrix® GeneChip® Whole Transcript 
(WT) Expression Array Protocol (P/N 4425209 Rev.B 05/2009) and GeneChip® WT Terminal 
Labeling and Hybridization User Manual for use with the Ambion® WT Expression kit (P/N 
702808 Rev.6) (Santa Clara, California, USA). Microarrays were then washed, stained and 
scanned according to manufacturer’s instructions. CEL files containing hybridization raw signal 
intensities were imported into Partek GS software (St. Louis, Missouri, USA) for further 
statistical analysis. First, probe intensities were summarized to gene expression signals using 
Partek default options (GC-content adjustment, RMA background correction, quantile 
normalization, log2 transformation and summarization by means). Variance in the dataset was 
then analyzed by using the Principal Component Analysis (PCA) approach. As PCA separated 
samples into four groups according to treatment and time, a two-way ANOVA followed by false 
discovery rate (FDR) correction were applied to detect differential expressed genes. Two cut-
offs were considered to identify those genes: FDR < 0.05 and absolute fold change ≥ 2. The 
networks were generated through the use of IPA (Ingenuity® Systems, Redwood City, CA, USA, 
www.ingenuity.com). Microarray expression data from LPS-stimulated dHL-60 cells are 
available at ArrayExpress (The EMBL-European Bioinformatics Institute, Cambridge, UK, 
www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-1393. Microarray 
expression data for SNARE expression from undifferentiated HL-60 cells, dHL-60 cells and 
human neutrophils are available under the accession number E-MTAB-2107.  
Quantitative real-time PCR (qPCR) 
cDNA was synthesized from 2 µg total RNA by using the ThermoScript™ Reverse 
Transcriptase System (Life Technologies). Forward and reverse primers (Table 1 and Table 2) 
were designed with the aid of the GenScript Online PCR Primer Design Tool 
(www.genscript.com). Primer efficiency and amplicon integrity were controlled by analysis of 
melting-curves, agarose gel and sequencing. Real-time qPCR was performed with iQ™ SYBR® 
Green Supermix (Bio-Rad Laboratories, Nazareth, Belgium) for 40 cycles on a MyIQ single 
color real-time qPCR detection system. All data were analyzed in triplicates. Quantification of 
mRNA levels was carried out with Bio-Rad iQ5 software and normalization of mRNA levels was 
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calculated with respect to the reference gene β-actin, according to the 2-ΔΔCT Livak method 
(Livak and Schmittgen, 2001). 
Short interfering RNA assays  
Double-stranded short interfering RNA (siRNA) of 19 nucleotides targeting human STX3 (as 
well as a non-silencing scramble siRNA) were custom-ordered from Eurogentec (Seraing, 
Belgium). Three synthesized siRNA candidate duplexes were tested for silencing efficiency. The 
most efficient siRNA to mediate knockdown expression of STX3 was chosen leading to ~80% 
expression inhibition and used for functional analysis. All experiments were performed with a 
siRNA duplex (sense: 5’-GGCACGAGAUGAAACGAAA-3’, antisense:                                            
5’-UUUCGUUUCAUCUCGUGCC-3’). The non-silencing control siRNA (sense:                          
5’-UGCGCUACGAUCGACGAUG-3’, antisense: 5’-CAUCGUCGAUCGUAGCGCA-3’) was used 
as a negative control. siRNA target sequences chosen in this study were screened by National 
Center for Biotechnology Information BLAST searches to avoid mismatches. dHL-60 cells 
(2x106) were transiently transfected with 2 µg of STX3 siRNA or non-silencing control sequence 
at day 3 of differentiation using the Nucleofector apparatus (Amaxa Biosystems, Cologne, 
Germany) and the Nucleofector V kit with program T-019 according to the manufacturer’s 
protocol. Terminally differentiated cells were processed for further experiments upon 48 h post-
transfection.    
Western Blot analysis  
Cells were lysed in a buffer containing 50 mM Hepes, pH 7.5; 150 mM NaCl; 10% glycerol;         
1 mM EDTA; 10 mM NaF; 0.5 mM Na3VO4; 1% Triton X-100; 1.5 mM MgCl2 supplemented with 
a mix of serine and cysteine protease inhibitors (cOmplete Protease Inhibitor Cocktail Tablets, 
Roche Molecular Biochemicals, Basel, Switzerland). For human neutrophil lysates, 30 µL of 
0.05 M diisopropylfluorophosphate (D0879, Sigma) was added to the 40x106 cell pellet prior to 
the addition of 500 µL lysis buffer. Lysates were centrifuged at 10 000 g at 4°C for 10 min and 
an equal volume of Laemmli 2X buffer was added to supernatants. After resolving heat-
denatured samples on 12% sodium dodecyl sulfate (SDS)-polyacrylamide gel, proteins were 
transferred onto nitrocellulose (HybondTM-ECL, Amersham, GE Healthcare, Belgium) 
membranes, which were saturated with blocking buffer containing 3% w/v non-fat milk. 
Immunodetection was realized by using rabbit polyclonal anti-STX3 (1:2000 dilution, clone 
A31534, Sigma) and mouse monoclonal anti-β-actin (1:500 dilution, clone C4, Millipore, 
Bruxelles, Belgium) as primary antibodies and horseradish peroxidase (HRP)-conjugated 
secondary antibodies directed against rabbit IgGs (1:10000 dilution, AP132P, Millipore) or 
mouse IgGs (1:20000 dilution, AP124P, Millipore). Revelation of bands was visualized by ECL 
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detection. Band intensities were quantified by densitometry using Image J densitometry 
software (National Institutes of Health, Bethesda, Maryland, USA). The integrated intensity of 
the target protein band was normalized to the reference protein (β-actin).  
Enzyme-linked immunosorbent assay (ELISA)  
To quantify the release of granule matrix proteins upon degranulation, supernatants from                 
LPS-stimulated dHL-60 cells were analyzed via human myeloperoxidase (MPO) ELISA kit 
(BMS2038INST, eBioscience, Vienna, Austria), human matrix metallopeptidase 9 (MMP-9) 
ELISA kit (ELH-MMP9-001, RayBio, Boechout, Belgium) and bovine albumin ELISA kit (E11-
113, Bethyl Laboratories) according to the manufacturer’s instructions. Cell cytotoxicity upon 
treatments was examined using lactate dehydrogenase assay (LDH, CytoTox 96® Non-
Radioactive Cytotoxicity Assay, G1780, Promega, Leiden, The Netherlands) according to 
manufacturer’s instructions. For normalization, ELISA absorbance results were divided by LDH 
absorbance values. 
Cell analysis by flow cytometry  
To analyze the rate of cell death, apoptotic cells were assessed by the use of annexin V-FITC 
apoptosis detection kit (556570, BD Biosciences) according to the manufacturer’s instructions. 
The percentage of apoptotic cells was determined as cells positive for annexin V-FITC labeling 
on the entire cell population.  
The most relevant markers have been selected for degranulation analysis, in accordance with 
the literature (Borregaard and Cowland, 1997). Degranulation was determined by measuring the 
expression of CD markers specific for azurophil granules (CD63-PE), gelatinase granules 
(CD11b-PE), and secretory vesicles (CD13-APC, CD14-APC, CD18-FITC, CD35-FITC, CD45-
APC) at the plasma membrane by flow cytometry (all antibodies are from BD Biosciences 
except CD14-APC from Immunotools). IgG1-FITC, IgG2a-PE (BD Biosciences) and IgG1-APC 
antibodies (Immunotools) were used as negative isotype controls, whereas CD45-FITC, CD45-
PE or CD45-APC (BD Biosciences) single dye staining was used to set compensations. Data 
analysis was performed by measuring the mean fluorescence intensity (MFI) for each CD 
marker with BD FACSDiva software (BD Biosciences) on the gated population of granulocytes 
(FSC-A vs. SSC-A), single (SSC-A vs. SSC-H) and living cells (negative cells for Sytox Blue 
staining (Life Technologies)). In total, 10,000 events were recorded per staining. The relative 
translocation at the plasma membrane of CD markers for each granule was determined by 
calculating the ratio between MFI of (+LPS/-LPS) of STX3 siRNA-treated dHL-60 cells and  
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Measurement of cytokine secretion by cytometric bead array (CBA) 
Cell density was adjusted to 2x106 cells per condition for subsequent quantitative measurement 
of cytokine secretion by LPS-stimulated cells. Fresh supernatants were collected and used 
directly for cytometric bead array (CBA, BD Biosciences) analysis. The multiplex standard curve 
composed of mixed cytokine standards was set up by serial dilutions according to the 
manufacturer’s instructions. Selected capture beads were prepared and added to supernatants. 
The following beads were used: CCL2 (MCP1, bead D8), CCL3 (MIP1α, bead B9), CCL4 
(MIP1ß, bead E4), CCL5 (RANTES, bead D4), IL-1α (bead D6), IL-1ß (bead B4), IL-6 (bead 
A7), IL-8 (CXCL8, bead A9), IL-12b (bead E5), and TNFα (bead C4). After 1 h of incubation, 
detection reagent was added to each sample. After 2 h of incubation, samples were rinsed with 
wash buffer and centrifuged. Samples were washed again prior to flow cytometry analysis (BD 
FACSCanto™ II, BD Biosciences). Results were quantified using the standard curves and the 
Flow Cytometric Analysis Program (FCAP) Array software (Soft Flow, Minneapolis, USA).  
Immunofluorescence analysis of STX3 localization 
Cells were centrifuged for 5 min at 300 g to adhere to glass coverslips. After fixation with 3% 
w/v paraformaldehyde/2% w/v sucrose in 1xPBS, cells were permeabilized in a 1xPBS buffer 
containing 0.1% w/v saponine and 0.5% w/v BSA, then blocked with 5% human IgG (Sigma). 
Cells were immunostained with the following primary antibodies: rabbit anti-human STX3 (1:400 
dilution, clone A31534, Sigma), mouse anti-human CD43 for plasma membrane (1:100 dilution, 
clone 290111, R&D Systems, Abingdon Oxon, United Kingdom), mouse anti-human calnexin 
(CNX) for endoplasmic reticulum (1:50 dilution, clone 546828, Millipore), mouse anti-human 
GM130 for Golgi (1:25 dilution, clone 35, BD Biosciences), mouse anti-human EEA1 for early 
endosomes (1:25 dilution, clone 14, BD Biosciences), mouse anti-human LAMP-1 (1:50 dilution, 
clone H4A3, BD Biosciences) and LAMP-2 (1:200 dilution, clone H4B4, BD Biosciences) for late 
endosomes, mouse anti-human myeloperoxidase (MPO) for azurophil granules (1:2500 dilution, 
clone 2C7, Thermo Scientific), mouse anti-human lactoferrin (LTF) for specific granules (1:1000 
dilution, clone 2B8, AbD Serotec, Düsseldorf, Germany), mouse anti-human MMP-9 for 
gelatinase granules (1:600 dilution, clone 5G3, Thermo Scientific), mouse anti-human 
tetranectin for secretory vesicles (1:40 dilution, clone 5B7, Thermo Scientific). To assure the 
specificity of the rabbit anti-human STX3 antibody, STX3 was immunostained in dHL-60 cells 
treated with non-silencing control siRNA and STX3 siRNA-treated dHL-60 cells. STX3 pixel 
intensities were quantified by densitometry using Image J densitometry software. The intensity 
of STX3 in STX3 siRNA-treated dHL-60 cells was normalized to the intensity in control dHL-60 
cells. These results show that STX3 fluorescent signal was significantly reduced in STX3 
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siRNA-treated dHL-60 cells, compared to the control siRNA-treated cells (Suppl. Fig. 3) and 
confirm the efficiently silenced STX3 protein level detected by Western blot in the entire siSTX3-
transfected cell population. In addition, immunostaining with each marker alone as positive 
controls served to detect and avoid any fluorescent signal bleed-through to other channels. The 
use of donkey serum (1:500 dilution, Jackson ImmunoResearch, Newmarket Suffolk, UK) 
served as negative control. After washing with blocking buffer, cells were incubated with cyanine 
3-conjugated donkey anti-mouse (1:150 dilution, 715-165-150, Jackson ImmunoResearch), 
AlexaFluor488-conjugated donkey anti-rabbit (1:200 dilution, A21206, Life Technologies) 
antibodies as well as DAPI for nuclear staining (1µM, D1306, Life Technologies). After washing, 
samples were mounted on Moviol/DABCO and monitored by confocal microscopy using a 
63×/1.4 oil objective with a 405 nm laser and a band pass BP 420-480 nm to excite and detect 
DAPI, a 488 nm laser and a BP 505-550 nm to excite and detect AlexaFluor488, and a 561 nm 
laser and a BP 575-615 nm to excite and detect cyanine 3, respectively (LSM 510 META; Zeiss, 
Zaventem, Belgium). Confocal 2D and z-stack images were deconvolved using AutoQuant X3 
(Media Cybernetics, Rockville, USA). A minimum of 100 cells per condition from z-stack images 
only was evaluated for Pearson correlation (PCC). The PCC was calculated since it is a rapid, 
simple and most importantly, robust tool to investigate co-localization of two proteins (Dunn et 
al., 2011). The PCC was evaluated for each entire image according to the equation mentioned 
by Barlow et al. (Barlow et al., 2010). In our case, we put the threshold of the PCC ≥ 0.7 in order 
to select only for highly positive correlation between green and red pixels. 
Statistical analysis 
Statistical analysis was performed by using the two-tailed unpaired Student's t-test in the Prism5 
software (Graph Pad Software, La Jolla, CA, USA). The difference between the means are 
considered statistically significant when the p-value is * p < 0.05; ** p < 0.01; *** p < 0.001. 
 
Results 
Cytokine expression network in differentiated HL-60 cells upon LPS stimulation 
So far, no complete pattern of cytokine secretion has yet been defined in dHL-60 cells upon 
LPS treatment. Further, data from the literature concerning the expression of many cytokines in 
human neutrophils (e.g. CCL2, CCL5, CCL7, CCL8, IL-10, IL-1B, IL-6 and TNF) are 
contradictory (Cassatella, 1995) and there are still many open questions about the exact 
cytokines actually released by human neutrophils upon pro-inflammatory conditions. To 
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examine the cytokine regulatory network, we firstly established the cytokine expression profile in 
LPS-treated dHL-60 cells and then validated our data in highly purified human neutrophils. 
We performed microarray gene expression analysis to define transcriptional alterations in  
dHL-60 cells upon LPS stimulation. dHL-60 cells were left untreated (non-stimulated control) or 
incubated in the presence of 100 ng/mL LPS for 2 or 6 h, and total RNA extracted from triplicate 
assays was analyzed. Hierarchical clustering of array data with average linkage and Pearson 
correlation as similarity metrics were used to examine the variability within the expression 
dataset. Correlation coefficients for replicates were > 0.995 indicating high assay reproducibility. 
Interestingly, among the 472 genes differentially regulated upon 6 h of LPS stimulation (only 70 
genes upregulated upon 2 h of LPS stimulation), 44 genes encoding cytokine molecules or 
receptors were found to be upregulated (microarray expression data are available under E-
MTAB-1393 at www.ebi.ac.uk/arrayexpress) emphasizing the importance of cytokine activity in 
the response to LPS. These include e.g. IL-6, TNF, IL-1B, CCL2, CCL5, CCL7, and CCL8. No 
downregulation of any of these 44 genes was observed at any time point of the study. 
To further explore the behavior of key players involved in the inflammatory response mediated 
by cytokines following LPS stimulation, our experimental data were analyzed using the Ingenuity 
Pathway Analysis platform (Ingenuity Systems®, www.ingenuity.com). Based on information 
available in the Ingenuity knowledge base describing the cytokines implicated in the biological 
response to LPS, a regulatory network was built by considering all genes that were 
overexpressed in our experimental dataset (treated vs. untreated cells after 6 h of stimulation). 
The resulting network represented in Fig. 1A shows that IL-8, IL-1A, IL-1B and TNF constitute 
four important nodes in the cytokine response to LPS. A direct impact of LPS treatment on 
CCL2, IL-12B and IL-6 gene expression was apparent from this analysis. In addition to these 
genes, three other relevant chemokines (CCL3, CCL4 and CCL5), described to have prominent 
roles in neutrophil-mediated inflammatory response (Lord et al., 1991; Kasama et al., 1993; 
VanOtteren et al., 1995; Kasama et al., 2005), have been chosen for qPCR validation. 
 
Cytokine mRNA expression in dHL-60 cells upon LPS stimulation 
Gene expression analysis of the selected set of cytokines by qPCR (Fig. 1B) was highly similar 
to the microarray results. The correlation of cytokine expression between microarray and qPCR 
data, derived from LPS-treated dHL-60 cells for 6 h, has been validated for statistical analysis 
using Pearson's correlation coefficient (R=0.79, p=4.45x10-5, data not shown) underlining the 
robustness of the analyses. Real-time qPCR time-series confirmed significant expression 
changes for 7 out of 10 genes examined. Transcript expression of selected cytokines was 
upregulated upon LPS stimulation, except for TNF, CCL3 and IL-8, for which no significant 
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change upon 6 h LPS treatment or downregulation was observed. Most of the cytokines 
presented a peak expression after 6 h, which decreased after 12 h of LPS stimulation. In 
addition, cytokine expression varied in magnitude. On this basis, cytokines can be classified into 
two groups: one grouping TNF, IL-1A, IL-1B, CCL2, CCL3, CCL5 and IL-8 showing moderate 
differential expression (inferior to 50-fold after LPS stimulation) and another including IL-6, IL-
12B and CCL4, exhibiting a high differential expression, superior to 50-fold after LPS 
stimulation. 
 
LPS-dependent cytokine release by dHL-60 cells  
Because mRNA levels do not necessarily reflect the relative amount of proteins, quantification 
of cytokine mRNA by qPCR needs to be interpreted carefully. To corroborate mRNA expression 
results at the protein functional level, we studied the ability of LPS to induce the release of 
cytokines.  
Differentiated HL-60 cells were treated with increasing concentrations of LPS and secreted 
cytokines were quantified using the CBA technology. Under non-stimulated conditions, CCL4 
and IL-8 were secreted to a basal level by dHL-60 cells. Stimulation of cells with low 
concentrations of LPS (0.1 ng/mL, 0.3 ng/mL, 1 ng/mL and 3 ng/mL) triggered a secretion of 
only IL-8 and CCL4 when compared to non-stimulated conditions (data not shown). Therefore, 
IL-8 and CCL4 can constitute a pool of pro-inflammatory mediators rapidly mobilized.  
In the presence of higher LPS concentrations (10 ng/mL, 30 ng/mL, and 100 ng/mL), all 
selected cytokines, whose transcripts were expressed, were also released into the extracellular 
medium upon LPS stimulation in a concentration-dependent manner (Fig. 2A). IL-8 and CCL4 
were found to be highly secreted whereas IL-1α, IL-1β, TNFα and CCL5 were only discretely 
detected. 
No variation of apoptosis rate has been observed in our experimental conditions (data not 
shown). In dHL-60 cells, the previously reported anti-apoptotic effect of LPS in neutrophils (Lee 
et al., 1993), is not pronounced, probably due the fact that they are derived from a patient with 
acute promyelocytic leukemia. 
 
Validation of cytokine secretion in highly purified human neutrophils 
Secretion of selected cytokines was additionally determined in primary human neutrophils 
isolated from peripheral blood. A preparation of neutrophils highly purified (≥ 98%) has been 
used for CBA experiments, avoiding as much as possible the presence of monocytes which 
have been reported to profoundly affect the data due to their high ability to secrete cytokines 
(Cassatella, 1999). To underline the fact that neutrophils are the source of the detected 
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cytokines, we analyzed cytokine secretion levels between neutrophils highly purified ≥ 98% and 
those purified to ≥ 90% (Suppl. Fig. 6) and observed that they are similar. Our purification data 
shows that the amount of monocytes is as low as 0.1%. According to our experimental 
conditions, we can conclude that the detected level of secreted cytokines such as IL-6 and 
CCL2 might not derive from monocytes. Additionally, monocytes are known to produce not only 
IL-6 in great quantities, but also TNFα, and IL-1. However, the latter two cytokines are secreted 
to a very low level (< 100 pg/mL). 
The maximal peak of secretion for the majority of the cytokines was reached at 12 h for a 
concentration of 100 ng/mL LPS. Fig. 2B shows that all the cytokines secreted by dHL-60 cells 
were also released by neutrophils. TNFα, IL-1α, IL-1β, CCL3, CCL5, and IL-12b were only 
discretely secreted (< 150 pg/mL) whereas IL-6, CCL4, and CCL2 were secreted at an 
intermediate level (~ 250-600 pg/mL) and IL-8 highly secreted (~ 10 000 pg/mL). The response 
is qualitatively similar in dHL-60 cells and neutrophils, despite quantitative difference in the 
cytokine secretion profile upon LPS stimulation. The similar cytokine secretion response from 
highly purified neutrophils as well as the neutrophil-like cell model additionally underlines the 
fact that neutrophils are the actual source of the detected cytokines. 
In accordance with the literature (Lee et al., 1993), cell apoptosis in neutrophils was shown to 
be significantly diminished upon 12 h of LPS treatment in our experimental conditions 
underlining the fact that LPS is able to delay apoptosis in freshly isolated human neutrophils 
(data not shown).  
 
Endogenous expression of v- and t-SNAREs in myeloid cells 
In a second step, we examined the expression of SNARE genes in promyelocytic non-
differentiated and DMSO-differentiated HL-60 cells to induce terminal differentiation along 
granulocyte lineage (Collins et al., 1977). For that, microarray experiments were conducted to 
detect the expression profile of SNARE genes (microarray expression data are available at 
www.ebi.ac.uk/arrayexpress). The docking and fusion of transport vesicles with target 
membranes are mediated by the direct interaction of vesicle SNAREs (v-SNAREs) including 
synaptobrevin/VAMP family members with target SNAREs (t-SNAREs) including syntaxins and 
SNAP25 homologues (Sollner et al., 1993). Data analysis revealed that 22 v- and t-SNAREs 
were expressed in HL-60 cells (Fig. 3A). 
To examine possible divergence of SNARE gene expression in native and differentiated                
HL-60 cells, we checked if SNARE mRNA patterns were modified during the process of DMSO 
differentiation. Considering a false discovery rate (FDR) < 5% and absolute fold changes (FC) ≥ 
2, Fig. 3A and Table 3 show that upon differentiation, the expression of two t-SNAREs (STX3 
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and STX11) and one v-SNARE (VAMP1) expression is upregulated at a level approximately 
2.5- to 3- fold higher than in undifferentiated HL-60 cells. To the contrary, mRNA expression 
levels of other SNAREs were not dramatically affected during the differentiation process.  
Then, microarray data were validated by qPCR using primers specifically designed and 
validated. Gene expression analysis was highly similar to the microarray results as highlighted 
by the upregulated expression of the same genes: STX3, STX11, and VAMP1 (Fig. 3B). For 
statistical analysis, correlation between the microarray and qPCR results has been validated 
using Pearson's correlation coefficient (R = 0.98, p < 0.0001, Fig. 3B insert). A comparable 
profile of SNARE mRNA expression has been found in highly purified human neutrophils except 
for STX2, STX18 and VAMP5, which were not expressed in primary cells (Table 3). 
Given that i) STX3, STX11 and VAMP1 are upregulated during the differentiation process in HL-
60 cells, ii) STX11 and VAMP1 had already been implicated in granule exocytosis in neutrophils 
(Nabokina, 2001; Mollinedo et al., 2006; Xie et al., 2009; D'Orlando et al., 2013), and iii) no 
study has ever considered the functional role of STX3 in neutrophils, we investigated whether 
STX3 is required for cytokine release in dHL-60 cells.  
Western blot analysis was carried out to correlate STX3 mRNA level to protein level and 
confirmed that this protein is expressed in mature peripheral blood human neutrophils and 
upregulated during neutrophil differentiation of HL-60 cells with DMSO (Fig. 4A). As expected, 
STX3 was found to be expressed in human neutrophils and dHL-60 cells using a specific 
antibody that recognized a band of 29 kDa. The level of STX3 protein was ~4.5-fold higher in 
differentiated HL-60 cells than in non-differentiated HL-60 cells. 
 
STX3 is required for LPS-induced release of IL-1α, IL-1β, IL-12b, and CCL4 from dHL-60 
cells 
To address the issue whether STX3 is functionally involved in cytokine secretion, we used 
specific siRNA sequences to target and selectively suppress endogenous STX3 protein. STX3 
siRNA led to an effective inhibition of the relevant target molecule. The mRNA level of targeted 
STX3 was reduced with a percentage of roughly 80% (Fig. 4B). Specificity of this knockdown 
was confirmed by the absence of any significant changes in the levels of other syntaxin isoforms 
(STX6, STX7 and STX11, data not shown). At the protein level, western blotting revealed that 
the knockdown resulted in a decrease of more than 50% of STX3 (Fig. 4C).  
In accordance with our results above, dHL-60 cells were stimulated for 6 h with 10 ng/mL LPS 
to analyze the role of STX3 on cytokine release. We found that downregulation of STX3 
reduced the secretion of IL-1α, IL-1β, IL-12b, and CCL4 elicited by LPS (Fig. 5). While STX3 
RESULTS  Manuscript II 
91 
 
deficiency affected the release of ~33% for IL-1α and IL-12b, ~23% for IL-1β, and ~16% for 
CCL4, STX3 siRNA did not affect the capacity of dHL-60 cells to release other cytokines. 
 
Downregulation of STX3 affects the LPS-mediated release of gelatinase granules in dHL-
60 cells 
Since i) STX3 affects the LPS-induced release of IL-1α, IL-1β, IL-12b, and CCL4, ii) it has been 
described that cytokines may be located in intracellular granules and vesicles (Gaudry et al., 
1997), and that iii) SNARE proteins are also involved in neutrophil granule exocytosis (Martin-
Martin et al., 2000; Mollinedo et al., 2003; Uriarte et al., 2011), we also investigated the 
requirement of STX3 for degranulation in dHL-60 cells. 
To this purpose, supernatants of dHL-60 cells stimulated by 10 ng/mL LPS for 6 h were tested 
by ELISA for secretion of soluble mediators that have been described characteristic for the 
different granule types: myeloperoxidase (MPO) for azurophil granules, matrix 
metalloproteinase-9 (MMP-9) for gelatinase granules, and serum albumin for secretory vesicles 
(Borregaard and Cowland, 1997). No marker of specific granules has been used since dHL-60 
cells are known to lack this type of granules (Harris and Ralph, 1985). 
As shown in Fig. 6A, dHL-60 cells treated with STX3 siRNA displayed about 50% reduction in 
their capacity to release MMP-9, compared to the control siRNA. On the contrary, MPO and 
albumin secretion was unchanged by the downregulation of STX3 expression. In parallel to the 
ELISA data, we performed additional experiments to investigate the effect of STX3 siRNA on 
the LPS-mediated degranulation in dHL-60 cells (Fig. 6B). Degranulation can be determined by 
the upregulation of granule membrane molecules as a consequence of membrane fusion from 
granules with the plasma membrane (Borregaard and Cowland, 1997; Cowland and 
Borregaard, 1999). Consequently, LPS-treated cells were analyzed for cell surface expression 
of several CD molecules known as degranulation markers, e.g. CD63 for azurophil granules. 
Consistent with our ELISA results, STX3 siRNA was able to inhibit the presence of CD11b at 
the plasma membrane about 65% upon 6 h of LPS stimulation and thus, the release of 
gelatinase granules in dHL-60 cells. Interestingly, knockdown of STX3 also altered the release 
of secretory vesicles, represented by the degranulation markers CD13, CD18, and CD45. 
 
Localization of STX3 in dHL-60 cells and human neutrophils 
Since STX3 knockdown affected the release of IL-1α, IL-1β, IL-12b, and CCL4, we investigated 
whether STX3 co-localized with organelles from the secretory pathways in dHL-60 cells and 
human neutrophils. In order to visualize intracellular proteins, immunofluorescence staining was 
performed: dHL-60 cells and human neutrophils were double-labeled with antibodies against 
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STX3 and markers for the nucleus (DAPI), plasma membrane (CD43), endoplasmic reticulum 
(calnexin), Golgi apparatus (GM130), early endosomes (EEA1), as well as the late endosomes 
(LAMP-1 and LAMP-2). Localization of STX3 was not observed at any of these subcellular 
levels in dHL-60 cells (Fig. 7A) and human neutrophils (Fig. 8A). 
Additional experiments were performed to address the question whether STX3 was located in 
the different types of granules. In this view, cells were co-labeled with STX3 antibodies and 
markers for the cytoplasmic granules, namely myeloperoxidase (MPO, azurophil granules), 
lactoferrin (LTF, specific granules), matrix metalloproteinase-9 (MMP-9, gelatinase granules), 
and tetranectin (TN, secretory vesicles). Results show that STX3 was partly co-localized with 
MMP-9 and TN in the membranes of gelatinase granules and secretory vesicles in dHL-60 cells 
(Fig. 7B), respectively. In human neutrophils, STX3 was also present in specific granules (Fig. 
8B).  
Same labeling procedures were performed in dHL-60 cells stimulated for 6 h with 100 ng/mL 
LPS and neutrophils stimulated for 12 h with 100 ng/mL LPS; STX3 did not relocalize in different 
organelles upon LPS stimulation (data not shown).  
 
Discussion 
Intensive research efforts have focused on the mechanisms leading to the production of pro-
inflammatory soluble mediators intimately involved in host immunity and the development of 
inflammatory disorders. Initially, macrophages were described as the major source of cytokines 
and neutrophils were considered unable to produce such molecules. Gradually, it became 
evident that cytokines are also released by neutrophils, which rapidly migrate to the 
inflammatory sites and play a preponderant role in the activation and recruitment of other cells 
of the immune system to sites of inflammation (Nathan, 2006). The first cytokine, and certainly 
the most studied, shown to be produced by human neutrophils is IL-8 (Altstaedt et al., 1996). 
Later, several studies have indicated that other pro-inflammatory cytokines including IL-1β, IL-6 
and TNFα as well as CCL3, CCL4, and IL-12 are also produced by neutrophils (Cassatella, 
1999), which may display some diversity in terms of expression. 
It is primordial to undoubtedly determine the cytokine profile in neutrophils and dHL-60 cells 
since controversies subsist on the nature of cytokines secreted by these cells (Cassatella, 
1999). After LPS stimulation, our data from microarray and qPCR experiments indicated that 
neutrophils and dHL-60 cells display a similar profile of cytokine mRNA expression (Suppl. Fig. 
4). Multiplex bead-based immunoassays afford a powerful strategy to sensitively detect 
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cytokines in the extracellular milieu, thereby allowing validation of cytokine expression at the 
functional level. Using the CBA technique, we found that TNFα, IL-1α, IL-1β, IL-6, IL-12b, CCL2, 
CCL3, CCL4, CCL5 and IL-8 are released by human neutrophils highly purified from peripheral 
blood and differentiated HL-60 cells confirming the capacity of these two cell types to similarly 
produce and secrete inflammatory mediators. For the first time, we were able to establish the 
strikingly similar transcriptome and cytokine secretion profiles in dHL-60 cells and human 
neutrophils. These results not only validated the attribute of the dHL-60 cell model, but also 
helped us to select significant pro-inflammatory mediators for further functional investigations in 
human cells. 
The mechanisms underlining cytokine release have been largely elusive but a few recent 
studies provided compelling evidence for an essential role of SNARE proteins in the exocytic 
pathway of myeloid cells. Initially, SNARE proteins have been involved in the process of 
cytosolic secretory granule fusion and exocytosis of their contents (Herrero-Turrion et al., 2008; 
Pivot-Pajot et al., 2008). Thereafter, several studies emphasized the critical role of SNAREs in 
many kinds of regulated secretory pathways in diverse cell types. In activated immune cells, an 
abundant increase of SNAREs at the plasma membrane allows the upregulation of vesicular 
traffic and secretion of cytokines (Pagan et al., 2003). Recently, a subset of t-SNAREs (STX4, 
SNAP23) has been reported to be substantially increased by LPS in a temporal pattern 
coinciding with TNFα peak secretion in activated macrophages. The increased trafficking of 
TNFα by overexpression of STX4 provided evidence that upregulation of STX4 is a necessary 
event for the TNFα secretion process (Pagan et al., 2003). A similar study using overexpression 
of intracellular SNARE proteins showed that STX6 has a rate-limiting role in TNFα trafficking 
and secretion (Murray et al., 2005). Therefore, we speculated on the contribution of distinct 
SNAREs in the release of cytokines in human neutrophils.  
Microarrays were used in a wider screen to search for all SNARE genes expressed in dHL-60 
cells and human neutrophils. In accordance with previous studies, we identified a range of 
SNAREs in both cell types among them diverse t-SNAREs: STX1, 3-7, 9, 11, 16 (Martin-Martin 
et al., 1999; Mollinedo et al., 2006). In particular, the expression of STX3 at mRNA and protein 
levels was upregulated upon differentiation of HL-60 cells towards neutrophil-like cells 
suggesting a functional role of this protein in mature neutrophils. Thus, STX3 has been selected 
from this screen as a potential regulator of cytokine release. By analyzing the participation of 
STX3 to cell-specific functional activities, we provide the first evidence of a role of STX3 in the 
release of four particular cytokines (IL-1α, IL-1β, IL-12b, and CCL4) in a model of neutrophils. 
Even though STX3 had been implicated in the release of de novo synthesized cytokines IL-8, 
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CCL2, CCL3 and CCL4 by mature human mast cells based on the use of neutralizing antibodies 
(Frank et al., 2011), its comparable role may not be obvious in neutrophils. In accordance with 
the SNARE hypothesis, different SNARE complexes constituted of variable SNARE proteins 
could be associated with specific functions in different cell types. For example, STX4 acts with 
VAMP3 in TNF secretion and phagocytosis in macrophages (Pagan et al., 2003; Murray et al., 
2005) whereas these two proteins are involved in degranulation in mast cells (Paumet et al., 
2000; Vaidyanathan et al., 2001; Pombo et al., 2003; Puri and Roche, 2006). It is also 
conceivable that STX3 interacts with different partners according cell types to control similar or 
different functions (Stow et al., 2009). To support this hypothesis, data established that STX4-
SNAP23 form a complex with VAMP1 or VAMP2 according to the different granule types for 
directing secretion (Martin-Martin et al., 2000; Mollinedo et al., 2006).  
The knockdown of STX3 protein led to different inhibition levels on secretion of IL-1α, IL-1β, IL-
12b, and CCL4 as well as MMP-9. In fact, the maximal amount of IL-1α and IL-1β was present 
in the supernatants of dHL-60 cells upon stimulation with 10 ng/mL LPS. IL-12b and CCL4 were 
maximally secreted upon stimulation with 100 ng/mL LPS. However, the different release 
pattern of these four cytokines does not preclude a role of STX3 in the regulation of the 
secretion pathway of these cytokines. It remains elusive in which way STX3 is specifically 
affecting cytokine release, therefore as a perspective, SNARE partners that form complexes 
with STX3 and lead to the specific release of these cytokines need to be revealed. Effectively, 
STX3 can have different SNARE partners in order to define the specific transport of the 
cytokines to the extracellular milieu. Alternatively, in neutrophils a release mechanism called 
compound exocytosis has been described in which granules fuse in a multivesicular manner 
with one another in the cytosol prior to fusion with the plasma membrane, or sequentially with 
the plasma membrane (Lollike et al., 2002). Thus, STX3 could be involved in the secretion of 
cytokines with different release pattern by regulating the fusion between individual vesicles 
before exocytosis. 
Traditionally, neutrophils have been seen as stores of preformed granules, and degranulation 
has been believed to mainly occur in a short-time range, meaning within maximally 2 h upon 
stimulation (Bentwood and Henson, 1980). However, this assumption needs to be balanced 
since granule mobilization differs on the agonist used (e.g. fMLF, PMA) and its applied 
concentration. Under our experimental conditions, the maximal degranulation level upon LPS 
stimulation occurs far later than upon 2 h. In accordance with our ELISA results, flow cytometry 
analysis confirms the time-dependent degranulation upon LPS stimulation (see Manuscript I). 
Also, it is generally admitted that neutrophils have the capacity to store and release loaded 
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cytokines into secretory granules (Gaudry et al., 1997). In dHL-60 cells, our data underline the 
evidence that STX3 is partly localized in gelatinase granules and secretory vesicles and 
involved in the regulation of the exocytosis of their components such as MMP-9. In neutrophils, 
STX3 co-localizes also with MMP-9 that tends to prove that similar mechanisms involving STX3 
for exocytosis may also occur in primary cells. Confirmation of this assumption is necessary but 
remains challenging since neutrophils are not amenable for genetic manipulations. Our results 
show that the knockdown of STX3 affects only MMP-9 release upon 6 h of LPS stimulation. 
Although STX3 siRNA was not able to trigger inhibition of albumin release, the mobilization of 
degranulation markers characteristic for secretory vesicles to the plasma membrane was 
disturbed upon STX3 deficiency (Fig. 6B). Because, the preponderant role of secretory vesicles 
is to fuse with the plasma membrane to deliver receptors to the cell surface (Borregaard and 
Cowland, 1997), we can hypothesize that STX3 is nevertheless involved in this phenomenon.  
Controversial reports have been published about the expression of MMP-9 in dHL-60 cells (Le 
Cabec et al., 1996). Our data provide clear evidence that i) MMP-9 mRNA is expressed (Suppl. 
Fig. 1), ii) MMP-9 protein is expressed in non-stimulated and LPS-stimulated dHL-60 cells (6h, 
100ng/mL LPS), and iii) MMP-9 protein is time-dependently secreted from dHL-60 cells upon 
stimulation with 100 ng/mL LPS. Additionally, we observed that MMP-9 mRNA expression was 
significantly upregulated upon LPS stimulation of dHL-60 cells pointing out that neutrophil-
specific granule proteins are not only preformed but also de novo synthesized (Suppl. Fig. 1). 
To assess whether dHL-60 cells and neutrophils release MMP-9 similarly, we observed that 
MMP-9 release levels were not as high in human neutrophils as in dHL-60 cells but were time-
dependently increased upon LPS stimulation (data not shown). 
According to our results, we can hypothesize on the location of IL-1α, IL-1β, IL-12b, and CCL4 
in gelatinase granules before exocytosis. These types of granules may be readily mobilized at 
the early stages of neutrophil activation inferring a major role of these four cytokines in the initial 
stage of inflammation. Though, confirmation of the subcellular organelle location of IL-1α, IL-1β, 
IL-12b, and CCL4 still remains a challenge since no convincing methods to determine the 
intracellular location of cytokines in neutrophils have been described to our knowledge. Actually, 
the low amount of cytokines often leads to non-reliable staining by electron microscopy and 
other techniques used to document subcellular organelle localization of cytokines have limited 
resolution (e.g. subcellular fractionation experiments) (Pasquali et al., 1999). Currently, some 
research groups dedicate efforts to develop more sensitive techniques that would be a 
significant achievement for the understanding of mechanisms underlining cytokine secretion 
(Lacy and Stow, 2011). Also, since STX3 knockdown induced a ~50% inhibition in the release 
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of MMP-9 but lower inhibition of IL-1α, IL-1β, IL-12b, and especially CCL4, it remains elusive to 
which amount the given cytokines could be stored in granules and to which extent the STX3 
interaction partners can lead to the specificity of this transport.   
We provide evidence that STX3, which has typically been described as a t-SNARE, is mainly 
localized in granules and secretory vesicles in neutrophils. In line with this result, STX7 has 
been previously reported to be present in azurophil granule membranes and relocalized to the 
plasma membrane after cell activation (Xie et al., 2010). Although in our experimental 
conditions, we did not observe any relocalization of STX3 upon LPS stimulation. These findings 
suggest that STX3 participates in fusion events between a compartment of the secretory 
pathway and gelatinase granules/secretory vesicles but not with the plasma membrane. As 
mentioned, at this level other SNARE partners could be implicated in the STX3-mediated 
release of IL-1α, IL-1β, IL-12b, and CCL4 and direct vesicle trafficking in a specific manner. 
Further interaction studies are required to identify partners of STX3 at the compartment of the 
secretory pathway and characterize potential other SNARE complexes involved in the release of 
these cytokines.  
Although mechanisms for cytokine secretion in neutrophils are still elusive, lines of evidence 
demonstrated that multiple pathways co-exist, in which SNAREs appear to play a fundamental 
role (Lollike et al., 2002; Stanley and Lacy, 2010). These distinct pathways may ensure a 
spatiotemporal regulation of cytokine release in line with their intended functions during the 
inflammatory response. The next interesting step is the identification of SNARE interactions and 
their distribution in order to determine relevant SNARE complexes dedicated to specific 
functions of neutrophils in a physiological state as well as in pathological conditions. Disruption 
of SNARE complexes may also offer a window for the development of novel pharmacological 
molecules for the treatment of chronic inflammatory diseases. 
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Table I Primer sequences used for cytokine gene expression by qPCR. 
Gene GenBank Ref Forward primer (5’ – 3’) Reverse primer (5’ – 3’) 
β-actin NM_001101 TGA-CCC-AGA-TCA-TGT-TTG-AGA AGT-CCA-TCA-CGA-TGC-CAG-T 
TNF NM_000594.2 GGA-CAC-CAT-GAG-CAC-TGA-AA AAG-AGG-CTG-AGG-AAC-AAG-CA 
IL1A NM_000575.3 GGA-GAT-GCC-TGA-GAT-ACC-CA CCG-TGA-GTT-TCC-CAG-AAG-AA 
IL1B NM_000576.2 CAC-ATG-GGA-TAA-CGA-GGC-TT TCC-ATA-TCC-TGT-CCC-TGG-AG 
IL6 NM_000600.3 CAC-ACA-GAC-AGC-CAC-TCA-CC AGT-GCC-TCT-TTG-CTG-CTT-TC 
IL12B NM_002187.2 AAG-GAG-GCG-AGG-TTC-TAA-GC GAA-TAA-TTC-TTG-GCC-TCG-CA 
CCL2 NM_002982.3 AGG-AAC-CGA-GAG-GCT-GAG-AC GCA-GAG-ACT-TTC-ATG-CTG-GA 
CCL3 NM_002983.2 TGC-TCA-GAA-TCA-TGC-AGG-TC TGA-TGC-AGA-GAA-CTG-GTT-GC 
CCL4 NM_002984.2 GGA-CAC-AGC-TGG-GTT-CTG-A TGG-TAT-TGG-TGG-CAA-AGA-GG 
CCL5 NM_002985.2 GGT-TCT-GAG-CTC-TGG-CTT-TG GCC-AGT-AAG-CTC-CTG-TGA-GG 
IL8 NM_000584.2 CTC-CAT-AAG-GCA-CAA-ACT-TTC-A GTT-CCT-TCC-GGT-GGT-TTC-TT 
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Table II Primer sequences used for SNARE gene expression by qPCR. 
Gene GenBank Ref Forward primer (5’ – 3’) Reverse primer (5’ – 3’) 
STX3 NM_000594.2 GAG-TGG-CCT-AAG-AGG-CTG-CTG-CA  GAA-CGG-GTC-GCA-CTC-GCT-CTC 
STX6 NM_005819.4 TGA-TCC-TGT-GTC-TGA-TCC-CA ACA-TTT-GGA-GCC-TGA-GTG-GA 
STX7 NM_003569.2 CTT-AGT-GCT-GTG-CTG-CCT-GA ACC-TGG-AGT-GAA-CTG-GTG-CT 
STX8 NM_004853.2 TGA-AGA-GGC-TAA-GCG-AGG-AG AAA-CCC-AAG-CCT-CTG-GTC-TC 
STX11 NM_003764.3               TTC-GCA-CTC-TCG-CTC-CCA-GTC-C GGA-TGT-GGT-CCG-TCT-CGA-ACA-CG 
STX16 NM_001001433.1 CCG-ACG-CTT-TCT-TGT-TGT-T GCA-ATG-CTA-CGT-GAA-TGC-AG 
SNAP23 NM_003825.2 AAG-AAC-TTT-GAG-TCT-GGC-AAG-G TTG-CTG-AAG-CTG-ACC-ATT-TG 
SNAP29 NM_004782.3 CAA-AGC-AAA-GGA-AAC-CTC-CA GCC-TAT-GGA-GGC-TGT-GGA-TA 
VAMP3 NM_004781 CAG-CTG-GCA-GTG-TTA-GGA-CA CAG-GAG-CCA-GTG-GGT-TAC-AT 
VAMP4 NM_003762.4 TCA-CTT-TGG-TAA-GTG-CCT-TTG-A TGA-GGA-ATT-GAG-AAG-CTA-GGG-A 
VAMP7 NM_005638.5 GCT-CGA-GCC-ATG-TGT-ATG-AA GCT-TGG-CCA-TGT-AAA-TCC-AC 
VAMP8 NM_003761.4 AAA-GTT-GGA-GCA-AGC-AGG-AA CAC-GAT-CAT-TTC-CTC-CAC-CT 
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Table III Genomic expression of SNAREs in HL-60 cells and neutrophils. 
 
! = no significant variation of genomic expression after differentiation of HL-60 cells 
" = increase of genomic expression after differentiation of HL-60 cells 
X = SNARE mRNA is not expressed in neutrophils 
ν = SNARE mRNA is expressed in neutrophils 
 
  
Official Symbol Gene Name HL-60 differentiation Neutrophils
STX2 syntaxin 2 X
STX3 syntaxin 3 ν
STX4 syntaxin 4 ν
STX5 syntaxin 5 ν
STX6 syntaxin 6 ν
STX7 syntaxin 7 ν
STX8 syntaxin 8 ν
STX10 syntaxin 10 ν
STX11 syntaxin 11 ν
STX12 syntaxin 12 ν
STX16 syntaxin 16 ν
STX17 syntaxin 17 ν
STX18 syntaxin 18 X
SNAP23 synaptosomal-associated protein (23 kDa) ν
SNAP29 synaptosomal-associated protein (29 kDa) ν
VAMP1 vesicle-associated membrane protein 1 ν
VAMP2 vesicle-associated membrane protein 2 ν
VAMP3 vesicle-associated membrane protein 3 ν
VAMP4 vesicle-associated membrane protein 4 ν
VAMP5 vesicle-associated membrane protein 5 X
VAMP7 vesicle-associated membrane protein 7 ν
VAMP8 vesicle-associated membrane protein 8 ν
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Figure Legends 
Figure 1 Cytokine transcript analysis of dHL-60 cells under pro-inflammatory conditions.  
(A) Microarray analysis was used to generate a literature-based cytokine expression network in 
LPS-stimulated dHL-60 cells using Ingenuity Pathway designer. The representation includes the 
biological interaction network of significant differentially expressed cytokine genes                       
(cut-off: FDR < 0.05 and FC ≥ 2) upon stimulation of dHL-60 cells for 6 h with 100 ng/mL LPS 
from E. coli O111:B4. LPS is represented as the single agonist for induction of cytokine 
expression network. Arrows represent interactions that promote expression. (B) Time-
dependent effect of LPS on cytokine mRNA expression. Validation of cytokine mRNA 
expression was performed by qPCR after treatment with 100 ng/mL LPS for 2, 6, and 12 h. Data 
were normalized to β-actin and expressed relative to the calibrator (non-stimulated control) at 
the corresponding time ± SEM of at least five independent experiments. Significantly different 
from cytokine expression in the non-stimulated control: * p < 0.05, ** p < 0.01.  
Figure 2 LPS-induced cytokine secretion in dHL-60 cells. (A) Concentration-dependent 
effect of LPS on cytokine secretion in dHL-60 cells. Cytokine secretion was measured by CBA 
upon 6 h stimulation with 10, 30, and 100 ng/mL LPS. Results are mean ± SEM of at least three 
independent experiments. Significantly different from cytokine secretion in 6 h non-stimulated 
control: ** p < 0.01. (B) LPS-induced cytokine secretion in highly purified peripheral blood 
neutrophils. Cytokine secretion was measured by CBA in ≥ 98% pure neutrophils upon 12 h 
stimulation with 100 ng/mL LPS. Results are mean ± SEM of at least three independent 
experiments. Significantly different from cytokine secretion in non-stimulated cells (control):              
** p < 0.01. 
Figure 3 Endogenous SNARE mRNA expression in dHL-60 cells compared to 
undifferentiated cells. (A) Screening of 22 SNARE genes was performed by microarray 
analysis. Data are given as ratio between DMSO-differentiated and undifferentiated HL-60 cells 
of three independent experiments (ANOVA, FDR < 0.05 and absolute FC ≥ 2). (B) SNARE 
expression of 14 genes was validated by qPCR in undifferentiated and differentiated HL-60 
cells. Data were normalized to β-actin and expressed relative to the SNARE expression in 
undifferentiated HL-60 cells ± SEM of at least three independent experiments. Significantly 
different from the SNARE expression in undifferentiated HL-60 cells: * p < 0.05. Correlation 
between microarray and qPCR SNARE expression log data is shown in insert.   
Figure 4 STX3 protein expression and efficiency of siRNA-mediated knockdown of STX3.  
(A) STX3 protein expression in undifferentiated HL-60 cells (ND), differentiated HL-60 cells (D) 
and neutrophils was determined by western blotting. Proteins were detected with specific rabbit 
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polyclonal anti-STX3. A western blot representative of nine independent experiments is shown. 
Histogram representing the densitometry evaluation of western blots was performed by Image J 
software. Protein level was normalized to β-actin. Results are given in ratio between 
differentiated and undifferentiated HL-60 cells ± SEM of at least nine independent experiments. 
Significantly different from undifferentiated HL-60 cells (control): * p < 0.05. (B) Efficiency of 
STX3 siRNA was determined by qPCR analysis. Differentiated HL-60 cells were transiently 
transfected with STX3 siRNA. The amount of STX3 mRNA in cells was normalized to β-actin and 
expressed as % of STX3 mRNA obtained from cells transfected with a non-silencing sequence 
used as control. Results are expressed as % ± SEM of at least five independent experiments. 
Significantly different from control: * p < 0.05. (C) Specificity of STX3 antibody was determined by 
western blot analysis. A western blot representative of three independent experiments is shown. 
Histogram shows efficiency of STX3 siRNA on protein expression. The integrated intensity of the 
target protein band was normalized to β-actin and expressed as % of control (non-silencing 
siRNA sequence). Results are expressed as % ± SEM of at least three independent experiments. 
Significantly different from control: * p < 0.05. 
Figure 5 Effect of STX3 knockdown in dHL-60 cells on cytokine secretion. Differentiated 
HL-60 cells were transiently transfected with STX3 siRNA. Transfected cells were assessed for 
cytokine secretion using CBA after 6 h stimulation by LPS (10 ng/mL). Results are expressed in 
relative cytokine secretion meaning the ratio between siRNA STX3 (+LPS/-LPS) and control-
transfected cells (+LPS/-LPS) ± SEM of at least three independent experiments. Significantly 
different from non-silencing siRNA: * p < 0.05.  
Figure 6 Effect of STX3 knockdown in dHL-60 cells on granule exocytosis. (A) Transfected 
cells were assessed for degranulation using myeloperoxidase (MPO), MMP-9, and albumin 
ELISA kits after 6 h stimulation by LPS (10 ng/mL). Cells transfected with a non-silencing 
sequence were used as control. Results are expressed in relative degranulation meaning the 
ratio between siRNA STX3 (+LPS/-LPS) and control-transfected cells (+LPS/-LPS) ± SEM of at 
least three independent experiments. Significantly different from non-silencing siRNA: ** p < 
0.01. (B) Degranulation was determined by measuring the expression of CD markers specific for 
different types of granules at the plasma membrane by flow cytometry. The relative 
translocation at the plasma membrane of CD markers for each granule was determined by 
calculating the ratio between MFI of (+LPS/-LPS) of STX3 siRNA-treated dHL-60 cells and 
(+LPS/-LPS) of non-silencing siRNA-treated dHL-60 cells. Data are given as fold control ± SEM 
of at least three independent experiments. Significant differences are indicated as follows: **p < 
0.01, ***p < 0.001. 
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Figure 7 Intracellular STX3 localization in dHL-60 cells. Colocalization experiments by 
immunofluorescence staining were performed with STX3 (green), (A) CD43 for plasma 
membrane, calnexin (CNX) for endoplasmic reticulum, GM130 for Golgi, EEA1 for early 
endosomes, LAMP-1 and LAMP-2 for late endosomes/lysosomes, (B) MPO for azurophil 
granules, lactoferrin (LTF) for specific granules, MMP-9 for gelatinase granules, tetranectin (TN) 
for secretory vesicles (red), and DAPI for cell nucleus (blue). Scale bar, 5 µm. Merge confocal 
images only represent green and red channels in order to conclude for co-localization. 
Corresponding scatter plots of the paired intensities of the green (y-axis for STX3 pixels) and 
red (x-axis for CD43, CNX, GM130, EEA1, LAMP-1, LAMP-2, MPO, LTF, MMP-9, or TN pixels) 
channels are depicted on the right column for the entire overlay image. Pearson correlation 
coefficients were calculated for both channels in deconvolved z-stack confocal images by 
AutoQuant X3. Values ≥ 0.7 were considered strongly positive for co-localization. I, II, III and IV 
represent the azurophil, specific and gelatinase granules as well as secretory vesicles, 
respectively. 
Figure 8 Intracellular STX3 localization in human neutrophils. Colocalization experiments 
by immunofluorescence staining were performed with STX3 (green), (A) CD43 for plasma 
membrane, calnexin (CNX) for endoplasmic reticulum, GM130 for Golgi, EEA1 for early 
endosomes, LAMP-1 and LAMP-2 for late endosomes/lysosomes, (B) MPO for azurophil 
granules, lactoferrin (LTF) for specific granules, MMP-9 for gelatinase granules, tetranectin (TN) 
for secretory vesicles (red), and DAPI for cell nucleus (blue). Scale bar, 5 µm. Merge confocal 
images only represent green and red channels in order to conclude for co-localization. 
Corresponding scatter plots of the paired intensities of the green (y-axis for STX3 pixels) and 
red (x-axis for CD43, CNX, GM130, EEA1, LAMP-1, LAMP-2, MPO, LTF, MMP-9, or TN pixels) 
channels are depicted on the right column for the entire overlay image. Pearson correlation 
coefficients were calculated for both channels in deconvolved z-stack confocal images by 
AutoQuant X3. Values ≥ 0.7 were considered strongly positive for co-localization. I, II, III and IV 
represent the azurophil, specific and gelatinase granules as well as secretory vesicles, 
respectively. 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
(A) 
STX3 CD43 DAPI Merge Correlation 
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(B) 
STX3 MPO DAPI Merge Correlation 
     
STX3 LTF DAPI Merge Correlation 
     
STX3 MMP-9 DAPI Merge Correlation 
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Figure 8 
(A) 
STX3 CD43 DAPI Merge Correlation 
     
STX3 Calnexin DAPI Merge Correlation 
     
STX3 GM130 DAPI Merge Correlation 
     
STX3 EEA1 DAPI Merge Correlation 
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(B) 
STX3 MPO DAPI Merge Correlation 
     
STX3 LTF DAPI Merge Correlation 
     
STX3 MMP-9 DAPI Merge Correlation 
     
STX3 TN DAPI Merge Correlation 
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1. Supplemental Data  
Suppl. Fig. 1 Time-dependent effect of LPS on MMP-9 mRNA expression in dHL-60 
cells. Validation of MMP-9 mRNA expression was performed by real-time qPCR after 
treatment with 100 ng/mL LPS for 2, 4, 6, and 12 h. Data were normalized to β-actin and 
expressed relative to the calibrator (non-stimulated control) at the corresponding time ± SEM 
of at least four independent experiments. Significantly different from MMP-9 expression in 
the non-stimulated control: ** p < 0.01, * p < 0.05. 
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Suppl. Fig. 2 Granule exocytosis from (A) dHL-60 cells and (B) human neutrophils 
upon LPS stimulation. Cells were assessed for degranulation using MMP-9 ELISA kit after 
2, 6 and 12 h stimulation by 100 ng/mL LPS. Supernatants from non-stimulated cells at the 
same time point served as control. ELISA results were normalized by LDH absorbance 
values. Results are expressed in relative degranulation meaning the ratio between LPS-
stimulated samples and non-stimulated samples ± SEM of at least four independent 
experiments. Significantly different from non-stimulated control: * p < 0.05. 
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Suppl. Fig. 3 Immunofluorescence analysis of STX3 in dHL-60 cells treated with non-
silencing siRNA (control) or STX3 siRNA and the corresponding densitometry evaluation. 
Results are given in ratio between STX3 siRNA- and non-silencing siRNA-treated (control) 
dHL-60 cells ± SEM of at least three independent experiments. Significantly different from 
non-silencing siRNA-treated dHL-60 cells (control): * p < 0.05. Scale bar, 5 µm. 
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Suppl. Fig. 4 Only highest cytokine mRNA expression pattern of dHL-60 cells and 
freshly purified neutrophils. Data were normalized to β-actin and expressed relative to the 
non-stimulated control ± SEM of at least five independent experiments. Significantly different 
cytokine expression between dHL-60 cells and human neutrophils: * p < 0.05. 
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Suppl. Fig. 5 Representative evaluation of neutrophil purity in our cell preparations. 
To specifically identify neutrophils, purity of isolated neutrophils was analyzed by the BD 
FACSCanto™ II flow cytometer (BD Biosciences) using two mixtures of selection markers 
CD66b-FITC/CD11b-PE/CD14-APC and CD15-FITC/CD16-PE/CD45-APC on 10,000 events 
in the gated population of homogenous (FSC-A vs. SSC-A), single (SSC-A vs. SSC-H) and 
living cells (negative cells for Sytox Blue staining). In our evaluation, neutrophils are 
CD11b+CD66b+CD14low (98.1%), monocytes are CD11b+CD66b-CD14high (0.1%), and 
lymphocytes are CD11b- CD66b-CD14- (1.8%). Eosinophils, that are CD45+ CD16- and 
SSChigh, are embedded in the lymphocyte gate of the last plot. 
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Suppl. Fig. 6 Purity of neutrophil preparations and LPS-induced cytokine secretion. 
Cytokine secretion was measured upon 12 h stimulation with 0, 10, 30, and 100 ng/mL LPS 
by (A) ≥ 98% pure neutrophils (n=3) and (B) ≥ 90% pure neutrophils (n=5). Results are mean 
± SEM of at least three independent experiments. Significantly different from cytokine 
secretion in non-stimulated control: * p < 0.01.  
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Manuscript III to$be$submitted 
 
III STX3 and SNAP29 assemble in a SNARE complex 
to regulate IL-12b secretion and MMP-9 exocytosis 
 
Previously, we identified the Qa-SNARE STX3 as a major player in secretion of cytokines 
and granules. However, further investigations are still needed to elucidate the precise 
mechanism by which STX3 specifically regulates the trafficking pathway.  
It is known that the first step in the SNARE assembly-disassembly cycle consists of the 
clustering of SNAREs into acceptor complexes and represents a rate-limiting step in the 
whole cycle. Hence, the aim of this part of the study was to identify potential Qb,c-SNARE 
partners interacting with STX3 which are specific for the pro-inflammatory mediator 
release.  
 
We investigated the expression of Qb,c-SNAREs in our cells and identified SNAP23 and 
SNAP29 to be potential candidates of STX3 interaction partners. Functional analysis shows 
that SNAP23 did not affect neutrophil functions whereby SNAP29 knockdown significantly 
inhibited the release of IL-12b, CCL2 and IL-8 as well as MMP-9. Immunofluorescence 
studies as well as proximity ligation experiments confirmed the colocalizaton of STX3 and 
SNAP29.  
 
Taken together, our findings point towards the formation of a cognate STX3-SNAP29 
complex with functional impact on cytokine release and degranulation.  
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Abstract  
During inflammatory processes, cascade of events leading to exocytosis in neutrophils need 
to be rigorously regulated in order to prevent chronic tissue injuries. Intracellular trafficking 
pathways are governed by components of the SNARE (soluble N-ethylmaleimide sensitive 
factor attachment protein receptor) fusion machinery. Formation of SNARE complexes 
mediates the fusion of two opposed membranes and, ultimately, the release of cargo 
proteins into the extracellular milieu.  
We have recently shown that the Qa-SNARE syntaxin 3 (STX3) is required for the release of 
IL-1α, IL-1β, IL-12b, CCL4 and MMP-9 upon LPS stimulation. Here, we analyze the 
involvement of Qb,c-SNARE partners in exocytosis and their potential association with STX3. 
Determination of SNARE mRNA expression revealed that SNAP29 and SNAP23 are 
expressed in neutrophil-like HL-60 cells and neutrophils isolated from venous peripheral 
blood. Inhibition of SNAP29 using a target-specific RNAi approach decreased IL-8, IL-12b, 
CCL2 and MMP-9 release whereas SNAP23 knockdown altered IL-8 release. Additionally, 
immunofluorescence studies showed that SNAP29 colocalizes and interacts with STX3.  
In summary, we provide evidence that SNAP29 in conjunction with STX3 are crucial for the 
release of IL-12b and MMP-9 and different combinations of SNARE proteins may adjust the 
secretion of other pro-inflammatory mediators. 
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Introduction 
Upon infection by microbial agents, activation of neutrophils is pivotal for the onset of 
inflammatory responses and thus, for efficient host defense mechanisms. During these 
processes, neutrophils aim to kill invading pathogens and recruit other immune cells to the 
site of inflammation (Cassatella, 1995; Borregaard and Cowland, 1997). Among other 
functions, they are able to release a large plethora of granule proteins (e.g. antimicrobial 
proteins, alarmins and proteases) and pro-inflammatory mediators such as cytokines, which 
are critical events for antimicrobial activity and communication between the innate and 
adaptive immune systems. Preformed or de novo synthesized mediators are specifically 
transferred between the different intracellular compartments to be exocytosed to the 
extracellular milieu in order to ensure an appropriate and adapted response.  
Because tissue integrity can be dramatically compromised by defective mechanisms of 
vesicle trafficking along the secretory pathway leading to the development of severe chronic 
inflammatory diseases such as inflammatory bowel disease (Radford-Smith and Jewell, 
1996), or rheumatoid arthritis (Edwards and Hallett, 1997), mechanisms of secretion of the 
various proteins involved must be firmly controlled. The identification of molecules involved 
in exocytosis of mediators is a critical step to provide novel therapeutic targets for the 
modulation of immune responses by neutrophils and thus, prevent inflammatory disorders 
since these cells are directly involved in the exacerbation of inflammation. 
In eukaryotic cells, vesicle-mediated trafficking and exocytosis are governed by key 
coordinators collectively called soluble N-ethylmaleimide sensitive factor attachment protein 
receptor (SNARE) proteins (Sanderfoot and Raikhel, 1999; Chen and Scheller, 2001). 
Different SNAREs from two opposing membranes act together in order to form complexes in 
trans-configuration and lead to the release of cargo molecules via fusion of vesicle and 
plasma membranes. To date, the highly conserved SNARE superfamily consists of 38 
mammalian members that are subdivided, accordingly to their central residue contributing to 
the SNARE complex formation, into Qa-, Qb,c- and R- SNAREs (Jahn and Sudhof, 1999). In 
general, one Qa- (syntaxin family) and two Qb,c-SNAREs (SNAP25 homologues) located on 
the target membrane generate so-called “acceptor complexes”. Previous study has shown 
that this step is rate-limiting for subsequent interaction with one R-SNARE (synaptobrevin 
family) located on the vesicle membrane in order to assemble to a twisted parallel 4-helical 
bundle and lead to the formation of the trans-SNARE complex (Jahn and Scheller, 2006). 
Many combinations between Q- and R-SNAREs exist in order to assure the specificity of 
intracellular trafficking and, ultimately, secretion.  
While SNAREs have first been discovered and broadly described in neuronal cells, their 
specific role and functional combination in immune cells still remains largely unknown. In 
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neutrophils, the Qa- and Qb,c-SNAREs syntaxin 6 and SNAP23 have been shown to form a 
complex mediating the release of CD67-enriched specific granules (Martin-Martin et al., 
2000).  
In a recent study, we determined the role of the Qa-SNARE syntaxin 3 (STX3) in the 
exocytosis pathway of gelatinase B (MMP-9), as well as the cytokines IL-1α, IL-1β, IL-12b 
and CCL4 upon LPS stimulation (see Manuscript II). Here we aim to further investigate the 
molecular machinery implicated in the trafficking pathway of mediators in neutrophils. Our 
research emphasizes on the identification of potential binding partners of STX3 regulating 
specific protein secretion. Since the rate-limiting step in the SNARE assembly-disassembly 
cycle consists of the formation of acceptor complexes by Qa- and Qb,c-SNAREs, we 
speculate on the participation of SNAP25 homologues in the release of cytokines in human 
neutrophils and degranulation together with STX3. In this study, we report that SNAP29 is 
associated to STX3 and regulates IL-12b and MMP-9 secretion under pro-inflammatory 
conditions in DMSO-differentiated HL-60 cells, a neutrophil cell model. 
 
Materials and Methods 
Cell culture  
The promyelocytic HL-60 cell line (Collins et al., 1979) was purchased at ATCC-American 
Type Culture Collection (Manassas, VA, USA) (CCL-240) and was cultured in RPMI-1640 
medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 
U/mL penicillin and streptomycin (Lonza, Verviers, Belgium). HL-60 cells were differentiated 
into neutrophil-like cells by addition of 1.3% DMSO to the culture medium for 4.5 days. 
Purification of human neutrophils 
Peripheral blood of healthy volunteers was collected in EDTA-containing Vacutainer® tubes         
(BD Biosciences, Erembodegem, Belgium). Samples were collected in accordance with the 
good clinical practices and following the national and international ethical recommendations. 
Neutrophils were isolated from blood samples by Polymorphprep™ separation procedure            
(Axis-Shield, Dundee, Scotland) according to manufacturer’s instructions. Remaining 
erythrocytes in the neutrophil cell suspension were lysed for 10 min with red blood cell lysis 
buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA, pH 7.4). Neutrophils were washed 
and resuspended in PBS 1X (pH 7.4). Purity of isolated neutrophils was analyzed by the BD 
FACSCanto™ II flow cytometer (BD Biosciences) using two mixtures of selection markers 
CD66b-FITC (clone B13.9)/ CD11b-PE (clone MEM-174)/ CD14-APC (clone MEM-18) and 
CD15-FITC (clone MEM-158)/ CD16-PE (clone LNK16)/CD45-APC (clone MEM-28) 
(Immunotools, Friesoythe, Germany) on 10,000 events in the gated population of 
homogenous (FSC-A vs. SSC-A), single (SSC-A vs. SSC-H) and living cells (negative cells 
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for Sytox Blue staining (Life Technologies, Gent, Belgium)). Purified neutrophils were 
positive for all the selection markers used by flow cytometry. Human neutrophils were 
cultured in X-VIVO™ 15 medium with L-glutamine, and gentamicin (Lonza) at 37°C and 5% 
CO2 up to 24 h after purification. 
Total RNA extraction  
RNA from dHL-60 cells was extracted using innuPrep RNA mini kit (Analytik, Jena, 
Germany) according to manufacturer’s instructions. The quantity and quality of total RNA 
were evaluated by a NanoDrop® ND-2000 spectrophotometer (Thermo Scientific, 
Erembodegem, Belgium).  
Quantitative real-time PCR (qPCR) 
cDNA was synthesized from 2 µg total RNA by using the ThermoScript™ Reverse 
Transcriptase System (Life Technologies, Gent, Belgium). Forward and reverse primers (for 
SNAP23: forward: 5’-AAG-AAC-TTT-GAG-TCT-GGC-AAG-G-3’; reverse: 5’-TTG-CTG-AAG-
CTG-ACC-ATT-TG-3’; for SNAP29: forward: 5’-CAA-AGC-AAA-GGA-AAC-CTC-CA-3’; 
reverse: 5’-GCC-TAT-GGA-GGC-TGT-GGA-TA-3’) were designed with the aid of the 
GenScript Online PCR Primer Design Tool (www.genscript.com). Primer efficiency and 
amplicon integrity were controlled by analysis of melting-curves, agarose gel and 
sequencing. qPCR was performed with iQ™ SYBR® Green Supermix (Bio-Rad Laboratories, 
Nazareth, Belgium) for 40 cycles on a MyIQ single color real-time qPCR detection system. 
All data were analyzed in triplicates. Quantification of mRNA levels was carried out with Bio-
Rad iQ5 software and normalization of mRNA levels was calculated with respect to the 
reference gene ß-actin according to the 2-ΔΔCT Livak method (Livak and Schmittgen, 2001). 
Short interfering RNA assays  
Double-stranded short interfering RNA (siRNA) of 19 nucleotides targeting human SNAP23 
and SNAP29 (as well as a non-silencing scramble siRNA) were custom-ordered from 
Eurogentec (Seraing, Belgium). Three synthesized siRNA candidate duplexes were tested 
for silencing efficiency. The most efficient siRNA to mediate knockdown expression of 
SNAP23 and SNAP29 was chosen leading to ~40% protein expression inhibition and used 
for functional analysis. All experiments were performed with a siRNA duplex against 
SNAP23 (sense: 5’-GAGCAAAGAAACUCAUUGA-3’; antisense: 5’-
UCAAUGAGUUUCUUUGCUC-3’) or SNAP29 (sense: 5’- GCCCAACAACAGAUUGAAA-3’, 
antisense: 5’- UUUCAAUCUGUUGUUGGGC-3’). The non-silencing control siRNA (sense: 
5’-UGCGCUACGAUCGACGAUG-3’, antisense: 5’-CAUCGUCGAUCGUAGCGCA-3’) was 
used as a negative control. siRNA target sequences chosen in this study were screened by 
National Center for Biotechnology Information BLAST searches to avoid mismatches.          
dHL-60 cells (2x106) were transiently transfected with 2 µg of SNAP23 or SNAP29 siRNA or 
non-silencing control sequence at day 3 of differentiation using the Nucleofector apparatus 
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(Amaxa Biosystems, Cologne, Germany) and the Nucleofector V kit with program T-019 
according to the manufacturer’s protocol. Terminally differentiated cells were processed for 
further experiments upon 48 h post-transfection.   
Western Blot analysis  
Cells were lysed in a buffer containing 50 mM Hepes, pH 7.5; 150 mM NaCl; 10% glycerol;        
1 mM EDTA; 10 mM NaF; 0.5 mM Na3VO4; 1% Triton X-100; 1.5 mM MgCl2 supplemented 
with a mix of serine and cysteine protease inhibitors (cOmplete Protease Inhibitor Cocktail 
Tablets, Roche Molecular Biochemicals, Basel, Switzerland). For human neutrophil lysates, 
30 µL of 0.05 M diisopropylfluorophosphate (D0879, Sigma) was added to the 40x106 cell 
pellet prior to the addition of 500 µL lysis buffer. Lysates were centrifuged at 10 000 g at 4°C 
for 10 min and an equal volume of Laemmli 2X buffer was added to supernatants. After 
separating samples on 12% SDS-PAGE, proteins were transferred onto nitrocellulose 
(HybondTM-ECL, Amersham, GE Healthcare, Belgium) membranes, which were saturated 
with a blocking buffer containing 3% w/v non-fat milk. Immunodetection was realized by 
using rabbit polyclonal anti-human SNAP23 (1:500 dilution, HPA001214, Sigma), mouse 
monoclonal anti-human SNAP29 (1:500 dilution, 3E4-E6, Novus Biologicals, Cambridge, 
United Kingdom) and mouse monoclonal anti-β-actin (1:500 dilution, clone C4, Millipore, 
Bruxelles, Belgium) as primary antibodies and horseradish peroxidase (HRP)-conjugated 
secondary antibodies directed against rabbit IgGs (1:10000 dilution, AP132P, Millipore) or 
mouse IgGs (1:20000 dilution, AP124P, Millipore). Revelation of bands was visualized by 
ECL detection. Band intensities were quantified by densitometry using ImageJ densitometry 
software (National Institutes of Health, Bethesda, Maryland, USA). The integrated intensity 
of the target protein band was normalized to the reference protein (β-actin).  
Enzyme-linked immunosorbent assay (ELISA)  
To quantify the release of granule matrix proteins upon degranulation, supernatants from                
dHL-60 cells, stimulated with 10 ng/mL bacterial LPS from E. coli serotype 0111:B4 (Sigma, 
Bornem, Belgium) for 6 h, were analyzed via human myeloperoxidase (MPO) ELISA kit 
(BMS2038INST, eBioscience, Vienna, Austria), human matrix metallopeptidase 9 (MMP-9) 
ELISA kit (Cat#: ELH-MMP-9-001, RayBio, Boechout, Belgium) and bovine albumin ELISA 
kit (E11-113, Bethyl Laboratories, Antwerpen, Belgium) according to the manufacturer’s 
instructions. Cell cytotoxicity upon treatments was examined using lactate dehydrogenase 
assay (LDH, CytoTox 96® Non-Radioactive Cytotoxicity Assay, G1780, Promega) according 
to manufacturer’s instructions. For normalization, ELISA absorbance results were divided by 
LDH absorbance values. The relative degranulation was determined by calculating the ratio 
between absorbance values of (+LPS/-LPS) of SNAP23 or SNAP29 siRNA-treated dHL-60 
cells and (+LPS/-LPS) of non-silencing siRNA-treated dHL-60 cells. 
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Measurement of cytokine secretion by cytometric bead array (CBA) 
dHL-60 cell density was adjusted to 2x106 cells per condition for subsequent quantitative 
measurement of cytokine secretion cells stimulated with 10 ng/mL bacterial LPS from E. coli 
serotype 0111:B4 for 6 h. Fresh supernatants were collected and used directly for cytometric 
bead array (CBA, BD Biosciences) analysis. The multiplex standard curve composed of 
mixed cytokine standards was set up by serial dilutions according to the manufacturer’s 
instructions. Selected capture beads were prepared and added to supernatants. The 
following beads were used: CCL2 (MCP1, bead D8), CCL3 (MIP1α, bead B9), CCL4 
(MIP1ß, bead E4), CCL5 (RANTES, bead D4), IL-1α (bead D6), IL-1ß (bead B4), IL-6 (bead 
A7), IL-8 (CXCL8, bead A9), IL-12b (bead E5), and TNFα (bead C4). After 1 h of incubation, 
detection reagent was added to each sample. After 2 h of incubation, samples were rinsed 
with wash buffer and centrifuged. Samples were washed again prior to flow cytometry 
analysis (BD FACSCanto™ II, BD Biosciences). Results were quantified using the standard 
curves and the Flow Cytometric Analysis Program (FCAP) Array software (Soft Flow, 
Minneapolis, USA).  
Immunofluorescence analysis of STX3-SNAP29 localization 
Cells were centrifuged for 5 min at 300 g to adhere to glass coverslips. After fixation with 3% 
w/v paraformaldehyde/2% w/v sucrose in PBS 1X, cells were permeabilized in a PBS 1X 
buffer containing 0.1% w/v saponine and 0.5% w/v BSA, then blocked with 5% human IgG 
(Sigma). Cells were immunostained with the following primary antibodies: rabbit anti-human 
STX3 (1:400 dilution, HPA002191, Sigma) and mouse anti-human SNAP29 (1:100 dilution, 
3E4-E6, Novus Biologicals). In addition, immunostaining with each marker alone as positive 
controls served to detect and avoid any fluorescent signal bleed-through to other channels. 
The use of donkey serum (1:500 dilution, Jackson ImmunoResearch, Newmarket Suffolk, 
UK) served as negative control. After washing with blocking buffer, cells were incubated with 
cyanine 3-conjugated donkey anti-mouse (1:150 dilution, 715-165-150, Jackson 
ImmunoResearch), AlexaFluor488-conjugated donkey anti-rabbit (1:200 dilution, A21206, 
Life Technologies) antibodies as well as DAPI for nuclear staining (1µM, D1306, Life 
Technologies). After washing, samples were mounted on Moviol/DABCO and monitored by 
confocal microscopy using a 63×/1.4 oil objective with a 405 nm laser and a band pass BP 
420-480 nm to excite and detect DAPI, a 488 nm laser and a BP 505-550 nm to excite and 
detect AlexaFluor488, and a 561 nm laser and a BP 575-615 nm to excite and detect 
cyanine 3, respectively (LSM 510 META; Zeiss, Zaventem, Belgium). Confocal 2D and         
z-stack images were deconvolved using AutoQuant X3 (Media Cybernetics, Rockville, USA). 
A minimum of 100 cells per condition from z-stack images only was evaluated for Pearson 
correlation (PCC). The PCC was calculated since it is a rapid, simple and most importantly, 
robust tool to investigate co-localization of two proteins (Dunn et al., 2011). The PCC was 
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evaluated for each entire image according to the equation mentioned by Barlow et al. 
(Barlow et al., 2010). In our case, we put the threshold of the PCC ≥ 0.7 in order to select 
only for highly positive correlation between green and red pixels. 
In situ proximity ligation assay (PLA) 
To investigate STX3 protein-protein interaction, we used the Duolink reagent kit (Sigma). 
Cell adherence, fixation, permeabilization, blocking steps and incubation with STX3 and 
SNAP29 primary antibodies were performed as described above. Then, procedures 
including PLA probes, hybridization, ligation, amplification, and detection were followed 
according to the manufacturer's protocol. Samples incubated with each primary antibody 
alone, as well as only PLA probes served as controls. After washing with wash buffer B 
(0.1M NaCl, 0.2M Tris base, 26g Tris-HCl, pH 7.5), samples were mounted on Duolink 
mounting medium (containing DAPI for nucleus staining) and monitored by confocal 
microscopy using a 63×/1.4 oil objective with a 405 nm laser and a band pass                          
BP 420-480 nm to excite and detect DAPI, and a 561 nm laser and a long pass LP 575 nm 
to excite and detect orange fluorescent dots, respectively. A minimum of 100 cells per 
condition from confocal 2D images were evaluated using Duolink® ImageTool.  
Statistical analysis 
Statistical analysis was performed by using the 2-tailed unpaired Student's t-test in the 
Prism5 software (Graph Pad Software, La Jolla, CA, USA). The difference between the 
means are considered statistically significant when the p-value is * = p < 0.05; ** = p < 0.01;    
*** = p < 0.001. 
 
Results 
Expression of SNAP23 in HL-60 cells and human neutrophils 
We have previously demonstrated that STX3 is expressed in both, human neutrophils and 
differentiated HL-60 cells, a cell model for neutrophils. By using the CBA technique, we 
showed that STX3 is involved in the exocytosis pathway of MMP-9 and secretion of 
cytokines IL-1α, IL-1β, IL-12b, and CCL4 upon LPS stimulation. Further, our microarray 
gene expression analysis (Arrayexpress, E-MTAB-2107) performed on HL-60 cells showed 
that SNAP23 and SNAP29 were the only Qb,c-SNAREs expressed in native and 
differentiated cells. Based on these elements, we hypothesized that at least one of these two 
proteins participates with STX3 in IL-1α, IL-1β, IL-12b, and CCL4 secretion in differentiated 
HL-60 cells and MMP-9 release. 
We assessed first the expression of SNAP23 in human neutrophils, promyelocytic native   
HL-60 cells and DMSO-treated HL-60 cells inducing terminal differentiation along 
granulocyte lineage (Collins, 1987).  
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To confirm microarray results, we used qPCR to determine the relative expression of 
detected SNAP23 mRNA. In both cell types, SNAP23 mRNA was similarly expressed and no 
modification during differentiation of HL-60 cells was observed (Fig. 1A). Because the 
mRNA level does not necessarily correlate to the protein level, Western blot analysis was 
carried out to quantify SNAP23 in native and differentiated HL-60 cells. In contrast to 
transcript expression, SNAP23 protein expression was more than 2-fold upregulated upon 
cell differentiation (Fig. 1B). The expression of SNAP23 protein was checked and confirmed 
in human neutrophils (Fig. 1B). 
  
Downregulation of SNAP23 inhibits LPS-mediated IL-8 secretion  
To address the issue whether SNAP23 is functionally involved in the cytokine secretion 
under pro-inflammatory conditions in neutrophils, we used siRNA sequences to selectively 
suppress SNAP23 proteins. Specific siRNA sequences led to effective knockdown of the 
respective target molecules compared to non-silencing siRNA; SNAP23 protein was reduced 
up to 40% (Fig. 1C).  
Unexpectedly, after 6 h stimulation of dHL-60 cells with 10 ng/mL LPS, we found that 
downregulation of SNAP23 decreased secretion of IL-8 of about 30% (Fig. 2A) without 
affecting the release of other cytokines, except for TNFα. Because adapted SNARE 
complexes with different sets of SNARE partners are probably associated with distinct 
inflammatory responses in neutrophils and since STX3 has also been demonstrated to 
regulate MMP-9 release, we approach the role of SNAP23 in the process of degranulation. 
To this end, supernatants of dHL-60 cells stimulated by 10 ng/mL LPS for 6 h were tested by 
ELISA for secretion of soluble mediators that have been described characteristic for the 
different granule types: myeloperoxidase (MPO) for azurophil granules, matrix 
metalloproteinase-9 (MMP-9) for gelatinase granules, and serum albumin for secretory 
vesicles (Borregaard and Cowland, 1997). No marker of specific granules has been used 
since dHL-60 cells are known to lack this type of granules (Harris and Ralph, 1985). 
SNAP23 siRNA does not affect the capacity of dHL-60 cells to secrete MMP-9 (Fig. 2B). In 
addition, release of MPO, and albumin was also not altered. 
  
SNAP29 knockdown affect LPS-mediated IL-12b secretion and MMP-9 exocytosis 
Beside SNAP23, our microarray data showed that SNAP29, a second homolog of SNAP25, 
was also expressed in HL-60 cells. This result was confirmed by qPCR and western blotting, 
although no upregulation during the differentiation process was observed (Fig. 3A and 3B). 
As expected, SNAP29 expression was also found in human neutrophils (Fig. 3B). 
Since SNAP29 has been reported to bind to a broad variety of syntaxin isoforms in in vitro 
studies (Steegmaier et al., 1998), we next examined if SNAP29 does possess a role in the 
intracellular signaling trafficking in combination with STX3. dHL-60 cells were transfected 
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with specific SNAP29 siRNA, which inhibited approximately 40 % of the protein level (Fig. 
3C). Upon LPS stimulation, SNAP29 knockdown reduced the release of IL-12b by almost 
40%, IL-8 by 33% and CCL2 by 30% (Fig. 4A). As previously observed for SNAP23, 
inhibition of SNAP29 triggered an increase of TNFα and IL-1β secretion. As shown in Fig. 
4B, SNAP29 siRNA led to a reduction of MMP-9 release by dHL-60 cells. MPO and albumin 
secretion was unchanged by the downregulation of SNAP29 expression. Because SNAP29 
and STX3 affected the release of MMP-9 and IL-12b we postulate that STX3 and SNAP29 
are involved in the formation of the same complex for the intracellular transport of MMP-9 
and IL-12b. 
  
SNAP29 colocalizes with STX3  
To assess our hypothesis, we investigated if SNAP29 and STX3 colocalize in dHL-60 cells 
and human neutrophils at the resting level. For that, cells were double-labeled with primary 
antibodies against STX3 and SNAP29 and the localization of endogenous proteins was 
examined by immunofluorescence microscopy. According to the pixel-based evaluation of 
our confocal images by Pearson correlation, we found a colocalization of STX3 with SNAP29 
in cytoplasmic granules of dHL-60 cells and human neutrophils (Fig. 5).  
Similar labeling procedures were performed in dHL-60 cells stimulated for 6 h with            
100 ng/mL LPS and neutrophils stimulated for 12 h with 100 ng/mL LPS. Interestingly, 
Pearson correlation coefficients were unchanged upon LPS stimulation (data not shown). 
These results are in accordance to our previous study in which STX3 did not relocalize to 
another cellular compartment upon LPS stimulation. Altogether, these data suggest that 
STX3 and SNAP29 participate to the regulation of the fusion events between individual 
cellular compartments before exocytosis. 
  
SNAP29 interacts with STX3  
In order to confirm that SNAP29 is a binding partner of STX3 involved in the secretory 
pathway, we performed interaction studies. First, interactions were examined via co-
immunoprecipitation experiments in total lysates of dHL-60 cells and human neutrophils. Our 
preliminary results suggested that STX3 was able to interact with SNAP29. However, 
probably due to the low expression level of SNAP29, only weak signals were detected and 
experiments were difficult to reproduce with reliability (data not shown). Consequently, to 
directly examine SNAP29 and STX3 interactions, we decided to use the in situ proximity 
ligation assay (PLA) technology which detects protein-protein interactions quantitatively as 
fluorescent distinct punctate spots by rolling-circle amplification reactions dependent on the 
close proximity of the both proteins (Soderberg et al., 2006). dHL-60 cells were probed with 
a combination of rabbit anti-human STX3 and mouse anti-human SNAP29 as primary 
antibodies as described in Materials and Methods. As shown in Fig. 6, red fluorescent spots 
RESULTS  Manuscript III 
130 
 
indicated close proximity of SNAP29 and STX3 heightening the fact that SNAP29 and STX3 
interact at the subcellular localization in our cells.  
 
Discussion  
In eukaryotic cells, SNARE proteins are known to be the major players of membrane fusion 
events. Initially, the involvement of SNAREs in the process of exocytosis has been 
extensively studied in neuronal cells. Over the years, studies underlining the role of these 
exocytotic proteins have been expanded to other cell types including immune cells. 
However, most research efforts focused on mast cells and macrophages and the regulation 
of protein trafficking by SNAREs in neutrophils remains largely elusive. It has been shown 
that Qa-SNARE STX4, located at the plasma membrane, is involved in the secretion of 
tertiary and specific granules in association with the Qb,c-SNARE SNAP23 and R-SNAREs 
VAMP1 and VAMP2 (Mollinedo et al., 2006; Logan et al., 2006). STX4 may also mediate the 
secretion of azurophil granules with R-SNAREs VAMP1 and VAMP7. Moreover, STX6 
present at the plasma membrane has been described as target SNARE for CD66b-positive 
specific granules containing SNAP23 (Martin-Martin et al., 2000). To our knowledge, the role 
of SNAREs has been investigated only in degranulation and has not yet been reported to be 
involved in cytokine secretion by neutrophils. We previously reported that the Qa-SNARE 
STX3 is expressed in neutrophils and knockdown of STX3 inhibited degranulation of MMP-9 
and secretion of IL-12b, CCL4, IL-1α and IL-1β. However, it is unknown which SNARE 
proteins interact with STX3 to ensure this specific regulation.  
In this study, we aim to identify STX3 partners, which are implicated in the regulation of the 
same protein trafficking pathway in a model of neutrophils. We show that Qb,c-SNARE 
SNAP29, a homologue of SNAP25 present in non-neuronal cells, is required for IL-12b and 
MMP-9 release in association with STX3. SNAP29 has been considered to be ubiquitously 
located on multiple membranes (Steegmaier et al., 1998) and to bind to a variety of syntaxin 
isoforms that reside on distinct intracellular organelles. In accordance with the literature 
(Steegmaier et al., 1998), we found that STX3 and SNAP29 also interact in dHL-60 cells. In 
addition, these results are the first documentation that SNAP29 is present in secretory 
compartments of neutrophil-like HL-60 cells, colocalizes with STX3 and participates in 
trafficking events leading to cytokine release.  
Interestingly, our results also showed that inhibition of SNAP29 mediated an increase of 
TNFα and IL-1β secretion. Downregulation of SNAP29 could disturb the steady state 
between the different SNAREs or regulatory factors leading to the formation or/and 
reorganization of specific SNARE complexes. 
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In addition, we cannot exclude the possibility that the downregulation of SNAP29 is 
compensated by other Qb,c-SNAREs. In this respect, also SNAP23 has been found 
colocalized with STX3 at the level of cytoplasmic granules (data not shown). However, 
inhibition of SNAP23 affected only the secretion of IL-8 and not IL-12b, CCL4, IL-1α and    
IL-1β release as previously observed for STX3 (see Manuscript II). In accordance with the 
SNARE hypothesis, neutrophils possess distinct secretory compartments whose exocytosis 
is regulated by different SNARE complexes constituted of different SNARE isoforms. In this 
regard, SNAP23 could interact with STX3 but depending on the other binding partners 
involved in the complex, different fusion steps and trafficking pathways could be regulated. 
Alternatively, SNAP23 could form “non-cognate” STX3-SNAP23 complex since SNARE 
proteins concentrated in overlapping membrane microdomains have been reported to form 
interactions with no functional cross-talk (Bethani et al., 2007). It is important to note that 
non-cognate SNARE complexes are able to fine-tune the fusion machinery and the 
specificity of vesicle trafficking by regulating the different levels of SNAREs available for 
trans-complex formation (Varlamov et al., 2004). In this sense, the purpose of STX3-
SNAP23 complexes in dHL-60 cells would result in the decrease of individual SNAP23 
protein and thus, downregulate the number of its cognate complexes and functional role.  
Further, while the formation of acceptor complexes by Qa- and Qb,c-SNAREs represent the 
rate-limiting step in the SNARE assembly-disassembly cycle, R-SNAREs have been 
proposed to have a role for specificity (Bennett, 1995). This specificity is probably also 
ensured by the assistance of other regulatory proteins (e.g. Sec1/Munc18-like proteins, 
complexins), which restrict the activity of interacting SNARE proteins in a spatial or temporal 
fashion (McNew et al., 2000).  
It will be now important to identify which other SNARE is associated to SNAP29-STX3 to 
mediate IL-12b and MMP-9 secretion. Under the assumption that a SNARE complex may 
generally consist of a bundle of four α-helices of three Q-SNAREs and one R-SNARE 
(Hong, 2005), several possibilities of SNARE association can be envisaged with the general 
idea that different associations could direct the secretion of specific cytokines. It is given that 
synaptobrevins attach to SNAP29-STX3 for the formation of the functional trans-SNARE 
complex. Moreover, SNAP29 could be present in multiple complexes and interact with 
different syntaxin isoforms to regulate diverse pathways of secretion and release of other 
cytokines (e.g. IL-8 and CCL2). 
To date, the specificity of vesicle-mediated transport pathways in neutrophils is still elusive. 
However, since we provide evidence that SNAP29 in association with STX3 are crucial for 
the release of IL-12b and MMP-9 and different combinations of SNARE proteins, the next 
steps are to identify R-SNAREs that interact with the STX3-SNAP29 complex and confirm 
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their common impacts to improve our understanding on cytokine secretion and 
degranulation. 
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Figure Legends 
Figure 1 Endogenous SNAP23 expression. 
(A) SNAP23 mRNA expression was validated by qPCR in dHL-60 cells. Data were 
normalized to β-actin and expressed relative to the SNAP23 expression in native HL-60 cells 
± SEM of at least three independent experiments.  
(B) SNAP23 protein expression in native HL-60 cells, DMSO-differentiated HL-60 (dHL-60) 
cells and neutrophils was determined by Western blotting. Proteins were detected with 
specific anti-SNAP23 antibodies. A western blot representative of four independent 
experiments is shown. Histogram representing the densitometry evaluation of western blots 
was performed by Image J software. Protein level was normalized to β-actin. Results are 
given in % ± SEM of at least four independent experiments. Significantly different from native 
HL-60 cells: * p < 0.05.  
(C) Efficiency of SNAP23 knockdown in dHL-60 cells. Differentiated HL-60 cells were 
transiently transfected with SNAP23 siRNA. The efficiency of SNAP23 protein knockdown is 
given in % ± SEM from at least three independent experiments, respectively. Significant 
differences in expression relative to the non-silencing siRNA control: * p < 0.05.  
Figure 2 Effect of SNAP23 knockdown in dHL-60 cells on cytokine secretion and 
granule exocytosis. Transfected cells were assessed after stimulation by 6 h LPS           
(10 ng/mL) for (A) cytokine secretion using CBA, and (B) for degranulation using MPO, 
MMP-9, and albumin ELISA kits. Cells transfected with a non-silencing sequence were used 
as control. Results are expressed in ratio of SNAP23 siRNA and non-silencing siRNA-
transfected cells ± SEM of at least three independent experiments. Significantly different 
from non-stimulated dHL-60 cells: * p < 0.05. 
Figure 3 Endogenous SNAP29 expression. 
(A) SNAP29 mRNA expression was validated by qPCR in the dHL-60 cells. Data were 
normalized to β-actin and expressed relative to the SNAP29 expression in native HL-60 cells 
± SEM of at least three independent experiments. Significantly different from native HL-60 
cells: * p < 0.05.  
(B) SNAP29 protein expression in native HL-60 cells, DMSO-differentiated HL-60 (dHL-60) 
cells and neutrophils was determined by Western blotting. Proteins were detected with 
specific anti-SNAP29 antibodies. A western blot representative of four independent 
experiments is shown. Histogram representing the densitometry evaluation of western blots 
was performed by Image J software. Protein level was normalized to β-actin. Results are 
given in % ± SEM of at least four independent experiments.  
(C) Efficiency of SNAP29 knockdown in dHL-60 cells. Differentiated HL-60 cells were 
transiently transfected with SNAP29 siRNA. The efficiency of SNAP29 protein knockdown is 
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given in % ± SEM from at least three independent experiments, respectively. Significant 
differences in expression relative to the non-silencing siRNA control: * p < 0.05.  
Figure 4 Effect of SNAP29 knockdown in dHL-60 cells on cytokine secretion and 
granule exocytosis. Transfected cells were assessed after stimulation by 6 h LPS            
(10 ng/mL) for (A) cytokine secretion using CBA, and (B) for degranulation using MPO, 
MMP-9, and albumin ELISA kits. Results are expressed in ratio of siRNA SNAP29 and non-
silencing siRNA-transfected cells ± SEM of at least three independent experiments. 
Significantly different from non-stimulated dHL-60 cells: * p < 0.05, ** p < 0.01. 
Figure 5 STX3 colocalizes with SNAP29. 
Intracellular localization of STX3, and SNAP29 in dHL-60 cells and human neutrophils. 
Colocalization experiments by immunofluorescence staining were performed with STX3 
(green), SNAP29 (red) and DAPI for cell nucleus (blue). Corresponding correlation 
histogram is depicted for the entire overlay image. Scale bar, 5 µm. Pearson correlation 
coefficients were calculated for red and green channels in z-stack confocal images by 
AutoQuant. Values between 0.4 and 0.7 were considered positive, whereas ≥ 0.7 were 
considered highly positive for the co-localisation.  
Figure 6 Intracellular interaction between STX3 and SNAP29.  
Protein interaction experiments by proximity-ligation assay were performed with primary anti-
STX3, anti-SNAP29, and Duolink kit on dHL-60 cells. DAPI in the mounting medium served 
to stain the nucleus (blue). Only interacting STX3 proteins with SNAP29 result in fluorescent 
dots as depicted in merge images. Scale bar, 5 µm. Negative control samples were only 
incubated with PLA probes, anti-STX3 alone, or anti-SNAP29 alone, respectively. 
Quantification of protein interactions was performed via Duolink Image Tool. Results are 
given in signals in the cytoplasm per cell ± SD from at least three independent experiments.  
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Figure 5 
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Figure 6 
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Additional Results 
  
IV VAMP3 R-SNARE-mediated secretion of IL-8 and 
MMP-9 
 
Previously, we found that the Qa-SNARE STX3 and the Qb,c-SNARE SNAP29 are co-localized 
in cytoplasmic granules and are able to form acceptor complexes. However, specificity of 
vesicle transport is concentrated on the interaction of the trans-SNARE complex with the R-
SNARE on the vesicle membrane. We therefore aimed to find a potential R-SNARE 
candidate for the STX3-SNAP29-SNARE complex. 
 
Endogenous expression level of R-SNARE VAMP3 
To investigate which R-SNAREs are expressed in human neutrophils and our cellular model, 
whole-transcript expression was analysed. Microarray expression data for SNARE expression 
from native HL-60 cells, dHL-60 cells and human neutrophils are available at ArrayExpress 
(www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-2107. In our cells, we 
determined the expression of 7 R-SNAREs: VAMP1-4 and VAMP7-8. Results showed that HL-
60 cells express VAMP1 to VAMP8. VAMP5 is the only one not expressed in human 
neutrophils. While VAMP1 seems to be the only R-SNARE whose expression is upregulated 
upon DMSO differentiation, all other VAMPs are equally expressed in native as well as in dHL-
60 cells.  
Literature-based analysis via Ingenuity showed that potential STX3 interaction partners are 
VAMP2, VAMP3, VAMP7 and VAMP8 (data not shown). Because i) VAMP1, VAMP2 and 
VAMP7 have already been largely described to act during degranulation within a SNARE 
complex involving STX4 and SNAP23 (Mollinedo et al., 2003; Mollinedo et al., 2006; Logan et 
al., 2006), and ii) VAMP8 mRNA expression was downregulated upon HL-60 differentiation, we 
focused on the potential role of VAMP3 in neutrophil degranulation and cytokine secretion and 
correlated to the functional analysis already performed on STX3- and SNAP29-mediated effects 
in neutrophils under pro-inflammatory conditions.  
In platelets, VAMP3 has been found in α-granules (Polgar et al., 2002). Regarding cytokine 
secretion pathways, VAMP3 is required for trans-Golgi transport of TNFα, together with STX4 
and STX6, in macrophages (Murray et al., 2005). Interestingly, VAMP3 overexpression results 
in increased IL-6 secretion in macrophages (Manderson et al., 2007).  
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To verify the transcript expression level of VAMP3, we performed qPCR and found that VAMP3 
was equally expressed in native HL-60 as well as in dHL-60 cells (data not shown). Western 
blot analysis using rabbit polyclonal antibodies targeted against human VAMP3 (1:1000 dilution, 
NB300-510, Novus Biologicals) revealed that VAMP3 protein expression was however 
upregulated upon DMSO differentiation (Fig. 1A). The upregulated expression of VAMP3 might 
point towards a functional role.  
 
  
VAMP3 knockdown affects secretion of the cytokines IL-8 and CCL4 as well as gelatinase 
degranulation  
To investigate the functional implication of VAMP3 in vesicle trafficking and exocytosis in 
neutrophils, we used an RNAi approach (sense: 5’-GCCAAGUUGAAGAGGAAAU-3’, antisense: 
5’-AUUUCCUCUUCAACUUGGC-3’) specifically targeting VAMP3 transcript. Efficient 
knockdown of VAMP3 was observed on the mRNA level with more than 70% inhibition (Fig. 
1B), and on protein level with more than 50% inhibition (Fig. 1C). The knockdown of VAMP3 
was also observed in VAMP3 siRNA-treated dHL-60 cells (Fig. 1D) upon immunofluorescence 
staining with primary sheep antibodies targeted against human VAMP3 (1:50 dilution, Novus 
Biologicals) and secondary AlexaFluor647-conjugated donkey anti-sheep (1:200 dilution, 713-
605-147, Jackson ImmunoResearch) antibodies as well as DAPI for nuclear staining (1µM, 
D1306, Life Technologies).  
To analyze the functional role of VAMP3 in cytokine secretion, we transfected the cells and 
stimulated them with 10 ng/mL LPS for 6 h. Compared to the non-silencing control, VAMP3 
siRNA affected the release of IL-8 and CCL4 of more than 50% upon LPS stimulation in the cell 
supernatants (Fig. 2A). However, we determined the STX3-SNAP29 couple to act in IL-12b and 
MMP-9 release, and not IL-8 and CCL4. STX3 knockdown affected also CCL4 release, and 
SNAP29 knockdown inhibited IL-8 release. In order to determine if VAMP3 might act in a 
different SNARE complex with STX3 (with another Qb,c-SNARE) or SNAP29 (with another Qa-
SNARE), we further investigated the impact of VAMP3 knockdown on the release of different 
granule types upon LPS stimulation. ELISA results show that VAMP3 knockdown specifically 
affects MMP-9 release about 50% in LPS-stimulated dHL-60 cells but leaves the release of 
MPO, and albumin unchanged (Fig. 2B). These results are in concordance with the effect of 
STX3- and SNAP29-mediated knockdown on gelatinase degranulation. 
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VAMP3 does not colocalize or interact with SNAP29  
As VAMP3 exerts a similar inhibitory effect on MMP-9 release, compared to STX3 and SNAP29, 
we investigated the intracellular localization of VAMP3 in order to conclude on a possible 
SNARE interplay with STX3 and SNAP29. Therefore, we labeled VAMP3 and performed 
immunofluorescence analysis. Previously, we demonstrated that SNAP29 is colocalized with 
STX3 in cytoplasmic granules. However, confocal images show that VAMP3 does not colocalize 
with SNAP29 (Fig. 3A). The same observation could be made with dHL-60 samples stimulated 
with LPS (data not shown).  
To confirm our findings, we performed proximity-ligation studies on dHL-60 cells labeling 
VAMP3, and SNAP29. Cells incubated with PLA probes only, or each of the primary antibodies 
alone served as negative controls. Additionally, samples incubated with mouse anti-human 
STX6 (1:100 dilution, clone 30, BD Biosciences) and sheep anti-human STX6 (1:40 dilution, 
AF5664, R&D Systems) served as positive control (Fig. 3B). Our results show that dHL-60 cells 
incubated with VAMP3 and SNAP29 primary antibodies did not result in any fluorescent spots 
visible in our confocal images. This means that VAMP3 does not interact with SNAP29 in dHL-
60 cells in non-stimulated or LPS-stimulated conditions, and is thus excluded as a candidate in 
the STX3-SNAP29 complex.  
  
VAMP3 is localized at the plasma membrane 
As VAMP3 does not colocalize with SNAP29, we want to determine the exact intracellular 
location of VAMP3 in our cells, and performed further labeling experiments. Confocal images of 
dHL-60 cells show that VAMP3 does not colocalize with the different markers of granule types, 
MPO, LTF, MMP-9 and TN (Fig. 4A). These results confirm that VAMP3 is not colocalized with 
SNAP29 (Fig. 3A), and thus not with cytoplasmic granules.  
In addition, VAMP3 was not observed to share same location with markers of the ER, Golgi, 
endosomes or lysosomes (Fig. 4B). The strongest colocalization could be found for VAMP3 and 
CD43, marker of the plasma membrane. These results confirm that VAMP3 is not implicated in 
the STX3-SNAP29 complex situated at the membrane of cytoplasmic granules. 
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Conclusion 
In the SNARE assembly-disassembly cycle, the interaction of the acceptor SNARE complex 
(consisting of Qa- and Qb,c-SNAREs) with the R-SNAREs confers to the specificity of the 
intracellular vesicle transport. In previous studies, we have already determined that i) the Qa-
SNARE STX3 is involved in the release of cytokines IL-1α, IL-1β, CCL4 and IL-12b, as well as 
gelatinase degranulation, ii) the Qb,c-SNARE SNAP29 represents a potential STX3 interaction 
partner, while it colocalizes with STX3 on cytoplasmic granules. In this part of the study, we 
questioned whether the R-SNARE VAMP3 is forming cognate complexes with STX3-SNAP29 to 
mediate neutrophil functions.  
Using an RNAi approach in our neutrophil-like HL-60 cell model, we show that VAMP3 
knockdown affects the secretion of the cytokines IL-8 and CCL4 upon LPS stimulation. Since IL-
8 and CCL4 are known to be stored and to be constitutively secreted in our cells (Pellme et al., 
2006), the specific inhibition of these cytokines points towards a key role of VAMP3 in 
constitutive exocytosis. 
Furthermore, VAMP3 also affects the release of MMP-9, the characteristic matrix protein of 
gelatinase granules. As we have identified STX3 and SNAP29 to affect specifically the same 
type of granules, VAMP3 could have been seen as a potential candidate for the STX3-SNAP29 
complex. Immunofluorescence and proximity ligation studies nevertheless demonstrated that 
VAMP3 and SNAP29 are not localized at the same intracellular level. While STX3 and SNAP29 
are present at cytoplasmic granules, further results revealed that VAMP3 is partly localized at 
the plasma membrane. Given our data, it is tempting to speculate that VAMP3 is implicated at 
the very end of the exocytotic event of gelatinase granules while STX3 and SNAP29 rather act 
on the level of cytoplasmic granules deeper inside the cell.  
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Figure Legends 
Figure 1 VAMP3 protein expression.  
(A) VAMP3 protein expression in undifferentiated HL-60 cells (ND), differentiated HL-60 cells 
(D) and neutrophils was determined by western blotting. Proteins were detected with specific 
rabbit polyclonal anti-VAMP3. A western blot representative of four independent experiments is 
shown. Histogram representing the densitometry evaluation of western blots was performed by 
Image J software. Protein level was normalized to β-actin. Results are given in ratio between 
differentiated and undifferentiated HL-60 cells ± SEM of at least four independent experiments.  
(B) Efficiency of VAMP3 siRNA was determined by qPCR analysis. Differentiated HL-60 cells 
were transiently transfected with VAMP3 siRNA. The amount of VAMP3 mRNA in cells was 
normalized to β-actin and expressed as % of VAMP3 mRNA obtained from cells transfected 
with a non-silencing sequence used as control. Results are expressed as % ± SEM of at least 
seven independent experiments. Significantly different from control: * p < 0.05.  
(C) Specificity of VAMP3 antibody was determined by western blot analysis. A western blot 
representative of three independent experiments is shown. Histogram shows efficiency of 
VAMP3 siRNA on protein expression. The integrated intensity of the target protein band was 
normalized to β-actin and expressed as % of control (non-silencing siRNA sequence). Results 
are expressed as % ± SEM of at least three independent experiments. Significantly different 
from control: * p < 0.05. 
(D) Immunofluorescence analysis of VAMP3 in dHL-60 cells treated with non-silencing siRNA 
(control) or VAMP3 siRNA. Scale bar, 5 µm. 
Figure 2 Functional role of VAMP3.  
(A) Effect of VAMP3 knockdown in dHL-60 cells on cytokine secretion and granule exocytosis. 
Differentiated HL-60 cells were transiently transfected with VAMP3 siRNA. Transfected cells 
were assessed for cytokine secretion using CBA after 6 h stimulation by LPS (10 ng/mL). 
Results are expressed in relative cytokine secretion meaning the ratio between siRNA VAMP3 
(+LPS/-LPS) and control-transfected cells (+LPS/-LPS) ± SEM of at least three independent 
experiments. Significantly different from non-silencing siRNA: * p < 0.05.  
(B) Transfected cells were assessed for degranulation using myeloperoxidase (MPO), MMP-9, 
and albumin ELISA kits after 6 h stimulation by LPS (10 ng/mL). Cells transfected with a non-
silencing sequence were used as control. Results are expressed in relative degranulation 
meaning the ratio between siRNA VAMP3 (+LPS/-LPS) and control-transfected cells                
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(+LPS/-LPS) ± SEM of at least three independent experiments. Significantly different from non-
silencing siRNA: ** p < 0.01.  
Figure 3 Colocalization and intracellular interaction between VAMP3 and SNAP29. 
(A) Colocalization experiments by immunofluorescence staining were performed with VAMP3 
(green), SNAP29 (red) and DAPI for cell nucleus (blue). Scale bar, 5 µm. Merge confocal 
images only represent green and red channels in order to conclude for co-localization. 
Corresponding scatter plots of the paired intensities of the green (y-axis for VAMP3 pixels) and 
red (x-axis for SNAP29 pixels) channels are depicted on the right column for the entire overlay 
image.  
(B) Protein interaction experiments by proximity-ligation assay were performed with primary 
anti-VAMP3, anti-SNAP29, and Duolink kit on dHL-60 cells. DAPI in the mounting medium 
served to stain the nucleus (blue). Only interacting VAMP3 proteins with SNAP29 result in 
fluorescent dots as depicted in merge images. Scale bar, 5 µm. Quantification of protein 
interactions via Duolink Image Tool.  
Figure 4 Intracellular VAMP3 localization in dHL-60 cells.  
Colocalization experiments by immunofluorescence staining were performed with VAMP3 
(green), (A) MPO for azurophil granules, lactoferrin (LTF) for specific granules, MMP-9 for 
gelatinase granules, tetranectin (TN) for secretory vesicles (red), (B) CD43 for plasma 
membrane, calnexin (CNX) for endoplasmic reticulum, GM130 for Golgi, EEA1 for early 
endosomes, LAMP-2 for late endosomes/lysosomes, and DAPI for cell nucleus (blue). Scale 
bar, 5 µm. Merge confocal images only represent green and red channels in order to conclude 
for co-localization. Corresponding scatter plots of the paired intensities of the green (y-axis for 
VAMP3 pixels) and red (x-axis for CD43, CNX, GM130, EEA1, LAMP-2, MPO, LTF, MMP-9, or 
TN pixels) channels are depicted on the right column for the entire overlay image. Pearson 
correlation coefficients were calculated for both channels in deconvolved z-stack confocal 
images by AutoQuant X3. Values ≥ 0.7 were considered strongly positive for co-localization.          
I, II, III and IV represent the azurophil, specific and gelatinase granules as well as secretory 
vesicles, respectively. 
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Figure 3 
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Figure 4 
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I Neutrophil-like HL-60 cells as experimental model 
Neutrophils are terminally differentiated cells with a very short lifespan in the blood circulation as 
well as in in vitro culture. Hence, manipulations on primary neutrophils are challenging and long-
term transfections for investigations are merely impossible. Further, isolated neutrophil 
preparations from the blood samples of different donors can be highly variable (e.g. alcohol 
consumption, smokers). The conditions of specimen handling (e.g. anticoagulant, buffy coat or 
fresh blood) have substantial impact on the outcome. Also, the preparation of ultra-pure 
neutrophil samples from whole blood is time-consuming, highly sensitive to temperature, can 
easily affect cell viability and lead to cellular pre-activation.  
Therefore, cell lines represent an asset to analyze neutrophil functions due to their unlimited 
supply of cell material and availability of more homogeneous cell populations. To date, 
conditional immortalization of human neutrophil precursor cells has been unsuccessful and has 
only been achieved in murine cells (McDonald et al., 2011). However, murine cells do not 
appropriately reflect the behavior of human neutrophils due to interspecies variability. For 
example, the azurophil granule protein defensin is present in human neutrophils but absent in 
murine neutrophils. Also while neutrophils represent 50-70% of the human peripheral white 
blood cells, they account only for 10-25% in the murine organism (Doeing et al., 2003).  
Since many years, the most extensively used cell line for investigating human neutrophil 
function has been the HL-60 cell line (Collins et al., 1978; Drexler et al., 1995), derived from a 
36 years old female patient with acute promyelocytic leukemia, and differentiated by the use of 
chemicals (mostly DMSO) into neutrophil-like cells. Several reports have characterized the 
morphological and functional changes upon differentiation in HL-60 cells (dHL-60 cells) 
(Gallagher et al., 1979; Mollinedo et al., 2008). The differentiation status of HL-60 cells upon 
DMSO treatment can effectively be monitored by the upregulation of CD11b (Carrigan et al., 
2005), and downregulation of transferrin receptor (CD71) at the plasma membrane (Mora-
Jensen et al., 2011). The HL-60 cell line is easily transfectable and has been regarded as a very 
suitable model for studies on respiratory burst activity (Teufelhofer et al., 2003), phagocytosis 
(Fleck et al., 2005), and cell migration (Millius and Weiner, 2010).  
 
However, early reports on dHL-60 cells demonstrated a lack in granule maturation and the 
absence of specific granules (Collins, 1987; Parmley et al., 1987; Gallagher et al., 1979; 
Johnston et al., 1992; Le Cabec et al., 1997). In our studies, the characteristic protein for 
specific granules, LTF, was indeed undetectable by immunofluorescence microscopy or ELISA. 
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The absence of LTF however might not be a consequence of a genetic aberration, as the LTF 
gene was reported to be structurally intact and the sequence of the 5’ region completely normal 
(Johnston et al., 1992). Therefore, Johnston et al. only questioned the absence or dysfunction of 
an essential factor in the induction of mRNA transcription. Alternative cell lines such as PLB-985 
cells have similarly been reported to lack this type of granules (Pivot-Pajot et al., 2010) and thus 
do not represent a more suitable model for neutrophils. 
dHL-60 cells have been claimed to exclusively express azurophil granules (Dahlgren, 1989). 
The amount of the matrix protein MPO (4.4 µg per 106 cells) in azurophil granules was found to 
be similar in dHL-60 cells and in mature neutrophils. We provide evidence via 
immunofluorescence microscopy that MPO is present and detectable in dHL-60 cells. In the 
same line, azurophil granules were also determined by the presence of the CD63 granule 
marker via flow cytometry. However, MPO release and CD63 mobilization to the plasma 
membrane were both not significantly changed upon LPS stimulation. This might be explained 
by the fact that azurophil granules can only partially be mobilized (Sengelov et al., 1993; Nusse 
et al., 1998; Faurschou et al., 2002). 
Even though several reports also questioned the formation of gelatinase granules along HL-60 
differentiation (Lubbert et al., 1991; Newburger et al., 1979; Borregaard and Cowland, 1997), 
our data demonstrate that MMP-9 mRNA is expressed in dHL-60 cells (see Supplementary 
Data Manuscript II) and supports the first reports from Davis et al., in which MMP-9 is 
synthesized in HL-60 cells (Davis and Martin, 1990). Another report suggested that the 
continuous MMP-9 mRNA synthesis in HL-60 cells is regulated via ERK1/2 activity (Heidinger, 
2006). On the protein level, a previously published report from our group already detected basal 
MMP-9 activity in supernatants from DMSO-differentiated HL-60 cells via gelatinase 
zymography (Bernard et al., 2008). Ries et al. suggested that basal MMP-9 release is 
dependent on the TNFα-induced protein kinase C signaling pathway (Ries et al., 1994), and that 
other biologically active agents such as growth factors (e.g. EGF) and cytokines (e.g. IL-1, 
TNFα) might induce MMP-9 production in HL-60 cells in a para- or autocrine pathway 
(Gazzanelli et al., 2000). In addition, ELISA results showed that MMP-9 release levels from 
human neutrophils and dHL-60 cells were time-dependently increased upon LPS stimulation in 
a similar fashion (see Supplementary Data Manuscript II). 
Our report proves that the serum protein tetranectin is detectable in dHL-60 cells via 
immunofluorescence microscopy. These results are in consistence with the report from 
Clemmensen et al., which describes the low expression of tetranectin in HL-60 cells 
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(Clemmensen et al., 1991). Although Gallagher et al. argumented that secretory vesicles might 
be absent due to the lack of alkaline phosphatase (Gallagher et al., 1979; Garattini and Gianni, 
1996), other reports indicated that granulocyte-colony stimulating factor and all-trans retinoic 
acid (ATRA) synergistically induce expression of alkaline phosphatase in a protein kinase C-
dependent manner (Taoka et al., 1993) in HL-60 cells (Gianni et al., 1994; Garattini and Gianni, 
1996; Tsuruta et al., 1999). Moreover, we provide first evidence via ELISA that serum albumin 
was present in supernatants from LPS-stimulated dHL-60 cells. 
Typically, we were able to detect an overall higher level of degranulation in primary cells than in 
dHL-60 cells upon LPS treatment. In both cells, the peak of degranulation was detected upon 
12h of LPS stimulation pointing out that dHL-60 cells represent a suitable model for 
investigating neutrophil functions. Our flow cytometry results are in line with the statement that 
in general, a wide range of different stimuli (e.g. fMLF, A23187, or PMA) has been shown to 
induce a reasonably normal degranulation response in dHL-60 cells (Meagher and Cotter, 
1988), although less high in performance compared to primary neutrophils (Newburger et al., 
1979).  
 
In our study, we clearly demonstrated that the HL-60 cell model also has the capacity for 
cytokine production and release upon pro-inflammatory conditions. Regarding the cytokine 
response in neutrophil-like HL-60 cells, surprisingly only a few reports are known so far. The 
fact that Grande et al. discovered that ATRA-treated HL-60 cells are not only differentiated but 
already highly express cytokines, similar to LPS treatment (Grande et al., 1995), strongly 
supports the use of DMSO-differentiated HL-60 cells in our experiments and to analyze the 
effect of LPS. The cytokines investigated were notably IL-1α, IL-1β, IL-6, IL-8, IL-12b, CCL2, 
CCL3, CCL4, CCL5, as well as TNFα. In accordance with our results, Spear et al. indicated that 
IL-1 production and secretion is inducible in dHL-60 cells (Spear et al., 1988). Also, Mollinedo et 
al. described the expression of a variety of cytokines and cytokine receptors, i.e. CCL3, IL-1β, 
and IL-8, in DMSO-treated HL-60 cells (Mollinedo et al., 2008).  
While cytokine peak expression was detected after 6h LPS in dHL-60 cells but after 12h LPS in 
primary cells, similar expression levels of the major neutrophil-derived cytokines were profiled in 
both cells (see Supplementary Data Manuscript II). Our study revealed, for the very first time, 
the similar behavior of human neutrophils and HL-60 cells in the cytokine response under pro-
inflammatory conditions. As the question of neutrophil purity in primary cell preparations is 
constantly raised, HL-60 cells are a suitable model to facilitate investigations on cytokine 
responses. 
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II Controversies on neutrophil-derived cytokines 
Several reports have questioned the cytokines actually released by neutrophils due to many 
challenges in the purification steps of neutrophil preparations. Therefore, the evaluation of the 
purity needs to be highly accurate and representative of the population. Out-dated studies, in 
which the purity of only a low number of the whole population was evaluated by Giemsa staining 
is not acceptable anymore (Bazzoni et al., 1991; Melani et al., 1993; Retini et al., 1996). Up-to-
date technologies, such as multicolor flow cytometry or fluorescence-activated cell sorting 
(Dorward et al., 2013), enable the highly accurate analysis of several thousand cells per 
sample.  
In our studies, neutrophils isolated from the whole peripheral blood of healthy donors were 
obtained with an elevated purity of 98.1% according to our selection criteria 
CD11b+CD66b+CD14low (see Supplementary Data Manuscript II). Monocytes and lymphocytes 
in our preparations were identified by the markers CD11b+CD66b-CD14high (0.1%) and CD11b-
CD66b-CD14- (1.8%), respectively. Contrary to recent reports that highlight the dramatic impact 
of very low percentages of monocyte contamination on cytokine secretion (Tamassia et al., 
2014), we observed that levels of secreted cytokines are similar between neutrophils highly 
purified (≥ 98%) and those purified to ≥ 90% (see Supplementary Data Manuscript II). These 
data underline the fact that 0.1% contamination of our preparation by monocytes does not 
significantly impact the high level of secretion observed for certain cytokines (e.g. IL-6, TNFα). 
This conclusion is additionally supported by the results obtained in our neutrophil-like HL-60 cell 
model for which we found comparable levels of cytokine secretion.  
 
CBA experiments illustrate that our neutrophil preparations released IL-6 up to 600 pg/mL upon 
12h of LPS treatment. IL-6 is one of the cytokines that has been regarded as a sign of monocyte 
contamination in the neutrophil preparation (Cassatella, 1995). However, many reports showed 
that human neutrophils are able to produce IL-6 (Ericson et al., 1998). Some studies using buffy 
coats with concentrated content of leukocytes for neutrophil preparations detected IL-6 
expression (Palma et al., 1992; Melani et al., 1993). Other reports argumented that i) IL-6 gene 
expression is only induced upon LPS stimulation in peripheral granulocytes (Grande et al., 
1995), ii) IL-6 is produced upon GM-CSF and TNFα stimulation (Cicco et al., 1990) or upon IL-1 
induction of the IL-6 promoter (Cahill and Rogers, 2008) implying an auto- or paracrine fashion, 
iii) a plasma component might be essential for IL-6 secretion (Oishi and Machida, 1997), and          
iv) intracellular IL-6 protein is induced after cross-linking FcγRI or FcγRII (Ericson, 1998). Melani 
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et al. reported that levels of IL-6 are variable depending on the donor, the time-lag between 
donation and purification (possibly due to the short half-life of cytokines), and that abolished IL-6 
expression in ultra-pure neutrophil preparations can be re-activated by addition of growth factors 
to the culture medium (Melani et al., 1993; Ericson et al., 1998). IL-6 synthesis is known to be 
inducible via the NF-κB signaling pathway (Libermann and Baltimore, 1990), which is generally 
activated upon LPS stimulation. In addition, variations of measured IL-6 levels can largely 
depend on the fact that many immunoassays use antibodies generated against the recombinant 
non-glycosylated form of IL-6, and thus not its glycosylated form (Taupin et al., 1997; Van den 
Steen et al., 1998). Taken together, IL-6 detection in neutrophil preparations might be highly 
variable due to the low production level, the need of various activation stimuli, the donor, and 
the detection method and conditions.  
 
Another cytokine under debate is CCL2 (MCP-1) that has first been reported not to be inducible 
in neutrophils by LPS solely (Strieter et al., 1990). Our CBA results show that neutrophil 
preparations also released CCL2 up to 300 pg/mL upon 12 h of LPS treatment. This might be 
explained by the fact that an activation event upon longer incubation periods leads to CCL2 
production in neutrophils (Burn et al., 1994), probably due to a second induction by TNFα 
(Yamashiro et al., 1999). Also, Yoshimura et al. found that CCL2 was dramatically upregulated 
by the synergistic effect of IFNγ (Yoshimura and Takahashi, 2007). In addition, reports claimed 
that LPS-activated c-Jun N-terminal and Tec kinase activity play a critical role in CCL2 
expression in neutrophils (Malcolm and Worthen, 2003; Zemans and Arndt, 2009). Similar to          
IL-6, also CCL2 might require several activation events to be synthesized by neutrophils.  
 
III Intracellular localization of cytokines in neutrophils  
Emerging evidence shows that cytokines can be packaged in cell-specific cytoplasmic granules 
before extracellular release. Immunohistological examination of neutrophils suggests that TNFα 
(Beil et al., 1995), TGFβ (Calafat et al., 1997), IL-6 (Terebuh et al., 1992; Denkers et al., 2003), 
IL-12 (Bliss et al., 2000), CXCL2 (Matzer et al., 2001) and IL-8 (Brandt et al., 2000) are stored 
within specific or gelatinase granules, or endosomal secretory vesicles. Also, Elbim et al. 
suggested that an intracellular pool of IL-10 receptors is stored in specific granules, and is 
mobilized upon pro-inflammatory conditions (Elbim et al., 2001). Kinetics of fMLF- and TNFα-
induced secretion of LTF and VEGF were found to be similar, suggesting the intracellular 
localization of this growth factor in the specific granule fraction (Gaudry et al., 1997).! 
DISCUSSION 
160 
 
 
To date, investigations on the intracellular localization of cytokines in neutrophils are still 
challenging, most probably due to the low transcriptional and translational activity of these cells. 
Two methods have revolutionized the determination of the intracellular cytokine localization in 
blood cells. Firstly, Sander et al. detected cytokines microscopically in T cells and monocytes 
upon fixation with paraformaldehyde, permeabilization with saponin, immunofluorescence 
staining with monoclonal antibodies (Sander et al., 1991). Secondly, Jung et al. then showed for 
the first time via flow cytometry how to accumulate cytokines in the Golgi by monensin treatment 
(Jung et al., 1993). Although these methods are milestones to the research field, most studies 
were solely performed on T cells and monocytes due to their high intensity of cytokine 
generation (Mascher et al., 1999). Additionally, limited availability of appropriate antibodies 
recognizing the different forms of cytokines existent in the cells (Schauer et al., 1996) does not 
facilitate the investigations, and the number of alternative methods is restricted. For example, 
subcellular fractionation experiments show substantial limitations in resolution (Pasquali et al., 
1999).  
 
In order to provide a robust guideline to investigate the spatial regulation of neutrophil cytokine 
release, we developed a linear fitting approach on 6 different stimulation time points ranging 
from 0 to 24h (see Manuscript I). Since neutrophils have been recognized to exert combinatorial 
effects of their functions during inflammation, the correlation between kinetics of LPS-induced 
cytokine secretion and degranulation represents an interesting tool for further investigations on 
the potential localization of cytokines in granules. As an example, many cytokines that are 
synthesized as precursor forms need to be cleaved to become biologically active. In this sense, 
MMP-9 from gelatinase granules leads to specific processing and release of cytokines,               
e.g. IL-1β, TNFα, IL-8 (Vaday et al., 2001). Therefore, the release of granules and cytokines 
must be highly time-regulated in order to efficiently exert the combinatorial effects. 
Traditionally, neutrophils have been seen as stores of preformed granules, and degranulation 
has been believed to mainly occur in a short-time range, meaning within maximally 2h upon 
stimulation (Bentwood and Henson, 1980). However, this assumption needs to be balanced 
since granule mobilization differs on the agonist used (e.g. fMLF, PMA) and its applied 
concentration. Our results show that degranulation in neutrophils behaves not only in a time- but 
also concentration-dependent manner and could thus account for the differential mobilization of 
the readily and slowly releasable granule pools towards the extracellular milieu (see Manuscript 
I). In line with our results, previous reports already showed that upon LPS stimulation, a 
concentration-dependency could be observed within neutrophil microbial activity. LTF release 
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from neutrophils varied with the concentration of LPS (1 to 1000 ng/mL) as well as with the 
duration of incubation (2 to 60 min) (Koivuranta-Vaara et al., 1987). Our data demonstrates that 
upon LPS stimulation, the biggest release occurs far later than after 2h, and behaves similarly to 
the release of cytokines (see Manuscript I). Additionally, we observed that MMP-9 mRNA 
expression was significantly upregulated upon LPS stimulation of dHL-60 cells pointing out that 
neutrophil-specific granule proteins are also de novo synthesized (see Supplementary Data 
Manuscript II). Over the years, the concept of subdivided pools of granules has become largely 
accepted (Martin, 2002; Cassatella et al., 2006; Pellme et al., 2006) and overlaps with the 
recently described role of granule-specific proteins in the modulation of innate and adaptive 
immune responses (Wessels et al., 2010).  
In a similar fashion, time-course analysis with LPS resulted in early and late cytokine responses 
(Tsukahara et al., 2003). On one hand, among the early responding agonists, we found that the 
secretion of TNFα, CCL3 and IL-1β is maximal at 6h. On the other hand, CCL2, CCL4, IL-6 and 
IL-8 secretion is obtained at later time points (see Manuscript I). This time-regulated cytokine 
secretion from neutrophils is largely dependent on a previous accumulation of the 
corresponding mRNA transcripts (Bazzoni et al., 1991) and LPS-triggered protein synthesis that 
is under the control of MAP kinase-interacting serine/threonine-protein kinase 1 (MNK1) (Fortin 
et al., 2011). The release of TNFα, CCL3 and IL-1β might be due to the direct rapid 
transcriptional and/or translational effect of LPS (DeForge and Remick, 1991). A second 
delayed phase involving CCL2, CCL4, IL-6 and IL-8 secretion, depending on protein synthesis, 
could derive from the endogenous production of neutrophil-derived agonists acting in an auto- 
or paracrine manner and promoting the sequential generation or/and simply the secretion of 
pro-inflammatory mediators at longer stimulation points (Cassatella, 1995). In accordance with 
our results, TNFα, and IL-1β have been described to increase IL-8 production and release by 
human neutrophils (Cassatella et al., 1993; Ethuin et al., 2001) and CCL2 has been found to be 
selectively expressed in the delayed phase by cytokine-stimulated neutrophils (Yamashiro et al., 
1999).  
Upon analysis of LPS-induced kinetics of degranulation and cytokine release in neutrophils, we 
found that the IL-8 release is successfully fitted to the release of secretory vesicles, gelatinase 
granules and specific granules (see Manuscript I). This example underlines the importance of 
the time-regulated release of cytokines and granules, and thus the concurrent release into the 
inflammatory environment. Our linear fitting approach demonstrates that the exocytosis of 
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granules and cytokines is similarly regulated. The SNARE machinery present in our cells and its 
importance in the regulation of neutrophil functions is discussed in the next section.  
 
IV SNAREs in the regulation of neutrophil cytokine 
secretion and degranulation 
Over the last years, the involvement of SNAREs in immunological processes has been of great 
research interest due to its significant impact on the proper functioning of platelets (e.g. 
Flaumenhaft et al., 1999; Chen et al., 2000), mast cells (e.g. Paumet et al., 2000; Vaidyanathan 
et al., 2001), macrophages (e.g. Bajno et al., 2000; Pagan et al., 2003), eosinophils (e.g. Lacy 
et al., 2001; Logan et al., 2006), as well as plasma cells (Reales et al., 2005). In neutrophil 
functions, SNAREs have also been implicated in the regulated secretory pathway during 
inflammation (e.g. Mollinedo et al., 2006). While most of the studies focused on the role of 
SNAREs in degranulation, knowledge about their contribution to cytokine secretion is limited.  
To facilitate investigations on neutrophil functions, we profiled SNARE expression in dHL-60 
cells, and confirmed its similar profile expression in primary neutrophils. Our results showed that 
the transcripts of the Qa-SNAREs STX2-12, 16-18, the Qb,c-SNAREs SNAP23 and SNAP29; 
and the R-SNAREs VAMP1-5, 7-8 are expressed in HL-60 cells. These findings are largely 
overlapping with the report from Martín-Martín et al. in which STX1A, 3-7, 9-11, and 16 are 
expressed (Martin-Martin et al., 1999). Further, only the upregulation of STX3 and STX11 was 
detected along HL-60 differentiation, in addition to VAMP1. Moreover, STX2, STX18 and 
VAMP5 transcripts were not expressed in human neutrophils and thus neglected in our 
investigations. In line with our results, Mollinedo observed that the secretory capacity of HL-60 
cells was greatly increased during the differentiation process, and several exocytosis-related 
genes, i.e. SNAREs, were upregulated in parallel (Mollinedo et al., 2008). Also, Xie et al. 
demonstrated that the level of STX3, 4, 6 and 11 was increased upon DMSO (Xie et al., 2009).  
However, mRNA expression levels of SNAREs do not necessarily reflect the relative protein 
expression levels. Even though mRNA levels of SNAP23 and SNAP29 were not upregulated 
upon DMSO differentiation of HL-60 cells, in agreement with Mollinedo et al. (Mollinedo and 
Lazo, 1997), we found that SNAP23 protein was upregulated upon DMSO differentiation in          
HL-60 cells.  
Although previous studies reported that LPS could induce rapid down- or upregulation of 
SNARE expression in cells (e.g. Pagan et al., 2003; Murray et al., 2005), we did not observe 
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this dramatic change in expression upon LPS stimulation. In other words, LPS did not induce 
upregulation of STX3 expression (data not shown), suggesting that the trafficking machinery 
needs already to be set ready for action upon differentiation of HL-60 cells. 
 
In dHL-60 cells, we could determine the role of the Qa-SNARE STX3 in the release of the 
cytokines IL-1α, IL-1β, CCL4 and IL-12b, as well as the granule protein MMP-9. In accordance 
with our previous study, the linear fitting approach indicates that IL-1α belongs to secretory 
vesicles, gelatinase and specific granules, IL-1β to secretory vesicles, and CCL4 to specific 
granules. IL-12b however could not be fitted with high RSQ value (see Manuscript I). STX3 
siRNA induced different inhibition levels on the release of the cytokines and MMP-9. These 
results are clarified by the fact that STX3, localized to gelatinase granules and secretory 
vesicles, could affect the release of differentially distributed cytokines in the granules. The fact 
that CCL4 secretion is also influenced by STX3, although specific granules are absent from 
dHL-60 cells, could be explained by a possible relocalization towards other granules in the 
cellular model. Taken together, these results could indicate the existence of a pathway in which 
cytokines are transferred to, or are located in neutrophil-specific granules.  
The localization of STX3 in gelatinase granules and secretory vesicles under non-stimulated as 
well as LPS-stimulated conditions showed that STX3 was not translocated to another organelle. 
This statement does not collide with our previous results identifying the functional role of STX3 
in cytokine release and degranulation, since STX3 belongs to the subfamily of Qa- or also t-
SNAREs. This means that neutrophil granules represent the resident compartment of STX3 
(Brandhorst et al., 2006), and that STX3 does not need to be relocalized to fulfill its role in 
neutrophil functions. 
 
It is important to note that STX3 alone is not sufficient to mediate trafficking specificity. 
According to Bethani et al., each fusion step of the secretory pathway requires a specific set of 
SNAREs (Bethani et al., 2007). Therefore, SNARE partners that form complexes with STX3 and 
lead to the specific release of these pro-inflammatory mediators need to be uncovered (Martin-
Martin et al., 2000; Mollinedo et al., 2006). Our results show that the only Qb,c-SNAREs 
expressed in neutrophil-like HL-60 cells and neutrophils are SNAP23 and SNAP29. Since its 
discovery in neuronal cells, SNAP25 has always been regarded to be exclusively expressed in 
brain tissue (Brumell et al., 1995). Although SNAP25 expression has been reported in 
neutrophils (Nabokina et al., 1997), we could neither detect the expression of this Qb,c-SNARE 
in our cell model nor in primary neutrophils (data not shown).  
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To uncover the identity of potential SNARE proteins that interact with STX3, we performed 
immunoprecipitation experiments and applied a proteomics approach using mass spectrometry.  
Although in vitro studies could provide evidence that STX3 interacts with SNAP29 (Steegmaier 
et al., 1998), the difficulty of reproducibility to detect SNAP29 upon STX3 pull-down in dHL-60 
and neutrophil total lysates can be clarified by the fact that the Qb,c-SNARE SNAP29 is the 
lowest expressed SNARE detected in our cells (data not shown). Bethani et al. demonstrated 
that in case individual SNAREs are not present in stoichiometric amounts, co-
immunoprecipitation of SNAREs might be inappropriate to be used as evidence for their 
functional interaction in a fusion event (Brandhorst et al., 2006). Given the fact that quantitative 
precipitation of STX3 with monoclonal antibody brings down a little fraction of the SNAP29 pool, 
it is conceivable that this fraction can be difficult to detect and might also explain our unfruitful 
proteomics analysis.  
While SNAP29 has already been localized to the Golgi (Hohenstein and Roche, 2001), plasma 
membrane and endocytic compartments (e.g. Wesolowski et al., 2012), it was colocalized with 
STX3 on cytoplasmic granules in dHL-60 cells and neutrophils. Interestingly, SNAP29 is one of 
the SNAP25 homologues that lacks a membrane anchor (Steegmaier et al., 1998) but is 
capable to bind to a variety of syntaxins. Since the intracellular localization of SNAP29, similar 
to the one of STX3, does not change upon LPS stimulation, we can conclude that the resident 
compartment of SNAP29 is also referred to gelatinase granules and secretory vesicles 
(Brandhorst et al., 2006).  
Colocalization studies showed that also Qb,c-SNAREs SNAP23 shares common localization with 
STX3 in dHL-60 cells and human neutrophils (data not shown). On one hand, concerning the 
antibody-labeling of SNAP23, our results are in accordance with previous studies in which 
SNAP23 was primarily located in specific and gelatinase granules in neutrophils (Martin-Martin 
et al., 2000). Uriarte et al. already investigated the role of this Qb,c-SNARE by introducing a TAT-
SNAP23 fusion protein into primary neutrophils (Uriarte et al., 2011). By this treatment, they 
discovered inhibited exocytosis of granules in neutrophils. As we could not detect any effect of 
SNAP23 on the release of granules, and postulate that SNAP23 might form “non-cognate” 
SNARE complexes with no functional cross-talk (Bethani et al., 2007). Observations from 
Uriarte et al. can be explained by the assumption that increased abundance of SNAP23 protein 
might result in unbalanced stoichiometric amounts and thus lead to the formation of artificial 
SNARE complexes preventing other SNAREs from doing their work. In contrast, according to 
our analyses, STX3 and SNAP29 act together in the release of the cytokine IL-12b, as well as 
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MMP-9. We assume that the formation of so-called “cognate” SNARE complexes implicating 
STX3 and SNAP29 occurs at the level of cytoplasmic granules.  
The knockdown of the Qb,c-SNARE SNAP29 alone impacted the release of the cytokines IL-8, 
IL-12b, and CCL2, as well as the granule protein MMP-9. Hence, we hypothesize that SNAP29 
must act in other SNARE configurations without STX3 in the release of IL-8 and CCL2. In 
accordance with our previous study, the linear fitting approach indicates that IL-8 belongs to 
secretory vesicles, gelatinase and specific granules. However, IL-12b and CCL2 could not be 
fitted with high RSQ value to any granule marker (see Manuscript I). In this scenario, SNAP29 
localized to gelatinase granules and secretory vesicles could affect the release of IL-8, fitted to 
the same granule types in addition to specific granules in human neutrophils. Similar to the case 
of STX3, these results could indicate the existence of a pathway in which cytokines are 
transferred to, or are located in neutrophil-specific granules.  
 
In the last part of our study, we targeted VAMP3 to reveal if this R-SNARE is implicated in the 
STX3-SNAP29-mediated release of IL-12b and MMP-9. Our RNAi approach against VAMP3 led 
to the inhibited secretion of the cytokines CCL4 and IL-8, as well as the granule protein MMP-9. 
The intracellular localization of VAMP3 could be determined to be at the plasma membrane in 
dHL-60 cells. According to these results, we could assume that VAMP3 is interfering with 
cytokine release and degranulation at the “very last station” before exocytosis. Interestingly, as 
an R-SNARE generally localized at the vesicle membrane before fusion according to the 
SNARE hypothesis, it is quite surprising to find VAMP3 at the plasma membrane. This might be 
explained by the fact that VAMP3 has often been implicated in endocytic pathways (e.g. 
McMahon et al., 1993) in the recycling of the transferrin receptor (Galli et al., 1994; Daro et al., 
1996). Therefore, VAMP3 could be seen as having a dual role in the endocytic cycle and 
represent an interesting candidate for further investigations in neutrophil functions. 
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General Conclusion and Perspectives 
In the present study, we outlined the regulatory release mechanisms of neutrophil pro-
inflammatory mediators, with emphasis on the role of SNARE fusion proteins. Our results 
consist of the following points:  
! Generation of a linear fitting approach between similar kinetics of neutrophil cytokine 
secretion and degranulation, that can be used as a basis model for investigating spatial 
regulation of neutrophil cytokines,  
! Determination of the requirement of  
o the Qa-SNARE STX3 for the release of IL-1α, IL-1β, IL-12b, and CCL4,  
o the Qb,c-SNARE SNAP29 for the release of CCL2, IL-12b, and IL-8,  
o the R-SNARE VAMP3 for the release of CCL4 and IL-8,  
o STX3, SNAP29 and VAMP3 in MMP-9 exocytosis from gelatinase granules, 
! Identification of the intracellular localization of STX3, together with SNAP29, in gelatinase 
granules and secretory vesicles; and VAMP3 at the plasma membrane, 
! Exclusion of the R-SNARE VAMP3 as a candidate for being part of the STX3-SNAP29 
complex. 
A summarized view of the hypothetical SNARE-mediated trafficking pathways in dHL-60 cells is 
depicted in Figure 12. To conclude, this study describes for the first time a functional role of 
SNARE proteins, notably STX3, SNAP29 and VAMP3, in cytokine release in a cellular model for 
neutrophils. Due to their additional implication in gelatinase degranulation, this study speculates 
on the intracellular localization of cytokines in granules before exocytosis.  
 
Nevertheless, some questions on the regulatory mechanisms of neutrophil functions remain 
open.  
How can the linear fitting approach be improved to investigate LPS-mediated 
degranulation and cytokine release? The linear fitting approach could be improved by adding 
additional parameters that respect the endocytosis rate of the granule-specific membrane 
receptors from the plasma membrane, the half-lives of the cytokines in the extracellular milieu, 
the intracellular content of cytokines as well as of granules.  
Do STX3, SNAP29 and VAMP3 have the same functional role in primary neutrophils as in 
dHL-60 cells? Functional studies on primary neutrophils are still challenging due to purification 
steps, limited manipulation tools, short half-life, and low transcriptional activity. We performed 
transduction of primary neutrophils with lentiviral short-hairpin RNA (shRNA)-containing 
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constructs targeting STX3 but did not yield in sufficiently high percentages of positively 
transduced cells (3% of positively transduced neutrophils with lentiviral particles at MOI=3 upon 
6h incubation with polybrene, data not shown). A new challenging approach could include the 
transduction of precursor cells, and the subsequent differentiation to mature neutrophils. 
Do cytokines localize in, or are they translocated to neutrophil-specific granules for 
simultaneous exocytosis upon inflammation? To determine the localization of cytokines in 
neutrophils, the mediators could be stained intracellularly and subsequently analysed via flow 
cytometry. This method is also challenging due to the low content of cytokines but promising 
due to recent advances in this field (e.g. antibodies with high specificity and affinity, 
permeabilisation methods). Also, the localization of cytokines in different vesicle pools and the 
subsequent SNARE-regulated release upon stimulation could be visualized by total internal 
reflection fluorescence (TIRF) microscopy. 
Are STX3, SNAP29 and VAMP3 post-translationally modified under pro-inflammatory 
conditions? Several SNAREs need to be post-translationally modified to successfully interact 
with other SNARE proteins or regulators (Craig et al., 2003) and thus lead to vesicle trafficking. 
Mass spectrometry results have already predicted that i) STX3 possesses a phosphorylation 
site at serine 206, while ii) VAMP3 shows 7 different sites, and iii) SNAP29 even 23 different 
sites.  
Do STX3, SNAP29 and VAMP3 depend on intracellular Ca2+ mobilization in order to be 
regulated? Intracellular Ca2+ concentrations have been implicated in the differential release of 
granule types, in the orientation of opposing bilayers before membrane fusion, as well as in the 
requirement for regulatory proteins (such as synaptotagmins, Munc proteins). Under the pro-
inflammatory conditions used for our experiments, the induction of intracellular Ca2+ mobilization 
(e.g. by spectrofluorimetry, flow cytometry, or confocal microscopy), as well as the implication of 
regulatory proteins in this scenario could be investigated in more details. 
Which are the still unknown and remaining SNARE interactors of STX3, SNAP29 and 
VAMP3 for specificity of trafficking? In a first attempt, we performed co-immunoprecipitation 
experiments and analysis by mass spectrometry to find SNARE interaction partners of STX3, 
and had many difficulties for detecting SNAP29 due to its low expression level and the huge 
amount of cells needed for investigations. Therefore, the proximity-ligation analysis provides an 
alternative approach with higher sensitivity, and specificity. The same approach can be applied 
for identifying SNARE partners of SNAP29 and VAMP3.  
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The molecular mechanisms underlying exocytotic pathways in neutrophils are complex and 
have been largely unknown so far. In this scientific work, we provide evidence that the SNAREs 
STX3, SNAP29 and VAMP3 are implicated in neutrophil degranulation and cytokine release. 
Further experiments will be necessary to identify the unknown SNARE players that act in 
configuration with the three candidates and specifically lead to trafficking during inflammation.  A 
deeper understanding of the SNARE-regulated processes in neutrophils will help to determine 
new potential pharmacological targets in chronic inflammatory diseases that could prevent the 
release of mediators into the pro-inflammatory environment. 
 
!
Figure 12 Hypothetical SNARE-mediated trafficking in cytokine release and degranulation in dHL-60 cells.  
The scheme summarizes the implication of (1) STX3 and SNAP29 in the release of MMP-9 and IL-12b (with unknown 
R-SNARE), (2) STX3 in the release of IL-1α, IL-1β, and CCL4 (with unknown Qb,c- and R-SNARE), (3) VAMP3 
located at the plasma membrane in the release of CCL4 and IL-8 (with unknown Qa- and Qb,c-SNARE), (4) SNAP23 
in the release of IL-8 (with unknown Qa- and R-SNARE), and (5) SNAP29 in the release of IL-8 and CCL2 (with 
unknown Qa- and R-SNARE). 
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